Genome-wide analyses of expression data and HIF-1 binding sites provide insights to the HIF-1 hypoxia-inducible factor in Caenorhabditis elegans by Feng, Dingxia
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2013
Genome-wide analyses of expression data and
HIF-1 binding sites provide insights to the HIF-1
hypoxia-inducible factor in Caenorhabditis elegans
Dingxia Feng
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Biology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Feng, Dingxia, "Genome-wide analyses of expression data and HIF-1 binding sites provide insights to the HIF-1 hypoxia-inducible
factor in Caenorhabditis elegans" (2013). Graduate Theses and Dissertations. 13324.
https://lib.dr.iastate.edu/etd/13324
Genome-wide analyses of expression data and HIF-1 binding sites provide 
insights to the HIF-1 hypoxia-inducible factor in Caenorhabditis elegans 
 
 
 
by 
 
 
Dingxia Feng 
 
 
 
A dissertation submitted to the graduate faculty 
 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
 
Major: Genetics 
 
Program of Study Committee: 
Jo Anne Powell-Coffman, Major Professor 
Thomas Peterson  
Yanhai Yin  
Peng Liu  
Drena Dobbs 
Jeffrey Essner 
 
 
 
Iowa State University 
Ames, Iowa 
2013 
 
Copyright © Dingxia Feng, 2013. All rights reserved. 
 
 
 
 
ii 
 
 
 
TABLE OF CONTENTS 
 
CHAPTER 1. GENERAL INTRODUCTION ..................................................................... 1 
 
Literature Review ............................................................................................................... 4 
C. elegans HIF-1 and low oxygen adaptation ................................................................... 4 
HIF-1 has other functions besides hypoxia response in C. elegans .................................. 5 
Regulation of HIF-1 stability and activity in C. elegans .................................................. 8 
Other key stress responsive pathways in C. elegans....................................................... 10 
Thesis Organization .......................................................................................................... 11 
References .......................................................................................................................... 13 
Figure Legends .................................................................................................................. 22 
 
CHAPTER 2. SKN-1 INHIBITS THE HIF-1 HYPOXIA-INDUCIBLE FACTOR ...... 23 
 
Abstract .............................................................................................................................. 23 
Introduction ....................................................................................................................... 24 
Materials and Methods ..................................................................................................... 26 
Strains ............................................................................................................................. 26 
RNAi screen .................................................................................................................... 26 
Hypoxia stress and oxidative stress assays ..................................................................... 27 
Pegl-9:GFP expression constructs ................................................................................. 27 
Protein Blots.................................................................................................................... 28 
RNA extraction and real-time quantitative RT-PCR ...................................................... 28 
Results ................................................................................................................................ 28 
skn-1 attenuates HIF-1 protein levels and HIF-1 function .............................................. 30 
Differential requirements for skn-1 and hif-1 ................................................................. 30 
SKN-1/NRF promotes egl-9 expression ......................................................................... 31 
Separate and overlapping functions for SKN-1 and HIF-1 ............................................ 33 
Discussion........................................................................................................................... 34 
SKN-1 promotes egl-9 expression, thereby inhibiting HIF-1 ......................................... 34 
RNAi screen identifies genes that regulate nhr-57 expression ....................................... 36 
References .......................................................................................................................... 37 
Figure Legends .................................................................................................................. 41 
 
CHAPTER 3. TRANSCRIPTOME ANALYSES OF HIF-1 OVER-ACTIVATION .... 48 
 
Abstract .............................................................................................................................. 48 
Introduction ....................................................................................................................... 48 
Materials and Methods ..................................................................................................... 52 
Strains ............................................................................................................................. 52 
Gene expression microarray experiment and data analysis ............................................ 52 
Heat map ......................................................................................................................... 53 
Microarray datasets comparisons .................................................................................... 54 
iii 
 
Hypoxia survival and development assay ....................................................................... 54 
Results ................................................................................................................................ 54 
Transcriptional phenotypes of vhl-1, rhy-1, egl-9, and swan-1; vhl-1 ............................ 54 
Convergence of HIF pathway and pathogen immune response pathways ..................... 57 
HIF-1 and DAF-16 function synergistically in hypoxia resistance ................................ 59 
Discussion........................................................................................................................... 61 
RHY-1, EGL-9 and SWAN-1 function in common pathway(s) to regulate HIF-1 ........ 62 
The diverse cellular processes regulated by HIF-1 may account for its diversified 
functions .......................................................................................................................... 62 
Insights to other SWAN-1 and EGL-9 functions ............................................................ 63 
HIF-1 interacts with DAF-16 to regulate hypoxia survival ............................................ 63 
References .......................................................................................................................... 64 
Figure Legends .................................................................................................................. 69 
 
CHAPTER 4. GENOME-WIDE PROFILING OF HYPOXIA-INDUCED GENES ..... 79 
 
Abstract .............................................................................................................................. 79 
Introduction ....................................................................................................................... 79 
Materials and Methods ..................................................................................................... 81 
Strains ............................................................................................................................. 81 
Gene expression microarray experiment and data analysis ............................................ 81 
Consensus motifs at the promoters of HIF-1 dependent genes under hypoxia............... 83 
HIF-1 chromatin immunoprecipitation (ChIP) ............................................................... 83 
ChIP-Seq library preparation and sequencing ................................................................ 86 
ChIP-Seq data analysis ................................................................................................... 86 
Heat map ......................................................................................................................... 87 
Microarray datasets comparisons .................................................................................... 88 
RNA interference ............................................................................................................ 88 
Hypoxia survival and development assay ....................................................................... 88 
Results ................................................................................................................................ 89 
Identification of genes that respond to 2 hours hypoxia (0.5% oxygen) ........................ 89 
HIF-1 regulates metabolism, stress response and other functions under hypoxia .......... 93 
Effects of HIF-1-dependent hypoxia-responsive genes in hypoxia adaptation .............. 95 
Genes regulated by HIF-1 overlap with genes regulated by H2S ................................... 97 
Genes regulated under hypoxia overlap with genes regulated by DAF-16 .................... 98 
Identification of HIF-1 direct targets by ChIP (chromatin immunoprecipitation) ......... 98 
Discussion......................................................................................................................... 100 
Refined understanding of HIF-1 target genes ............................................................... 100 
HIF-1 directly regulates efk-1 to inhibit protein translation in hypoxia? ...................... 102 
Limitations of the ChIP assay in this study and improvement in the future ................. 104 
Gene expression difference in short-term hypoxia and constitutive HIF-1 activity ..... 104 
References ........................................................................................................................ 105 
Figure Legends ................................................................................................................ 110 
 
CHAPTER 5. GENERAL CONCLUSION ...................................................................... 119 
 
iv 
 
Summary .......................................................................................................................... 119 
General Discussion .......................................................................................................... 121 
Hypoxia resistance and survival ................................................................................... 122 
Gene expression profiles in response to 2 hours and 4 hours of hypoxia ..................... 123 
The complexity of the cross talk between HIF-1 and SKN-1 in C. elegans ................. 124 
The cross talk between HIF-1 and DAF-16 in C. elegans ............................................ 127 
Understanding why HIF-1 has multiple functions in C. elegans .................................. 129 
The limitations of the ChIP-seq analysis in this dissertation ........................................ 131 
References ........................................................................................................................ 133 
Figure Legends ................................................................................................................ 145 
 
1 
 
 
 
 CHAPTER 1. GENERAL INTRODUCTION 
Oxygen is an essential molecule to all the aerobic organisms. Aerobic respiration supplies 
the majority of the energy for most animals and provides the appropriate redox environment for 
the cellular biochemical reactions. Oxygen acts as the electron acceptor during the oxidative 
phosphorylation electron transport. To maintain oxygen homeostasis, vertebrates evolved 
sophisticated respiratory and circulatory systems to deliver oxygen (NYSTUL and ROTH 2004; 
SEMENZA 1999; SEMENZA 2012a). 
During normal development and homeostasis, organisms are often challenged by low 
oxygen (hypoxia). Understanding the molecular mechanisms by which organisms respond to 
hypoxia can also help with the treatment of hypoxia related diseases, such as cancer, ischemia, 
stroke and cardiac failure. In metazoans, the transcription factor HIF (hypoxia inducible factor) 
mediates the majority of transcriptional responses to hypoxia. HIF is conserved and expressed by 
all extant metazoan species analyzed to date (LOENARZ et al. 2011; SEMENZA 2000a; SEMENZA 
2012a). Under hypoxia, mammalian HIF target genes increase red blood cell production and 
angiogenesis, modify the extracellular matrix, regulate glucose metabolism, or contribute to 
cellular survival in stressful conditions (PFANDER et al. 2003; SEMENZA 1998; SEMENZA 1999; 
SEMENZA 2000b; SEMENZA 2001; SEMENZA 2009; SEMENZA 2010; SEMENZA 2011a; SEMENZA 
2011b; SEMENZA 2012a; SEMENZA 2012b; SEMENZA et al. 1996; SURAZYNSKI et al. 2008; 
WENGER 2002). Mammalian HIF is heterodimeric, composed of an α subunit and a β subunit, 
which are both bHLH (basic-helix-loop-helix)-PAS (PER/ARNT/SIM) domain proteins 
(SEMENZA 2012a; WANG et al. 1995). The human genome encodes three homologous HIFα 
proteins: HIF-1, -2 and -3α, and three ARNT/HIFβ proteins: HIF-1, -2 and -3β (SEMENZA 1999; 
TAKAHATA et al. 1998). While HIFβ has multiple bHLH-PAS (SCHOFIELD and RATCLIFFE 
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2004)dimerization partners and is relatively abundant, HIFα is short-lived under well-oxygenated 
conditions. Thus, HIFα is apparently dedicated to regulate oxygen-sensitive gene expression 
(BERRA et al. 2006; KAELIN and RATCLIFFE 2008; SEMENZA et al. 1996). 
Because of the importance of the HIF complex, regulation of the stability and activity of 
this protein is intensively studied in mammals. When the oxygen level is high, the PHD/EGL-9 
family of deoxygenases hydroxylate specific proline residues of HIFα, using oxygen and 2-
oxoglutarate as co-substrates. An ubiquitin E3 ligase, VHL (von Hippel-Lindau tumor 
suppressor), binds the hydroxylated HIFα and targets it for proteasomal degradation. This 
oxygen-dependent HIFα degradation pathway is well studied and conserved in metazoans 
(BERRA et al. 2006; EPSTEIN et al. 2001; JIANG et al. 2001a; KAELIN and RATCLIFFE 2008; 
SEMENZA 2001; SEMENZA 2011b; SEMENZA 2012a; SHEN et al. 2005a). Two VHL and oxygen-
independent HIFα degaradation pathways were also indentified. One pathway is that heat shock 
protein HSP90 and RACK1 competitively bind HIFα to either stabilize or promote HIF-1α 
degradation (LIU et al. 2007). The other pathway is that in breast cancer, SHARP1 binds to HIF 
α and presents it to proteasome in both normoxic and hypoxic conditions (MONTAGNER et al. 
2012). Previous studies have indicated that HIF α activity is tightly regulated, too. Besides 
hydroxylating HIF-1α for degradation in normoxia, PHD2 represses HIF-1α transcriptional 
activity in hypoxia (TO and HUANG 2005). However, the mechanism is not well known.  
Our lab uses C. elegans as a model organism to understand HIF-1 function and 
regulation. C. elegans do not have complex respiratory and circulatory systems; they rely on 
diffusion to deliver oxygen to 959 somatic cells and a variable number of germ cells in its gonad. 
C. elegans is a soil nematode. And in the wild, it is found on rotting vegetation (FELIX and 
DUVEAU 2012). Environmental oxygen might be limited in natural habitats enriched for 
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microbial food. However, in the lab, C. elegans are usually maintained on top of agar plates with 
only a thin lawn of bacterial food and in room air. The general strength for this system includes 
small body size, big brood size, ease of culture, populations of self-fertile hermaphrodites and 
males, short generation time, transparency and relatively easy forward and reverse genetics 
(POWELL-COFFMAN 2010; SHEN and POWELL-COFFMAN 2003). In terms of HIF function and 
regulation study, this system has other advantages. The genes and pathways that govern the 
oxygen-dependent stability of HIF-1 are conserved, while the corresponding counterparts are 
simplified in C. elegans. For example, C. elegans has a single HIFα homologue, termed HIF-1; 
and a single HIFβ homologue, termed AHA-1. And while mammals have three paralogous 
PHDs, C. elegans has one homolog, termed EGL-9. The single VHL homolog in C. elegans is 
VHL-1. This reduced complexity of the HIF pathway facilitates genetic analysis (EPSTEIN et al. 
2001; JIANG et al. 2001a; POWELL-COFFMAN 2010; POWELL-COFFMAN et al. 1998). Further, 
while the hif-1α -/- mouse dies by E9.0 with severe vascular defects (IYER et al. 1998; RYAN et 
al. 1998), C. elegans hif-1(ia04) loss-of-function mutants are viable under normal conditions, 
although they fail to adapt to hypoxia (0.5% or 1% oxygen) (JIANG et al. 2001a; PADILLA et al. 
2002). 
In my thesis study, I used C. elegans as a model to investigate HIF-1 function and the 
network regulating HIF-1. My studies have provided insights to the cross talk between the 
oxidative stress responsive transcription factor SKN-1/NRF and the hypoxia responsive 
transcription factor HIF-1. Using Affymetrix microarray, we were able to comprehensively 
define the molecular phenotypes of four known HIF-1 negative regulators mutants. We measured 
the genome-wide mRNA expression under short-term hypoxia treatment (2 hours, 0.5% oxygen). 
We compared the hypoxia response difference between wild-type animals and hif-1 mutants to 
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understand HIF-1 dependent short-term hypoxia response. Combining genome-wide gene 
expression studies with ChIP-seq, we identified potential HIF-1 direct targets.    
Literature Review 
C. elegans HIF-1 and low oxygen adaptation 
For C. elegans, hypoxia was defined as 0.1% to 2% oxygen (NYSTUL and ROTH 2004; 
VAN VOORHIES and WARD 2000). C. elegans kept moving and feeding on the plates seeded with 
bacterial food until the oxygen concentration dropped to 2%. At this oxygen concentration, 
worms stopped feeding and tried to escape from the plates (NYSTUL and ROTH 2004). C. elegans 
could survive 24 hours low oxygen treatment with more than 90% viability if the oxygen 
concentration was higher than 0.1%. If the oxygen concentration dropped to 0.1%, the viability 
dramatically decreased to only 2%. Interestingly, C. elegans can survive 24 hours anoxia at 20°C 
(<0.001% oxygen) by entering into a suspended animation. In the suspended animation state, C. 
elegans ceases microscopically observable activity including cell division and development 
process (PADILLA et al. 2002). In this way, the viability under anoxia was as high as 88% 
(FAWCETT et al. 2012; NYSTUL and ROTH 2004; VAN VOORHIES and WARD 2000). However, C. 
elegans did not survive well under the intermediate concentrations of oxygen, between 0.01% - 
0.1% oxygen, the viability was around 2% - 28% (FAWCETT et al. 2012; NYSTUL and ROTH 
2004). Also, extended anoxia or high temperature anoxia kills worms (ANDERSON et al. 2009; 
MABON et al. 2009a; MABON et al. 2009b; MAO and CROWDER 2010; MENDENHALL et al. 2006; 
PADILLA et al. 2002; SCOTT et al. 2002). 
The HIF transcriptional complex was conserved in C. elegans (EPSTEIN et al. 2001; 
JIANG et al. 2001a; POWELL-COFFMAN et al. 1998). The corresponding HIFα and HIFβ 
homologues are HIF-1 and AHA-1 (JIANG et al. 2001a; POWELL-COFFMAN et al. 1998). AHA-1 
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protein levels were constant, regardless of the oxygen concentration. In contrast, HIF-1 protein 
levels changed in response to the oxygen levels. In the room air, HIF-1 protein levels were low. 
Hypoxia treatment (0.1% or 1% oxygen) increased HIF-1 protein levels. However, upon 
reoxygenation, HIF-1 was degraded within 8-10 minutes (EPSTEIN et al. 2001; JIANG et al. 
2001a; TREININ et al. 2003).  
HIF-1 is required for worms to survive mild hypoxia (0.25%–1 % oxygen), treating the 
eggs with 0.5% oxygen for 24 hours caused less than 10% of the eggs to develop to adults (JIANG 
et al. 2001a; NYSTUL et al. 2003; PADILLA et al. 2002). C. elegans were able to survive anoxia 
(<0.001% oxygen) without requiring the function of HIF-1 by entering into a suspended 
animation. Under this condition, the adult worms arrested reproductive activities and suspended 
the development of embryos in the uterus. Although anoxia induced diapause did not require 
HIF-1 activity, neuronal HIF-1 activity determined the oxygen concentration at which embryos 
enter into diapauses. While in hif-1 loss-of-function mutants, the embryos initiated diapauses at 
0.5% oxygen, wild type embryos arrested at 0.1% oxygen (MILLER and ROTH 2009). Using two-
color microarray, our prior study identified 62 mRNAs that were differentially regulated by HIF-
1 in response to 4 hours 0.1% oxygen treatment in L3-stage worms (SHEN et al. 2005a). 
Mutations of some of these genes reduced the ability of C. elegans to develop to adulthood after 
24 hours 0.5% oxygen treatment (SHEN et al. 2005a). 
HIF-1 has other functions besides hypoxia response in C. elegans 
With research continued, HIF-1 was found to have other functions apart from enabling 
adaption to hypoxia in C. elegans. Heat acclimation (25°C, 18 hours) protected worms from 
severe heat stress (35°C), sodium azide treatment and heavy metal stress (cadmium) (TREININ et 
al. 2003). HIF-1 is required for this heat acclimation. Mutations increasing HIF-1 protein level 
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enhanced the heat tolerance of worms (TREININ et al. 2003). Interestingly, mammalian HIF 
complexes are also implicated in heat acclimation responses (SHEIN et al. 2005).  
HIF-1 is also involved in dauer formation, worms carrying a strong loss-of-function 
mutation in hif-1 were shown to form partial dauer at 27°C (SHEN et al. 2005a). Dauer is an 
arrested developmental stage of worms. Under favorable conditions, C. elegans larvae develop 
through L1, L2, L3 and L4 stages and enter the reproductive adult stage. However, when the 
environment is unfavorable, L1 and L2 animals divert to alternative L3 dauer status. Dauer 
larvae are long-lived and stress resistant (FIELENBACH and ANTEBI 2008; HU 2007).  
It has been shown that HIF-1 is required for C. elegans to resist the Pseudomonas 
aeruginosa PAO1 fast killing (SHAO et al. 2010). PAO1 paralyzes C. elegans by producing 
hydrogen cyanide (HCN) (DARBY et al. 1999; GALLAGHER and MANOIL 2001). egl-9 loss-of-
function mutatants are resistant to PAO1 fast killing (DARBY et al. 1999; GALLAGHER and 
MANOIL 2001). Genetically, hif-1 is epistatic to egl-9, loss-of-function mutation in hif-1 
supresses the PAO1 fast killing resistance phenotype caused by egl-9 mutations (BUDDE and 
ROTH 2011; SHAO et al. 2010). Stabilizing HIF-1 is not sufficient to cause PAO1 fast killing 
resistance. However, in a genetic background which stabilizes HIF-1, increasing HIF-1 activity 
causes PAO1 fast killing resistance (SHAO et al. 2010). Hydrogen cyanide exposure induces 
HIF-1, which induces cysl-2 mRNA. cysl-1 and cysl-2 are predicted to encode cysteine 
synthases, functioning to detoxify HCN. Budde and Roth proposed that CYSL-2 combines 
cysteine and HCN to form β-cyanoalanine, CYSL-1 combine β-cyanoalanine and hydrogen 
sulfide (H2S) to produce cysteine (BUDDE and ROTH 2011). HIF-1 involved pathogen responses 
are pathogen-specific, while egl-9 mutants are resistant to Pseudomonas aeruginosa, they are 
sensitive to Staphylococus aureus(LUHACHACK et al. 2012).  
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HIF-1 is also required for responding appropriately to hydrogen sulfide (H2S) in C. 
elegans. Survival to high concentration H2S (250 ppm or higher) requires hif-1, sqrd-1, ethe-1, 
cysl-1 and cysl-2 (BUDDE and ROTH 2010; BUDDE and ROTH 2011). Similar to HCN, H2S 
exposure induces HIF-1. HIF-1 then induces the mRNA levels of sqrd-1 and cysl-2. SQRD-1 is 
predicted to be a sulfide:quinone reductase, functioning to oxidize H2S (BUDDE and ROTH 2010; 
BUDDE and ROTH 2011). It was also proposed that CYSL-1 interacts with EGL-9 to mediate 
H2S-induced HIF-1 activation (MA et al. 2012). 
HIF-1 also protects C. elegans from bacterial pore-forming toxins (PFT). Mutations in 
egl-9 that increase HIF-1 protein level and activity result in the resistance to pore-forming toxins 
Cry5B and VCC. Loss-of-function mutations in hif-1 causes the worms hypersensitive to Cry5B 
and VCC (BELLIER et al. 2009).  
HIF-1 also modifies the neuron function and development. HIF-1 was shown to influence 
oxygen and CO2 chemotaxis in C. elegans. Wild-type C. elegans grown in standard lab 
conditions prefers the oxygen concentration at 10%. Wild-type worms that have not been 
subjected to hypoxic stress will not aerotax to the preferred oxygen levels if food is present.  
However, mutation in egl-9 or pre-exposure to hypoxia influence this behavior. Induction of 
HIF-1 by hypoxia or egl-9 mutation shifts the worms’ preferred oxygen concentration from 10% 
to 8%, no matter the food is present or not (CHANG and BARGMANN 2008). Well fed C. 
elegans avoid CO2 levels above 0.5%. However, mutation in egl-9 or hypoxia treatment caused 
the worms to be attracted to CO2. This CO2 chemotaxis was suppressed by the loss-of-function 
mutation in hif-1 (BRETSCHER et al. 2008). In C. elegans, HIF-1 was found to induce the 
expression of TYR-2 tyrosinase in ASJ neurons to antagonize p53-dependent germline apoptosis 
(POWELL-COFFMAN and COFFMAN 2010; SENDOEL et al. 2010). In addition, HIF-1 was shown to 
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affect the nervous system development. Over-expression of HIF-1 by hypoxia treatment or by 
mutations in egl-9 and vhl-1 causes C. elegans axon pathfinding defects (POCOCK and HOBERT 
2008).  
Recently, HIF-1 has been shown to modulate C. elegans lifespan. Interestingly, while 
moderate over-expression of HIF-1 can increase worm lifespan; hif-1 loss-of-function mutation 
affects longevity in a complex way, depending on the the environmental clues, such as 
temperature and food conditions (CHEN et al. 2009; LEISER et al. 2011; LEISER et al. 2013; 
MEHTA et al. 2009; MULLER et al. 2009; ZHANG et al. 2009).  
Regulation of HIF-1 stability and activity in C. elegans  
While AHA-1/HIFβ is constitutively expressed, HIF-1 protein level and activity are 
tightly regulated. When oxygen levels are high, HIF-1 is hydroxylated by EGL-9 at P621. This 
modified HIF-1 is bound by VHL-1 E3 ligase and targeted for proteosomal degradation (Figure 
1). This EGL-9/VHL-1 HIF-1 protein stability regulation pathway is conserved among mammals 
and C. elegans. (EPSTEIN et al. 2001; JIANG et al. 2001a; SHAO et al. 2009a).  
Besides the regulation of the stability, HIF-1 activity is also tightly regulated. So far, 
three genes have been identified as the HIF-1 activity negative regulators, they are egl-9, rhy-1 
and swan-1. Unless otherwise indicated, all the mutations for vhl-1, egl-9, rhy-1 and swan-
1described in this thesis are the strong loss-of-function alleles. 
Besides cooperating with vhl-1 to regulate HIF-1 stability, egl-9 inhibits HIF activity 
independent of vhl-1. HIF-1 protein levels were similar in egl-9(sa307) and vhl-1 (ok161), but 
the expression of HIF-1 target genes (K10H10.2, F22B5.4 and nhr-57:GFP) were markedly 
higher in egl-9(sa307) than in vhl-1 (ok161) (BISHOP et al. 2004; SHAO et al. 2009a; SHEN et al. 
2006).  
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rhy-1 encodes a multi-pass transmembrane protein. In rhy-1(ok1402) worms, HIF-1 
protein levels were lower than in animals carrying vhl-1(ok161) mutation, but the expression 
levels of HIF-1 targets (K10H10.2 and nhr-57:GFP) were higher than in vhl-1(ok161) mutants. 
Both egl-9 and rhy-1 mRNAs were up-regulated by HIF-1 under hypoxia; thus they form a 
negative feedback to inhibit HIF-1 stability and activity (Figure 1) (BISHOP et al. 2004; SHAO et 
al. 2009a; SHEN et al. 2005a; SHEN et al. 2006).   
A newly isolated HIF-1 activity negative regulator in our lab is swan-1. swan-1 encodes a 
conserved WD repeat protein. swan-1 loss-of-function mutation does not change HIF-1 protein 
levels. In swan-1 (ok267) animals, HIF-1 protein level was as low as in wild type. And in swan-1 
(ok267);vhl-1 (ok161) double mutants, HIF-1 protein level was the same as in vhl-1 (ok161) 
mutants. However, HIF-1 targets (K10H10.2, F22B5.4 and nhr-57:GFP) were expressed at 
higher levels in swan-1 (ok267);vhl-1 (ok161) double mutants than in the either single mutants. 
Furthermore, yeast two hybrid experiments showed that EGL-9 interacted with SWAN-1. This 
supports a model that a complex involving EGL-9 and SWAN-1suppresses HIF-1 activity (SHAO 
et al. 2010).  
Figure 1 summarizes the regulation of HIF-1 stability and activity based on the previous 
studies. Meanwhile, important questions remain to be answered. For example, besides vhl-1, egl-
9, rhy-1 and swan-1, what are other gene(s) that regulate HIF-1, directly or indirectly? What’s 
the relationship between HIF-1 and other stress responsive regulators? vhl-1, egl-9, rhy-1 and 
swan-1 are declared to be HIF-1 negative regulators based on the expression assay of a few HIF-
1 targets and the similarity of their visible phenotypes: the egg-laying defects and the shrinked 
brood size. We wondered how similar are these known HIF-1 negative regulators at the whole 
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genome expression level? Finally, which genes are directly bound by HIF-1 to realize its 
function? 
Other key stress responsive pathways in C. elegans 
One of the goals of my thesis research is to gain insights to how HIF-1 interacts with or 
cooperates with these other stress responsive pathways. C. elegans researchers have identified a 
small number of transcription factors that have key roles in stress response. These include HSF-
1, DAF-16, SKN-1 and HIF-1. 
C. elegans HSF-1 (heat shock factor 1) is the sole heat shock transcription factor in C. 
elegans. It activates heat shock (hsp) genes during the stress to aid in the refolding of misfolded 
peptides and to restrain protein aggregation (ANCKAR and SISTONEN 2011; MORLEY and 
MORIMOTO 2004; PANOWSKI and DILLIN 2009; SORGER 1991). HSF-1 also regulates pathogen 
resistance to Pseudomonas aeruginosa PA14, Salmonella enterica, Yersinia pestis, and Entero- 
coccus faecalis (SINGH and ABALLAY 2006). Besides stress adaptation, HSF-1 also promotes 
longevity (ANCKAR and SISTONEN 2011; MORLEY and MORIMOTO 2004; PANOWSKI and DILLIN 
2009). 
DAF-16 is a forkhead family DNA-binding transcription factor, and it is regulated by the 
sole C. elegans insulin-like receptor DAF-2. DAF-16 is one of the central regulators of stress 
response. DAF-16 is involved in oxidative stress, pathogen resistance, heat resistance and heavy 
metal resistance (ANCKAR and SISTONEN 2011; BARSYTE et al. 2001; BOLZ et al. 2010; CHAVEZ 
et al. 2007; HONDA and HONDA 1999; JENSEN et al. 2010; LARSEN 1993; LIN et al. 2001; 
LITHGOW et al. 1994; MURAKAMI and JOHNSON 1996; TROEMEL et al. 2006; VANFLETEREN 
1993). DAF-16 also plays roles in longevity, lipid metabolism and dauer formation (BARSYTE et 
al. 2001; BAUMEISTER et al. 2006; GAMI and WOLKOW 2006; HORIKAWA and SAKAMOTO 2010; 
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KENYON 2005; LARSEN 1993; LEISER et al. 2013; LIN et al. 2001; MCELWEE et al. 2004; 
MURPHY et al. 2003; OGG et al. 1997; PANOWSKI and DILLIN 2009; SAVORY et al. 2011). 
C. elegans SKN-1 is the homolog of mammalian NRF bZIP transcription factor. SKN-1 
has distinct embryonic and postembryonic functions. During the embryogenesis, SKN-1 is an 
essential maternal effect factor to specify the digestive system (BOWERMAN et al. 1992; MADURO 
et al. 2007; MADURO et al. 2005; MADURO et al. 2001). Postembryonic functions of SKN-1 are 
involved in longevity regulation and oxidative stress response caused by heat (20 hours at 29°C), 
asenite, t-butyl hydroperoxide or paraquat (AN and BLACKWELL 2003; BISHOP and GUARENTE 
2007; LEISER et al. 2013; LI et al. 2011; NIU et al. 2011; OLIVEIRA et al. 2009a; PAEK et al. 
2012; PARK et al. 2009; ROBIDA-STUBBS et al. 2012; SCHMEISSER et al. 2013; TULLET et al. 
2008; WANG et al. 2010). SKN-1 is constitutively expressed in ASI neurons under normal 
conditions. In response to oxidative stress, SKN-1 accumulates in the intestine nuclei to regulate 
phase II detoxification genes expression (for example, the gcs-1 and gst-4 genes, which have 
roles in glutathione synthesis) (AN and BLACKWELL 2003; OLIVEIRA et al. 2009a; TULLET et al. 
2008). skn-1 mutants are sensitive to oxidative stress and live shorter (AN and BLACKWELL 2003; 
OLIVEIRA et al. 2009a; TULLET et al. 2008; ZHANG et al. 2009).  
Thesis Organization 
My thesis research was dedicated to understanding of the function and regulation of HIF-
1. In this dissertation, I start with a general introduction chapter to describe the background 
information related to my study. The literature review in this chapter summarizes the known 
diverse functions of HIF-1 in C. elegans. The literature review also summarizes known 
mechanism for the regulation of HIF-1 stability and activity. 
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The thesis is then organized into three research manuscripts. All the research presented in 
chapters 2–4 was conducted under the guidance of Dr. Jo Anne Powell-Coffman. Chapter 2 is a 
manuscript being prepared for submission, and it describes the cross talk between SKN-1/NRF 
and HIF-1. In this study, Zhiwei Zhai, Zhiyong Shao and Yi Zhang performed the RNAi 
screening for HIF-1 regulators, the results are summarized in Figure 1. Dingxia Feng made wild-
type and mutant egl-9 promoter:GFP constructs under the mentoring of Zhiyong Shao and Yi 
Zhang. Zhiyong Shao did the micro-injection to generate the wild-type egl-9 promoter:GFP 
transgenic worms. Dingxia Feng did the micro-injection to generate the mutant egl-9 
promoter:GFP. Zhiwei Zhai tested the Pnhr-57:GFP and HIF-1 protein level in Figure 2. 
Dingxia Feng did the assays in Figures 3-7 that interrogate the relationship between SKN-1 and 
HIF-1.  
Chapter 3 is a manuscript being prepared for submission. In this chapter, we used 
microarray to compare the transcriptional phenotypes of vhl-1 (ok161), rhy-1(ok1402), egl-
9(sa307), and swan-1 (ok267);vhl-1 (ok161) with N2. Dr. Dan Nettleton at the Department of 
Statistics, Iowa State University helped us with the experimental design and general analysis 
strategy. Dingxia Feng performed the RNA preparation. Dr. Jiqing Peng at the Iowa State 
University GeneChip facility performed the probe synthesis, labeling, hybridization, washing, 
staining, and scanning. Dr. Long Qu at Department of Statistics, Iowa State University 
performed the data analysis. Dingxia Feng did the downstream genes annotation and function 
analysis.  
Chapter 4 is a manuscript being prepared for submission. In this chapter, we combined 
microarray and ChIP-seq to understand short-term hypoxia response and HIF-1 function under 
short-term hypoxia treatment. Dr. Dan Nettleton at the Department of Statistics, Iowa State 
13 
 
 
 
University helped us with the microarray experimental design and general analysis strategy. 
Dingxia Feng performed the RNA preparation. Dr. Jiqing Peng at the Iowa State University 
GeneChip facility performed the probe synthesis, labeling, hybridization, washing, staining, and 
scanning. Dr. Long Qu at Department of Statistics, Iowa State University performed the 
microarray data analysis. Dingxia Feng did the downstream genes annotation and function 
analysis. Dingxia Feng performed the ChIP-seq DNA samples. Dr. Michael Baker at the Iowa 
State University DNA facility performed the libraries preparation and sequencing. Dingxia Feng 
did the ChIP-seq data analysis with the consultation from Dr. Sunduz Keles and Dr. Dongjun 
Chung at Department of Statistics, University of Wisconsin and from Dr. Dan Nettleton and Dr. 
Long Qu at Department of Statistics, Iowa State University. 
The final part of this thesis is a general conclusion chapter that discusses the cross talk 
between HIF-1/hypoxia signaling pathway and other stress responsive pathways. This chapter 
also discusses HIF-1 function. In this chapter, I also propose potential experiments for future 
research.  
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Figure Legends 
Figure 1.  Model of HIF-1 regulation in C. elegans. The stability of HIF-1 protein is 
controlled by the evolutionarily conserved EGL-9/VHL-1 pathway. Under normoxic conditions, 
HIF-1 is hydroxylated by EGL-9. The ubiquitinated HIF-1 is then targeted for degradation by 
ubiquitin E3 ligase VHL-1. Hypoxia stabilizes HIF-1, HIF-1 dimerizes with AHA-1 and binds to 
target genes to regulate gene expression. HIF-1 transcriptional activity is regulated by RHY-1 
and EGL-9/SWAN-1 complex. 
 
 
Figure 1. Model of HIF-1 regulation in C. elegans. 
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CHAPTER 2. SKN-1 INHIBITS THE HIF-1 HYPOXIA-INDUCIBLE FACTOR 
 
Abstract 
During development, homeostasis, and disease, organisms must balance responses that 
allow adaptation to low oxygen (hypoxia) with those that protect cells from oxidative stress. The 
evolutionarily conserved hypoxia-inducible factors are central to these processes, as they 
orchestrate transcriptional responses to oxygen deprivation.  Here, we employ genetic strategies 
in C. elegans to identify stress-responsive genes and pathways that modulate the HIF-1 hypoxia-
inducible factor and facilitate oxygen homeostasis. Through a genome-wide RNAi screen, we 
determined that RNAi-mediated mitochondrial or proteasomal dysfunction increased expression 
of the Pnhr-57:gfp hypoxia-responsive reporter in C. elegans. Interestingly, only a subset of 
these effects required hif-1. Of particular importance, we found that skn-1 RNAi increased the 
expression of nhr-57: gfp reporter, indicating SKN-1/Nrf might attenuate HIF-1. The SKN-1 
transcription factor has been shown to activate the expression of a battery of genes that enable 
animals to survive oxidative stress. We further investigated the cross-talk between these two 
stress-responsive transcription factors, and we found that skn-1 RNAi increased HIF-1 protein 
levels and increased expression of HIF-1 target genes. Further, this inhibitory effect was 
mediated by EGL-9, the prolyl hydroxylase that targets HIF-1 for oxygen-dependent 
degradation. Expression of egl-9:gfp reporter was increased by heat stress or by gsk-3 RNAi, and 
this effect required skn-1 function and a putative SKN-1 binding site in egl-9 regulatory 
sequences. Collectively, these data show that SKN-1 promotes egl-9 transcription, thereby 
inhibiting HIF-1. 
We propose that this interaction enables animals to adapt quickly to changes in cellular 
oxygenation and to better survive accompanying oxidative stress. 
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Introduction 
Oxygen homeostasis has profound effects on health and fitness. Oxygen serves as the 
terminal electron acceptor in the biochemical processes that generate energy for life. When 
oxygen levels are low (hypoxia), cells and tissues must adapt quickly by increasing oxygen 
delivery, adjusting the levels of key metabolic enzymes, and limiting the accumulation of 
misfolded proteins. While oxygen is essential, it is also highly reactive. The reactive oxygen 
species (ROS) generated by cellular metabolism and signaling processes can damage 
macromolecules, and excess ROS are thought to contribute to cellular aging and deterioration 
(BECKMAN and AMES 1998; FINKEL 2003; FINKEL and HOLBROOK 2000; LIU et al. 2002). One of 
the central challenges of aerobic life is to coordinate the biological networks that control 
disparate aspects of oxygen homeostasis. 
This balance between surviving hypoxic stress and mitigating the potential damage 
caused by reactive oxygen species is especially important in cardiovascular development and 
disease. When ischemia blocks circulation to a tissue, oxygen levels drop, and cells induce 
hypoxia-inducible transcription factors (HIFs). Upon reperfusion and reoxygenation of the tissue, 
mammalian cells respond by rapidly degrading HIF and inducing the Nrf2 transcription factor 
(KIM et al. 2007; LEONARD et al. 2006). Continuous hypoxia induced only HIF-1α, intermittent 
hypoxia induce both HIF-1α and Nrf2 (MALEC et al. 2010).  Nrf2 activates phase II 
detoxification genes to mitigate the effects of the oxidative insults (HAYES and MCMAHON 2001; 
THIMMULAPPA et al. 2002). Although mammalian HIF and Nrf2 share some common targets 
genes such as aldehyde dehydrogenase 1A1 or heme oxygenase HO-1, the batteries of genes 
induced by re-oxygenation are different from those up-regulated by oxygen deprivation (HOUGH 
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and PIATIGORSKY 2004; LEONARD et al. 2006). Crosstalk between HIFs and SKN-1/Nrf2 
homologs might enable the rapid changes in gene expression needed to limit repurfusion injury. 
Many of the transcriptional responses to hypoxia are controlled by hypoxia-inducible 
factor (HIF) factors. HIFs are heterodimeric transcription factors, each consisting of an alpha 
subunit that is regulated by oxygen and a beta subunit (also termed ARNT) that can partner with 
related DNA-binding transcription factor proteins. HIF transcription complexes have critical 
roles in both normal human development and in disease (SEMENZA 2007; WEIDEMANN and 
JOHNSON 2008). HIF homologs have also been shown to have important functions in invertebrate 
development (GORR et al. 2006; MUKHERJEE et al. 2011; POWELL-COFFMAN 2010; SENDOEL et 
al. 2010) (GORR et al. 2006; JIANG et al. 2001a; LAVISTA-LLANOS et al. 2002).  
The C. elegans hif-1, aha-1, egl-9, and vhl-1 genes are orthologous to mammalian HIFα, 
HIFβ, PHD, and VHL, respectively (EPSTEIN et al. 2001; JIANG et al. 2001a; POWELL-COFFMAN 
et al. 1998). The targets of C. elegans HIF-1 include egl-9 and rhy-1, genes that inhibit HIF-1 
expression and activity (BISHOP et al. 2004; SHAO et al. 2009b; SHEN et al. 2005a; SHEN et al. 
2006). In wild-type animals, these negative feedback loops keep HIF-1 activity in check and 
limit the potentially adverse effects of HIF-1 over-activation. Like its mammalian cognates, the 
C. elegans HIF-1 protein levels are regulated by oxygen-dependent proteasomal degradation.  
When oxygen is abundant, HIF-1 protein is hydroxylated by the EGL-9 enzyme. Once modified, 
HIF-1 protein interacts with the Von Hippel-Lindau tumor suppressor (VHL-1) and is targeted 
for ubiquitination and proteasomal degradation (KAELIN and RATCLIFFE 2008). In hypoxic 
conditions, HIF-1 protein is stable, and the transcription factor complex can activate the 
expression of a battery of genes that enable adaptation to low oxygen. Interestingly, EGL-9 also 
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inhibits HIF-1 trancriptional activity through a pathway that does not include vhl-1 (SHAO et al. 
2009a).   
Here, we report that an unbiased genetic screen to identify genes that inhibit C. elegans 
HIF-1 led to the discovery that SKN-1/Nrf represses HIF-1 protein levels. SKN-1, the ortholog 
of the mammalian Nrf2 transcription factor, has been shown to mediate responses to oxidative 
stress, including the activation of phase II detoxification genes (AN and BLACKWELL 2003; 
INOUE et al. 2005; OLIVEIRA et al. 2009b; TULLET et al. 2008).  We present evidence that SKN-
1 promotes the transcription of egl-9. This provides a mechanism by which re-oxygenated cells 
can rapidly down-regulate HIF-1 and optimize gene expression to achieve oxygen homeostasis. 
Materials and Methods 
Strains 
The following strains were used in this study: wild-type N2 Bristol; ZG430: Pnhr-
57:gfp(iaIs07)IV; egl-9(sa307)V; hif-1(ia04)V; Phif-1:hif-1a:MYC:HA (iaIs28); ZG120: Pnhr-
57:gfp(iaIs07)IV; ZG509: rrf-3(pk1426)II; Pnhr-57:gfp(iaIs07)IV; ZG508: rrf-3(pk1426)II; 
Pnhr-57:gfp(iaIs07)IV; hif-1(ia04)V; ZG429: hif-1(ia04)V; Phif-1:hif-1a:MYC:HA(iaIs28); 
ZG472: hif-1(ia04)V; Pegl-9:gfp(iaEx84); ZG487: hif-1(ia04)V; P(m)egl-9:gfp(iaEx96); 
ZG488: skn-1(zu67)IV; hif-1(ia04)V; Pegl-9:gfp(iaEx84). The transgenes expressing epitope-
tagged HIF-1 protein were described and characterized previously (ZHANG et al. 2009).  
RNAi screen 
The RNAi screen was conducted as previously described (SIMMER et al. 2003), with few 
modifications. Each bacterial clone (expressing double-stranded RNA for one gene) was cultured 
in L-broth with 50 ug/mL ampicillin and 12.5 ug/mL tetracycline overnight at 37oC. The 
following morning, the bacteria were inoculated into new L-broth with 100 ug/mL ampicillin for 
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6 hours at 37oC before seeding on 24-well NGM agar plates with 25 ug/mL carbenicillin and 2 
mM IPTG. Each RNAi clone was plated in duplicate. The following day, 15-25 L1 worms were 
added to each well. The plates were incubated at 15oC for 5-6 days, and then the worms were 
screened for positive Pnhr-57:GFP green fluorescence by stereomicroscopy. Bacterial RNAi 
clones that increased the reporter were rescreened in two independent replicates, and the plasmid 
inserts were validated by sequencing. 
Hypoxia stress and oxidative stress assays 
To assess the relative effects of t-butyl-peroxide exposure, animals in the first day of 
adulthood were placed on NGM plates containing 7.5 mM t-butyl-peroxide, in the presence of 
bacterial food. The survival was scored after treating the animals for 6, 8 or 10 hours.  
For hypoxia experiments, adults were allowed to lay eggs on standard NGM plates with 
OP50 bacterial food for two hours. The adults were then removed, and the plates with embryos 
were then placed in a hypoxia chamber (0.5% oxygen; 21oC) for 24 hours. After 24 hours, the 
plates were removed from the hypoxia chamber, and the un-hatched eggs were counted 
immediately. The plates were then maintained in 21oC incubators in room air. The adult worms 
were counted 72 hous after the eggs had been laid. Wild-type control animals hatched within 24 
hours and reached adulthood within 72 hours. Each experiment was repeated 3 times.   
Pegl-9:GFP expression constructs 
To generate the Pegl-9:GFP construct, a fragment that contained 1.6 kb of sequence 
upstream of the initiation ATG was amplified by PCR using the forward primer 5’-
CGCGCATGCGTGTATGTGTGTGAAAGAG-3’ and the reverse primer 5’-
GCGGTCGACGCAACTTTTTTCTGTCACATTCAG-3’. The PCR product was cloned into the 
green fluorescence protein (GFP) vector pPD95.75 (gift from Andrew Fire). To create the 
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P(m)egl-9:GFP point mutation construct, the predicted SKN-1 binding site TTTGTCAT was 
altered to CGACGGGC. Transgenic animals were generated by injection of DNA into the 
gonadal syncitium, using standard methods with rol-6 (pRF4) as the co-injection marker (MELLO 
et al. 1991).  For each construct, two independent transgenic lines were generated and assayed. 
Protein Blots  
To assay the expression of GFP or HIF-1 proteins, lysates from 20 – 80 worms were size 
fractionated on polyacrylamide gels and analyzed by Western blots. The antibodies were diluted 
1:500 for the GFP-specific monoclonal (from Roche) and 1:250 for the HA-specific mouse 
monoclonal (from Cell Signaling). The secondary antibody (goat anti-mouse IgG+IgM from 
Biorad) was used at 1:2000 dilutions. The western blot images were analyzed by the Image J 
software. For each experiment, at least three independent biological replicates were included. 
RNA extraction and real-time quantitative RT-PCR 
Total RNA was isolated from synchronized L4-stage animals using Trizol (Invitrogen). 
After being treated by RNase free DNase (Promega), total RNA was reverse transcribed to 
complementary DNA using Oligo dT18 primer and AffinityScript reverse transcriptase 
(Stratagene). Real-time quantitative PCR was performed using the iQ SYBR GREEN supermix 
(Bio-Rad) and Stratagene Mx4000 multiplex PCR system. In each experiment, three biological 
replicates were included. For each sample, three technical replicates were included. And each 
reaction included cDNA from 62.5 ng total RNA. Relative mRNA quantification was performed 
using efficiency-corrected comparative quantification (PFAFFL 2001). inf-1, a gene not regulated 
by hypoxia, was used as the reference gene (SHEN et al. 2005a; SHEN et al. 2006).   
Results 
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To identify genes and cellular processes that attenuated HIF-1-mediated gene expression, 
we conducted a genome-wide RNAi screen. This experimental strategy relied on the Pnhr-
57:GFP reporter gene, which had been shown to be responsive to HIF-1 (SHAO et al. 2009b; 
SHEN et al. 2005a; SHEN et al. 2006). Through chromatin immunoprecipitation experiments, we 
confirmed that nhr-57 was a direct target of HIF-1 (Figure S1). We screened a bacterial RNAi 
library representing ~80% of C. elegans genes (KAMATH and AHRINGER 2003), and we identified 
179 genes for which RNAi increased Pnhr-57:GFP expression, as assayed by inspection under a 
fluorescent stereomicroscope (screen design illustrated in Figure 1A). These genes are listed in 
Table S1 and their functions are summarized in Figure 1B. Remarkably, 89 genes were predicted 
to have mitochondrial or metabolic functions, and the majority of these were electron transport 
chain components (42 genes) or subunits of mitochondrial ribosomes (24 genes). The second 
largest category of genes was protein folding or turnover (33 genes), and the majority of these 
were proteasomal components. The remaining major categories include vesicular transport, 
transporters and channels, signaling and cytoskeleton, transcription and DNA or RNA 
processing. 
Recognizing that most eukaryotic genes are coordinately regulated by multiple 
transcription factors, we did a secondary screen to identify those RNAi treatments that had a 
clear hif-1-dependent effect on Pnhr-57:GFP expression. Most of the 179 RNAi treatments 
caused some increase in the expression of the reporter in strains that carried a deletion in the hif-
1 gene.  Table S2 lists the 13 genes that had a much more pronounced effect on Pnhr-57:GFP 
expression in wild-type animals, compared to hif-1-deficient mutants. As expected, RNAi for 
egl-9, rhy-1, and vhl-1, three previously characterized negative regulators of C. elegans HIF-1, 
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increased Pnhr-57:GFP expression in wild-type animals, but not in hif-1 mutants. These results 
validated the efficacy of our screen.   
skn-1 attenuates HIF-1 protein levels and HIF-1 function  
We were especially intrigued by the finding that skn-1 RNAi inhibited expression of the 
HIF-1-responsive reporter, since the SKN-1 transcription factor has been shown to have critical 
roles in enabling C. elegans to respond to oxidative stress (AN and BLACKWELL 2003; INOUE et 
al. 2005; OLIVEIRA et al. 2009b; TULLET et al. 2008). To quantify this effect, we examined Pnhr-
57:GFP levels using protein blots. The effect of skn-1 RNAi on the reporter was small but 
significant (Figure 2A; p-value <0.01). To understand this interaction more fully, we asked 
whether skn-1 RNAi would also increase expression of the Pnhr-57:GFP reporter in hypoxic 
conditions. As shown in Figure 2A, hypoxia induced expression of the reporter in animals treated 
with either control RNAi or skn-1 RNAi. We next tested the hypothesis that skn-1 RNAi would 
result in increased HIF-1 protein levels. We tested two RNAi constructs, and each resulted in 
significant increases in HIF-1 protein levels. These data are shown in Figure 2B. 
Differential requirements for skn-1 and hif-1  
Our finding that SKN-1 repressed HIF-1 protein levels suggested that there might be 
conditions in which it would be beneficial to the animal to express one of these two stress-
responsive transcription factors, but not the other. To address this, we examined the relative 
requirements for skn-1 and hif-1 more closely.  In previous studies, we and others had shown 
that hif-1 was required for survival in moderate hypoxia (JIANG et al. 2001a; PADILLA et al. 
2002).  This was further validated in the experiments described in Table 1. Loss of hif-1 
affected animal development and survival in 0.5% oxygen. In stark contrast, skn-1 RNAi had no 
effect on C. elegans development and survival in hypoxic conditions. 
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Prior studies had also suggested that there could be differential requirements for HIF-1 
and SKN-1 in oxidative stress conditions. Mutants carrying loss-of-function mutations in skn-1 
have been shown to decrease the ability of C. elegans to survive exposure to agents that cause 
oxidative stress (AN and BLACKWELL 2003; AN et al. 2005). In contrast, C. elegans carrying 
loss-of-function mutations in hif-1 have been reported to be relatively resistant to peroxide 
(Zhang et al., 2009). We compared these phenotypes directly in the experiments shown in Table 
2. These experiments confirmed that, while skn-1-deficient animals were sensitive to t-butyl 
peroxide, hif-1 mutants were remarkably resistant to this oxidative stress. This provides 
additional support for the idea that in some conditions that activate SKN-1, it may be beneficial 
to suppress HIF-1 function.  
SKN-1/NRF promotes egl-9 expression 
We next sought to discover the mechanism by which SKN-1 inhibits HIF-1 protein 
levels. In silico analyses identified a potential SKN-1 binding site in the egl-9 promoter region 
(Figure 3A).  EGL-9 is a central inhibitor of HIF-1 protein levels (BISHOP et al. 2004; EPSTEIN 
et al. 2001) and of HIF-1 transcriptional activity (SHAO et al. 2009a; SHEN et al. 2006). This 
suggested a model in which the SKN-1 DNA-binding complex bound directly to the egl-9 
regulatory sequences to promote egl-9 expression, which, in turn, would ultimately decrease 
HIF-1 protein levels. To test this, we employed quantitative real-time PCR to compare egl-9 
mRNA levels in worms fed skn-1 RNAi versus control RNAi bacteria. In normal culture 
conditions, skn-1 RNAi decreased egl-9 mRNA levels by 24% (p-value = 0.002) (Figure 3B). 
HIF-1 has been shown to activate egl-9 mRNA expression, creating a negative feedback loop 
(BISHOP et al. 2004; SHEN et al. 2005a). In accordance with this, egl-9 mRNA levels quickly 
peaked after 1 hour of hypoxia treatment. In skn-1 (RNAi) mutants, the hypoxia induction of egl-
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9 mRNA was not as high as in wild-type animals. After 2 hours hypoxia treatment, the egl-9 
mRNA level was 14% lower than that in wild-type animals (p-value = 0.04) (Figure 3B). Thus, 
in room air or in 0.5% oxygen, skn-1 regulates egl-9 mRNA levels. 
To test the hypothesis that conditions that activate SKN-1 might increase egl-9 promoter 
activity, we generated a reporter construct in which 1.6 kb of egl-9 regulatory sequences directed 
the expression of GFP (Figure 4A). To distinguish the effects of SKN-1 on egl-9 expression from 
those of HIF-1, we conducted these experiments in a hif-1 mutant background. In standard 
culture conditions (20oC), Pegl-9:GFP was visible in several tissues, including the body muscle, 
vulva, pharynx, anterior intestine, rectal cells and additional cells in the tail (Figure 4B-C). When 
the animals were treated with heat shock conditions that had been shown to activate SKN-1 
(29°C for 20 hours) (AN and BLACKWELL 2003), Pegl-9:gfp was expressed more strongly in the 
intestine (Figure 4D-E).  
We next asked whether heat shock induction of Pegl-9:GFP required skn-1 function.  
Heat shock increased Pegl-9:GFP 2.5-fold in animals carrying the wild-type skn-1 allele, but the 
reporter was not induced by heat shock in skn-1(zu67) mutants (Figure 5A; p-value < 0.05).  
Analyses of an independent transgenic line yielded similar results (data not shown).   
To test the hypothesis that the putative SKN-1 binding site in the egl-9 promoter was 
required for heat shock induction of Pegl-9:GFP, we generated the P(m)egl-9:GFP construct, 
which contained mutations in the putative SKN-1 binding site (in red type in Figure 3A). There 
was a significant difference between relative induction of the Pegl-9:GFP, and the P(m)egl-
9:GFP constructs, and P(m)egl-9:GFP was not induced by heat shock (p-value < 0.01; Figure 
6B). Experiments with a second P(m)egl-9:GFP transgenic line gave similar results (data not 
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shown). Collectively, these data demonstrated that heat shock induction of Pegl-9:GFP required 
skn-1 function and the putative SKN-1 binding site in the egl-9 promoter. 
We employed gsk-3 RNAi as an independent means of activating SKN-1. GSK-3 
(glycogen synthase kinase-3) is a negative regulator of SKN-1 (AN et al. 2005; INOUE et al. 
2005). As expected, gsk-3 RNAi increased expression of Pegl-9:GFP, and this induction was 
dependent upon the putative SKN-1 binding site (p-value = 0.0013) (Figure 6). Thus, in some 
contexts, SKN-1 promotes transcription from the egl-9 promoter, thereby repressing HIF-1. 
Separate and overlapping functions for SKN-1 and HIF-1  
Do HIF-1 and SKN-1 ever act in concert to promote stress resistance?  Prior studies 
have identified genes regulated by SKN-1 upon exposure to arsenite or peroxide (OLIVEIRA et al. 
2009a) and genes that were induced by hypoxia in a HIF-1-dependent manner (SHEN et al. 
2005a). These two data sets are largely non-overlapping. The cysl-2 gene is an important 
exception, as it has been reported to be positively regulated by both SKN-1 and HIF-1 (BUDDE 
and ROTH 2011; MILLER et al. 2011; OLIVEIRA et al. 2009a; SHAO et al. 2009a; SHEN et al. 
2005a; SHEN et al. 2006). We sought to extend these findings and further characterize the roles 
of SKN-1 in the regulation of cysl-2 expression. We found that skn-1 RNAi caused a 5-fold 
reduction of cysl-2 mRNA levels in room air, as assayed by quantitative real-time PCR, and this 
confirms that SKN-1 promotes cysl-2 expression. Consistent with prior studies, we found that 
hypoxia treatment increased cysl-2 expression in animals fed control RNAi. skn-1 RNAi 
suppressed cysl-2 induction, but did not totally prevent it. After 1 hour in 0.5% oxygen, cysl-2 
mRNA levels were 3.7-fold lower in animals fed skn-1 RNAi, compared to the controls (p-value 
< 0.0001). (Figure 7B). As illustrated in Figure 7C, the relative importance of the SKN-1 or HIF-
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1 transcription complexes in cysl-2 regulation is dependent upon a combination of environmental 
factors or genetic conditions. 
Discussion 
While HIF-1 and SKN-1 are both stress responsive transcription factors, they have 
distinct functions. While skn-1-deficient mutants are less able to survive exposure to peroxide, 
hif-1 mutants exhibit increased resistance to this compound. Thus, animals may benefit from 
cross-talk between these two transcription factors as they are challenged by oxygen deprivation 
and oxidative stress. Here, we provide evidence that SKN-1 promotes egl-9 expression, thereby 
attenuating HIF-1 function. We propose that this may allow the rapid down-regulation of HIF-1 
in environments that activate SKN-1. 
SKN-1 promotes egl-9 expression, thereby inhibiting HIF-1 
HIF-1 and SKN-1 are both key components of the C. elegans stress response network. 
HIF-1 is stabilized by hypoxia, and SKN-1 is activated by chemicals or treatments that generate 
reactive oxygen species (AN and BLACKWELL 2003; AN et al. 2005; INOUE et al. 2005). We were 
intrigued to understand how skn-1 can affect the expression of HIF-1 function reporter gene 
Pnhr-57:GFP. We found that although skn-1 and hif-1 has distinct roles in oxidative and hypoxia 
stress response and genes regulated by these two transcription factors are largely non-
overlapping (OLIVEIRA et al. 2009a; SHEN et al. 2005a), there is a regulatory link between these 
two pathways. Our data evidenced that SKN-1 acts through egl-9 to inhibit HIF-1. We showed 
that the heat shock induction of egl-9:gfp reporter was skn-1 dependent, skn-1 RNAi decreased 
egl-9 mRNA level by 20% and increased HIF-1 protein levels by 2-3-fold (Figure3-5). It would 
be a benefit animals to inter-regulate different pathways under certain conditions, as it has been 
shown that in mammals, upon reperfusion and re-oxygenation of the tissue, HIF is degraded 
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quickly and Nrf2 is up-regulated to limit the oxidative damage (KIM et al. 2007; LEONARD et al. 
2006). And as continuous hypoxia induced only HIF-1α, intermittent hypoxia induce both HIF-
1α and Nrf2 (MALEC et al. 2010). Since EGL-9 can inhibit HIF-1 protein levels and activities 
and the enzymatic activity of EGL-9 is further modulated by mitochondrial function and by 
cellular oxygen levels (KAELIN and RATCLIFFE 2008; KLIMOVA and CHANDEL 2008; SHAO et al. 
2009a), EGL-9 is well-positioned to integrate information about cellular oxygenation and 
oxidative stress and to affect adaptive changes in HIF-1 function. The sets of genes up-regulated 
by SKN-1 or HIF-1 are largely non-overlapping, but a few genes are regulated by both 
transcription factors, including K10H10.2, F57B9.1, M05D6.5, and rhy-1. The rhy-1 gene has 
also been identified as a potential transcriptional target of SKN-1, potential SKN-1 binding sites 
were identified in the rhy-1 promoter region (Oliveira et al., 2009). Like egl-9, rhy-1 is also a 
negative regulator of HIF-1 (Shen et al., 2005). These data suggest a model in which the SKN-1 
regulates egl-9 and rhy-1 to control HIF-1 stability and activity (SHAO et al. 2009a; SHEN et al. 
2005a; SHEN et al. 2006).  
However, we also realized the the relationship between SKN-1 and HIF-1 is far more 
complexed. On one hand, they are required for different streees, as hif-1 is not susceptible to t-
butyl-peroxide treatment, skn-1 mutants is super-sensive to this oxidative stress; similarly, skn-1 
but not hif-1 mutants can survive the hypoxia treatment (Table 1 and Table 2). On the other 
hand, we also see situations when HIF-1 and SKN-1 are both required, as shwon by the 
regulation of cysl-2. As a classic HIF-1-dependent hypoxia responsive gene (SHAO et al. 2009a; 
SHEN et al. 2005a; SHEN et al. 2006), the expression of  cysl-2 requires SKN-1 both in the room 
air and under hypoxia (Figure 7B).  
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Interstingly, in whole genome microarray studies, we have found that skn-1 mRNA was 
expressed at levels about 2 times higher in vhl-1(ok161) mutants (q-value = 1.82E-03). skn-1 
mRNA was also over-expressed about 1.6-fold in egl-9(sa307) and rhy-1(ok1402) mutants (q-
value = 0.014 and 0.02, respectively). When considered with the data presented herein, this 
suggests that the HIF-1 and SKN-1 regulatory networks are coordinated at multiple levels. 
RNAi screen identifies genes that regulate nhr-57 expression   
Prior studies have demonstrated that nhr-57 was induced by hypoxia in a hif-1-dependent 
manner and that over-expression of Pnhr-57:GFP in egl-9 mutants required hif-1 (BISHOP et al. 
2004; BUDDE and ROTH 2010; SHAO et al. 2009b; SHEN et al. 2005a; SHEN et al. 2006).  
Moreover, Bellier et al (2009) found that HIF-1-mediated induction of nhr-57 helped to protect 
C. elegans from the lethal effects of pore-forming toxins (BELLIER et al. 2009). While these 
studies showed that nhr-57 is a direct target of HIF-1, other transcription factors must also 
contribute to its expression. The studies presented here show that RNAi treatments can activate 
Pnhr-57:GFP through hif-1-independent pathways, which provides some insights to the other 
factors that influence nhr-57 expression. 
We identified 179 genes for which RNAi increased expression of the Pnhr-57:GFP 
reporter. The studies presented here show that RNAi treatments can activate Pnhr-57:GFP 
through hif-1-independent pathways. 
 The RNAi screen revealed that Pnhr-57:GFP expression was influenced by the cellular 
processes that maintain metabolic function and protein homeostasis, and many of the genes 
integral to these processes have been shown to have roles in stress response and aging.  RNAi 
for 41 different components of the mitochondrial electron transport chain increased Pnhr-
57:GFP. In agreement with this, a recent study showed that inhibition of mitochondrial 
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replication via par-2.1/mtssb-1 RNAi caused a strong induction of hypoxia-responsive genes, 
including nhr-57 (SUGIMOTO et al. 2008). Most of the mitochondrial RNAi treatments that 
increase Pnhr-57:GFP have been shown to increase adult lifespan in C. elegans (CURRAN and 
RUVKUN 2007; HAMILTON et al. 2005; HANSEN et al. 2005; KIM and SUN 2007; LEE et al. 2003). 
The Pnhr-57:GFP reporter was also induced by RNAi-mediated depletion of many proteasomal 
components, and many of these treatments had been shown to affect polyglutamine toxicity and 
to induce expression of Pgpdh-1:GFP, a marker for osmotic stress and glycerol production 
(LAMITINA et al. 2006; NOLLEN et al. 2004).  
Further characterization of the 179 RNAi treatments that increased Pnhr-57:GFP 
identified 13 that had much stronger effects in animals carrying a wild-type hif-1 gene. These 
genes included vhl-1, egl-9, and rhy-1. These three genes had all been identified in prior studies 
as negative regulators of HIF-1 (EPSTEIN et al. 2001; SHEN et al. 2006). The succinate 
dehydrogenase subunit sdhb-1 was also found to have hif-1-dependent effects. This is in 
agreement with studies in cancer cell lines in which succinate inhibited the enzymatic activities 
of HIF prolyl hydroxylases (KOIVUNEN et al. 2007; SELAK et al. 2005). sams-1 and sbp-1 encode 
the C. elegans S-adenosyl methionine synthetase and the SREBP homologs, respectively. 
Analyses of HIF-1 protein levels and HIF-1-mediated gene expression suggest that sams-1 and 
sbp-1 limit HIF-1 transcriptional activity, directly or indirectly (Figure S2).   
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Figure Legends 
Figure 1  Genome-wide RNAi screen to identify negative regulators of HIF-1-mediated 
gene expression.  (A) Illustration of screen design.  The screen identified RNAi treatments that 
increased the expression of Pnhr-57:GFP, a reporter that has been shown to be induced by 
hypoxia and positively regulated by HIF-1.  (B)  Functional summary of the 179 genes identified 
from the RNAi screen. 
Figure 2 Identification of SKN-1 as a regulator of HIF-1. (A) skn-1 RNAi increased 
expression of the Pnhr-57:GFP reporter. Reporter gene expression was quantitated in L4 stage 
animals in normal culture conditions or after 2 or 4 hours of hypoxia treatment (0.5% oxygen). 
The protein levels were calculated from three independent experiments and normalized to 0 hour 
control RNAi.  Asterisks indicate significant differences between control RNAi and skn-1 RNAi 
at any given time point. *: p<0.05; **: p< 0.01.   (B)  skn-1 RNAi increased HIF-1 protein 
levels.These animals expressed an epitope-tagged HIF-1 protein (Zhang et al., 2009).  Bar 
heights reflect the average effects of skn-1RNAi on HIF-1 protein levels, as determined by 3 
biological replicates, and values were normalized to the control RNAi.  Two different RNAi 
clones were assayed, and they are designated skn-1(1) and skn-1(2) here.   
Figure 3  Identification of egl-9 as potential transcriptional target of SKN-1.  (A)  Sequence 
from the egl-9 promoter aligned with established SKN-1 binding sites in gcs-1, med-1, and med-
2.  Asterisks identify sequence identities shared by all four promoter regions in this interval, and 
predicted SKN-1 binding sites are in red.  (B)  skn-1 RNAi decreased egl-9 mRNA levels.  egl-
9 mRNA levels were quantitated in 3 independent RT-PCR experiments in L4-stage animals in 
normal or hypoxic conditions (1 or 2 hours in 0.5% oxygen).  In normal culture conditions, skn-
1 RNAi reduced egl-9 mRNA levels in L4 stage animals 24%. Asterisks indicate significant 
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differences between control RNAi and skn-1 RNAi at any given time point. *: p<0.05; **: p< 
0.01. 
Figure 4. Heat shock alters Pegl-9:GFP expression.  (A)  The Pegl-9:GFP construct includes 
1.6 kb of sequence 5’ to the egl-9 translational start. GFP coding sequence is diagramed as a 
green box. The red oval indicates the position of the putative SKN-1 binding site. (B-E)  Pegl-
9:gfp expression in L4-stage animals under normal culture conditions and heat shock.  Animals 
are shown as DIC images (B, D) and corresponding images of GFP fluorescence (C, E).  In all 
images, the head is to the right.  B, C. Under normal conditions, Pegl-9:GFP was expressed in 
the body muscle,  vulva, pharynx, anterior intestine, rectal cells and additional cells in the 
tail.  D, E.  After heat shock treatment (29°C for 20 hours), Pegl-9:GFP was expressed much 
more strongly in the intestine. ThePegl-9:GFP expression patterns in the L1, L2, L3 and adults 
were similar to that in the L4 worms, under both normal and heat shock conditions. 
Figure 5. SKN-1 acts through the putative SKN-1 binding site in the egl-9 promoter to 
activate egl-9 expression. (A) Heat shock induced Pegl-9:GFP in animals carrying the wild-
type skn-1 allele, but did not induce the reporter in animals carrying the skn-1(zu67) loss-of-
function mutation. (B) Heat shock increased total levels of Pegl-9:GFP expression, but did not 
increase the expression of the reporter in which the putative SKN-1 site was mutated (P(m)egl-
9:GFP). The vertical axes show the log2 fold change for each strain, as determined by five 
biological replicates.  To distinguish the SKN-1-mediated changes in Pegl-9:GFP expression 
from those that were mediated by HIF-1, these experiments were conducted in animals that 
lacked hif-1 function.  
Figure 6.  gsk-3 RNAi induction of Pegl-9:GFP. gsk-3 RNAi increased expression of Pegl-
9:GFP, relative to control RNA (the L4440 empty vector).  This effect was dependent upon the 
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putative SKN-1 binding site in the reporter (mutated in P(m)egl-9:GFP). The figure shows log2 
fold change from four biological replicates, with standard errors. 
Figure 7.  SKN-1 attenuates HIF-1, while also promoting expression of a common 
target.  (A)  Model showing that SKN-1 and HIF-1 respond to different environment stresses. 
SKN-1 promotes egl-9 expression, and EGL-9 inhibits HIF-1. While HIF-1 and SKN-1 targets are 
largely non-overlapping, both of these transcription factors promote expression of cysl-
2.  (B)  Effects of skn-1 RNAi on cysl-2 mRNA levels. L4-stage animals were assayed in normal 
culture conditions or after 1 or 2 hours of hypoxia treatment (0.5% oxygen).  Each point 
was calculated from three independent RT-PCR experiments. Asterisks indicate significant 
differences between control RNAi and skn-1 RNAi at any given time point. **: p< 0.001; ****: 
p<0.0001. (C) A schematic summarizing the contributions of SKN-1 and HIF-1 to cysl-2 
expression.  Hypoxia elevates HIF-1 protein levels, thereby increasing cysl-2 expression.  skn-1 
RNAi diminishes cysl-2 expression.  
 
Table 1 Relative requirements for skn-1 and hif-1:  survival in 0.5% oxygen 
 
Genotype % hatched ± SEM (%) % survive to adult ± SEM n a 
N2 (wild type) 99.1 ± 0.25 99.1± 0.3 672 
hif-1(ia04) 75.8 ± 2.5 25.6 ± 0.9 616 
N2;control(RNAi) 99.6 ± 0.19 99.6 ± 0.2 558 
N2;skn-1(RNAi) 99.4 ± 0.42 99.4 ± 0.4 640 
a n is the total number of animals assayed in three independent experiments. 
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Table 2 Relative requirements for skn-1 and hif-1:  survival on t-butyl-peroxide 
 
Exposure time Genotype Mean Survival  ± SEM p-valueb N  a 
6 hours N2 (wild type) 95.2 ± 2.6 - 106 
skn-1(zu67) 0.0 ± 0 1.6E-06 117 
hif-1(ia04) 100.0 ± 0 0.07 120 
8 hours N2 (wild type) 29.08 ± 7.7 - 106 
skn-1(zu67) 0.0 ± 0 0.001 117 
hif-1(ia04) 99.17 ± 0.8 4.1E-04 120 
10 hours N2 (wild type) 2.78 ± 2.8 - 106 
skn-1(zu67) 0.0 ± 0 0.19 117 
hif-1(ia04) 97.50 ± 2.5 7.2E-06 120 
        a n is the total number of animals assayed in three independent experiments. 
        b significance of differences between mutant and wild-type. 
 
 
 
Figure 1  Genome-wide RNAi screen to identify negative regulators of HIF-1-mediated gene 
expression. 
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Figure 2 Identification of SKN-1 as a regulator of HIF-1. 
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Figure 3 Identification of egl-9 as potential transcriptional target of SKN-1.  
 
Figure 4. Heat shock alters Pegl-9:GFP expression.   
 
 
Figure 5. SKN-1 acts through the putative SKN-1 binding site in the egl-9 promoter to activate egl-
9 expression.  
 
 
Figure 6.  gsk-3 RNAi induction of Pegl-9:GFP. 
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Figure 7.  Effects of skn-1 on HIF-1-mediated gene expression.   
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CHAPTER 3. TRANSCRIPTOME ANALYSES OF HIF-1 OVER-ACTIVATION 
 
Abstract 
Oxygen is an essential molecule to all the aerobic organisms. During normal 
development and homeostasis, organisms are often challenged by hypoxia (low oxygen). In 
metazoans, hypoxia responses are mediated by conserved transcription factor HIF complex 
(hypoxia-inducible factor). HIF complex is a dimer composed of HIFα and HIFβ. HIFα is 
dedicated to hypoxia response, its stability and activity are strictly regulated. In C. elegans, the 
homolog of HIFα is HIF-1. So far 4 HIF-1 negative regulators have been identified in C. 
elegans: vhl-1, rhy-1, egl-9 and swan-1. Prior studies have shown that selected HIF-1 targets are 
over-expressed in these mutants. Here, by using genome-wide gene expression analyses, we are 
able to describe the molecular phenotypes of these mutants more completely. This study also 
extends the insights into the effects of HIF-1 over-activation. In supporting the model that RHY-
1, EGL-9 and SWAN-1 act in common pathway(s) to repress HIF-1, our data show that the 
mutant phenotypes of rhy-1, egl-9 and swan-1 loss-of-function are similar at the molecular level. 
Prior studies suggest that besides hypoxia resistance, misregulation of HIF-1 disrupts multiple 
processes, including pathogen resistance and brood size. In consistent with this, we found that 
genes up-regulated by HIF-1 over-activation converge with genes involved in immune response 
pathways; and genes commonly misregulated in HIF-1 over-activation mutants are enriched in 
cell-cycle and reproduction functions. Intriguingly, we found that HIF-1 and DAF-16 converge 
on key stress-responsive genes and function synergistically to protect C. elegans from moderate 
hypoxia stress.  
Introduction 
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As the electron acceptor during the oxidative phosphorylation, oxygen is an essential 
molecule to all the aerobic organisms. Insufficient oxygen availability not only decreases the 
energy production but also changes the redox environment needed for the cellular biochemical 
reactions (SEMENZA 1999; SEMENZA 2012). During normal development and homeostasis, 
organisms are often challenged by hypoxia (low oxygen). In metazoans, the transcription factor 
complex HIF (hypoxia-inducible factor) mediates the majority of transcriptional responses to 
hypoxia. HIF is a heterodimeric complex, composed of an α subunit and a β subunit, which are 
both bHLH (basic-helix-loop-helix)-PAS (PER/ARNT/SIM) domain proteins (WANG et al. 1995). 
The human genome encodes three homologous HIFα proteins: HIF-1, -2 and -3α, and three 
ARNT/HIFβ proteins: HIF-1, -2 and -3β (TAKAHATA et al. 1998). While HIFβ has multiple bHLH-
PAS dimerization partners and is relatively abundant, HIFα is short-lived under well-oxygenated 
conditions. Thus, HIFα is apparently dedicated to regulate oxygen-sensitive gene expression 
(BERRA et al. 2006; KAELIN and RATCLIFFE 2008; SEMENZA et al. 1996). In mammals, HIF 
transcriptionally regulate target genes to promote angiogenesis, red cell production and glycolysis 
under hypoxia (PFANDER et al. 2003; SEMENZA 2009; SURAZYNSKI et al. 2008; WENGER 2002).  
HIF is conserved and expressed by all extant metazoan species analyzed to date (SEMENZA 
2012). C. elegans has been shown to be a good model system in dissecting the HIF pathway 
because of its well-known advantages such as short life cycle, easy maintenance, genome sequence 
availability and convenient forward and reverse genetics. And HIF complex was simplified in C. 
elegans, with only one HIFα and one HIFβ, namely HIF-1 and AHA-1. (EPSTEIN et al. 2001; JIANG 
et al. 2001; POWELL-COFFMAN et al. 1998). While the hif-1α -/- mouse dies by E9.0 with severe 
vascular defects (IYER et al. 1998; RYAN et al. 1998), C. elegans hif-1(ia04) loss-of-function 
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mutants survive and develop under normal conditions, although they fail to adapt to hypoxia (0.5% 
or 1% O2) (JIANG et al. 2001; PADILLA et al. 2002). 
Interestingly, in C. elegans, apart from enabling adaption to hypoxia, HIF-1 has been found 
to be involved in other stress and immunity response, such as heat acclimation (TREININ et al. 
2003), H2S and HCN response (BUDDE and ROTH 2010; BUDDE and ROTH 2011), Pseudomonas 
aeruginosa PAO1 fast killing resistance (BUDDE and ROTH 2011; SHAO et al. 2010), 
Staphylococcus aureus susceptibility (LUHACHACK et al. 2012), and the bacterial pore-forming 
toxins (PFT) resistance (BELLIER et al. 2009). And recently HIF-1 has been shown to modulate 
lifespan in a complicated and context dependent manner (CHEN et al. 2009; LEISER et al. 2011; 
LEISER et al. 2013; MEHTA et al. 2009; ZHANG et al. 2009). 
Understanding the function and regulation of HIF has potential therapeutic significance 
in hypoxia related disease, such as cancer and heart disease. The oxygen dependent HIFα/HIF-1 
degradation pathway is well established and conserved from human to C. elegans. When the 
oxygen level is high, the PHD/EGL-9 family of deoxygenases hydroxylate the specific proline 
residues of HIFα/HIF-1, using oxygen and 2-oxoglutarate as co-substrates. The hydroxylated 
HIFα/HIF-1 is targeted by an ubiquitin E3 ligase, VHL (von Hippel-Lindau tumor suppressor) 
for the proteasomal degradation (KAELIN and RATCLIFFE 2008; SEMENZA 2012). The 
corresponding human PHD/EGL-9 and VHL homologs are encoded by egl-9 and vhl-1 in C. 
elegans (EPSTEIN et al. 2001). In C. elegans, besides regulating HIF-1 stability with VHL-1, 
EGL-9 also functions to repress the transcriptional activity of HIF-1. These two functions of 
EGL-9 are separate (SHAO et al. 2009).  
In addition to vhl-1 and egl-9, another two HIF-1 negative regulators have been identified 
in C. elegans: rhy-1 and swan-1 (SHAO et al. 2010; SHEN et al. 2006). rhy-1 encodes a multi-pass 
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transmembrane protein. Although in rhy-1 loss-of-function mutants, HIF-1 protein levels are 
lower than that in vhl-1 loss-of-function mutants, HIF-1 targets (K10H10.2 and nhr-57:GFP) 
were expressed at higher levels in rhy-1 loss-of-function mutants than in vhl-1 loss-of-function 
mutants (Shen et al. 2006). swan-1 encodes a conserved WD repeat protein (YANG et al. 2006). 
swan-1 loss-of-function mutation does not change HIF-1 protein levels. However, in vhl-1 
loss-of-function background, which stabilizes HIF-1, SWAN-1 increases HIF-1 activity, as it has 
been shown that HIF-1 targets (K10H10.2, F22B5.4 and nhr-57:GFP) were expressed at higher 
levels in swan-1; vhl-1 double mutants than in either swan-1 or vhl-1 single mutants (Shao et al. 
2010). Further, yeast two-hybrid assays showed that EGL-9 interacts with SWAN-1. This 
supports a model that a complex involving EGL-9 and SWAN-1suppresses HIF-1 activity (SHAO 
et al. 2010). 
Thus, these 4 HIF-1 negative regulators regulate HIF-1 by different or similar 
mechanisms. VHL-1 suppresses HIF-1 stability. EGL-9 suppress HIF-1 stability and activity. 
RHY-1 and SWAN-1 suppress HIF-1 activity. And EGL-9 and SWAN-1 may function in a 
complex to repress HIF-1 activity. In consistence with this, mutations in egl-9, rhy-1 and swan-1 
cause an array of similar developmental and stress-responsive phenotypes, including egg-laying 
defects, reduced brood size and resistance to Pseudomonas aeruginosa PAO1 fast killing 
(DARBY et al. 1999; SHAO et al. 2010; SHEN et al. 2006; TRENT et al. 1983). The diagram in 
Figure 1 proposes the relationship between HIF-1 and these negative regulators. 
We recognized that our model is based on the assays of a limited number of HIF-1 targets 
and phenotypes. With this in mind, we challenged our model by asking how similar the effects of 
these known HIF-1 negative regulators are at the molecular level. We answered this question by 
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comparing the whole-genome transcriptional profiling in these HIF-1 negative regulator mutants. 
This genome-wise assay also enhances our understanding of the functions of HIF-1.  
Materials and Methods 
Strains 
The wild-type C. elegans used in this study was N2 Bristol. The mutant alleles used in 
this study were: LGI: daf-16(mu86)lf, daf-16(MgDf50)lf; LGII: rhy-1(ok1402)lf; LGV: hif-
1(ia04)lf, egl-9(sa307)lf, swan-1(ok267)lf; LGX: vhl-1(ok161)lf. All the worms were maintained 
at 20°C using the standard methods (BRENNER 1974).  
Gene expression microarray experiment and data analysis 
Randomized complete block design was followed for the microarray experiment, with 
three independently repeated experiments treated as blocks. Each block included eight 
treatments: N2 (wild-type animals), N2 with hypoxia treatment, hif-1(ia04), hif-1(ia04) with 
hypoxia treatment, vhl-1(ok161), rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267); vhl-1(ok161) 
double mutants. One experimental unit was assigned to each treatment within each block. To get 
sufficient RNA for hybridization, about 1,000 synchronized L4-stage larvae were pooled as one 
experimental unit. Total RNA isolated from each experimental unit using Trizol (Invitrogen) was 
hybridized onto one Affymetrix GeneChip® C. elegans Genome array to analyze gene 
expression. Probe synthesis, labeling, hybridization, washing, staining, and scanning were 
performed by the GeneChip facility at Iowa State University. The resulting CEL files were 
normalized and summarized using the robust multichip average (RMA) algorithm (IRIZARRY et 
al. 2003) in R (R development core team, 2009; Gentleman et al, 2004). An analysis of variance 
(ANOVA) model was then fitted to the summarized expression measures for each probeset 
separately, with the block (3 levels) and the treatment (8 levels) treated as fixed effect factors 
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following the experimental design. Residual model diagnostics identified no severe violations of 
model assumptions. Linear contrasts of treatment means that are of interests were tested using 
the general F-test for each contrast and each probeset separately. For each contrast of interest, 
histograms of p-values from all probesets were plotted. To account for multiplicities of 
hypothesis testing, conservative estimates of false discovery rates (FDR) were calculated 
according to the q-value procedure of Storey and Tibshirani (STOREY and TIBSHIRANI 2003) for 
each contrast separately. Probesets were converted to gene names using the Affymetrix 
annotation file “Celegans.na30.annottrimmed.csv” and wormbase (WS220). To avoid 
redundancy, we kept one probeset per gene. For probesets that hybridized to multiple genes, all 
the gene names are listed in Supplemental Tables S1 and S2. The total number of unique 
probesets detected was 18, 011. The gene functions were annotated using wormbase (WS220) 
(HARRIS et al. 2010).  
In this chapter, we discuss the gene expression changes in the HIF-1 negative regulator 
mutants: vhl-1(ok161), rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267); vhl-1(ok161) double 
mutants, compared to N2. The comparison of gene expression change between N2 wild type and 
hif-1(ia04) under short-term hypoxia will be described in chapter 4.                                                                                    
Heat map 
Heat maps for gene expression profiles were generated by PermutMatrix graphical 
analysis program (CARAUX and PINLOCHE 2005; EISEN et al. 1998). Average linkage clustering 
was performed using the estimated fold change values. Green color represents negative values 
(down-regulated), and red color represents positive values (up-regulated). The intensity of the 
color represents the magnitude of the expression levels. Other parameters were set as default.  
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Microarray datasets comparisons 
In order to determine whether the overlap between the differentially expressed gene lists 
from different microarray datasets is greater than expected by chance, Fisher’s exact test was 
performed. The number of 18, 011 unique probesets assayed on the microarray was used as the 
total population size. p-value < 0.001 was used as the cutoff to declare the overlap is 
significantly higher than expected by chance. 
Hypoxia survival and development assay 
For each genotype, 20 young adults (one day after L4 molt) were put on one NGM plate 
with OP50 (OD=0.6) to lay eggs for 0.5 hour. After counting the eggs laid, the plates were put 
into the hypoxia chamber for 24 hours (0.5% oxygen, 21°C). After 24 hours, the plates were 
taken out of the hypoxia chamber, and the un-hatched eggs were counted immediately. After 
that, all the plates were maintained in room air (21°C). The adult worms were counted at 72 
hours since the eggs had been laid. The experiment was repeated three times on three different 
days. The normoxia controls were done in parallel. The number of animals assayed for each 
strain under each condition was between 209 and 515. The binary hatched vs. unhatched or adult 
vs. non adult data were analyzed by fitting a generalized linear model using a logit link function 
with JMP 9 statistical software (SAS Institute Inc., Cary, NC, 2010). For each genotype, 
replicates and treatment conditions were used as factors in the model. 
Results 
Transcriptional phenotypes of vhl-1, rhy-1, egl-9, and swan-1; vhl-1 
To test our current model of HIF-1 regulation (shown in Figure 1) and to achieve a richer 
understanding of the consequences of HIF-1 over-activation, we employed whole-genome 
microarrays to compare the phenotypes of animals carrying strong loss-of-function mutations in 
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egl-9 or rhy-1 to those of wild-type animals. We also examined animals that carried a deletion in 
vhl-1 and animals that lacked both vhl-1 and swan-1 functions. If, as predicted, egl-9, rhy-1, and 
swan-1 act in common pathway(s) to inhibit HIF-1 transcriptional activity, then we would expect 
extensive overlaps between the gene expression changes caused by each mutation or mutation 
combination. Further, patterns of gene expression that were different in the mutants, relative to 
wild-type strains, would provide a compelling molecular description of the consequences of HIF-
1 over-activation. Our microarray analyses identified over 2000 genes that were differentially 
regulated, relative to wild-type, in at least one of the mutant strains (fold change ≥ 1.6 and q-
value ≤ 5%). Table S1 lists genes that were over-expressed in at least one of the mutants, and 
Table S2 lists genes that were down-regulated in at least one of the mutants.   
To further investigate the quality of these data sets, we compared the results to prior 
published studies. By RNA bolt and RNase protection assays, we and others have demonstrated 
that nhr-57, cysl-2/K10H10.2, F22B5.4, rhy-1/W07A12.7, phy-2, fmo-2, and egl-9 mRNAs are 
over-expressed in mutants lacking vhl-1 or egl-9 function (BISHOP et al. 2004; SHEN et al. 2005). 
Additionally, cysl-2/K10H10.2 and F22B5.4 mRNAs have been shown to be over-expressed in 
rhy-1 mutants and in vhl-1; swan-1 double mutants by real-time RT-PCR (SHAO et al. 2010; 
SHEN et al. 2006). The microarray studies reported herein identified each of these genes as being 
expressed at significantly higher levels in each of the four mutant strains, relative to wild-type. 
The one exception was expected: the rhy-1 mRNA was not detected at high levels in the rhy-1 
deletion mutant. In sum, these data are encouraging and are consistent with our estimated false 
discovery rates of less than 5% for the microarray analyses. 
The microarray data reveal striking similarities in the genes expression profiles of rhy-
1(ok1402), egl-9(sa307), and swan-1 (ok267); vhl-1(ok161) animals, and this is illustrated in 
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Figures 2A and 2B. Of the 335 genes that were over-expressed in rhy-1-deficient mutants, 300 
were also over-expressed in either the egl-9 loss-of-function mutants or in the swan-1; vhl-1 
double mutants (Figure 2A). Similarly, of the 381 genes that were down-regulated in the rhy-1 
mutants relative to wild-type, 263 were also suppressed in egl-9 or swan-1; vhl-1 mutants 
(Figure 2B). Prior studies have shown that egl-9 and swan-1 also have important functions in 
other pathways (PARK et al. 2012; YANG et al. 2006). In agreement with this, approximately 
26% of the genes that were differentially expressed in egl-9 mutants were not differentially 
expressed in the other two mutant backgrounds tested. And 33% of the genes that were 
differentially expressed in swan-1; vhl-1 mutants were not differentially expressed in the other 
two mutant backgrounds tested. 
These data provide insights to how HIF-1 over-activation alters the C. elegans 
transcriptome to influence stress response, development, and aging. Our analyses identified a 
common set of 219 genes that were over-expressed in rhy-1(ok1402), egl-9(sa307), and swan-1 
(ok267); vhl-1(ok161) and a common set of 155 genes that were expressed at lower levels in all 
these three mutant strains compared to wild-type (illustrated in Figure 2A and 2B). The gene 
names, predicted functions, fold change values, p-values, and q-values are in Tables S3 and S4. 
As illustrated in Figures 2C and 2D, the differentially expressed genes have varied roles in 
cellular metabolism (Table 1). Many of the genes have roles in the metabolism of amino acids 
and fatty acids to produce energy. For example, mce-1, mmcm-1, ppca-1, and ppcb-1 mediate the 
conversion of propionyl-CoA to succinyl-CoA. Other major classes of genes that were 
differentially expressed in these three mutants include: cell cycle and reproduction, cellular 
signaling, protein homeostasis, defense/immunity, detoxification/stress response, transcription 
57 
 
 
 
and translation, and transport proteins (Figure 2C and 2D). The genes in each major functional 
class are listed in Tables 1–4.   
The observation that genes that were misregulated in rhy-1(ok1402), egl-9(sa307), and 
swan-1 (ok267); vhl-1(ok161) have roles in cell cycle and reproduction or early embryogenesis 
(Table 2) is especially interesting. It has been shown that HIF-1 over-activation decreases 
fecundity, as assayed by viable progeny produced by rhy-1 and egl-9 loss-of-function mutants or 
swan-1; vhl-1 double mutants (SHAO et al. 2010; SHEN et al. 2006). Genes in this functional 
category have roles in cell cycle progression (cdc-25.3, cyb-3), telomere maintenance (trt-1), 
chromosome segregation (pzf-1, rmd-1), spindle organization (mei-2, mesp-1), spindle 
orientation (spn-4), germline development (fog-3, gld-3), and sperm motility (ssp-19, ssp-33, 
Y59E9AL.2) (Table 2).    
Convergence of HIF pathway and pathogen immune response pathways 
Pseudomonas aeruginosa can kill C. elegans quickly through the secretion of toxins that 
include cyanide (fast killing), and it can kill C. elegans slowly following colonization in the 
intestine (slow killing). Prior studies have shown that rhy-1(ok1402), egl-9(sa307) and swan-1 
(ok267); vhl-1 (ok161) mutants exhibit increased resistance to P. aeruginosa PAO1 fast killing 
(DARBY et al. 1999; SHAO et al. 2010). The NSY-1/SEK-1/PMK-1 mitogen-activated protein 
kinase pathway mediates responses to P. aeruginosa PA14 slow killing (KIM et al. 2002; 
TROEMEL et al. 2006). To ask whether these two protective pathways include similar targets, we 
compared our datasets (Table S1 and S2) with published full-genome olignonucleotide array 
studies that identified targets of PMK-1 and SEK-1 (TROEMEL et al. 2006). Among the 86 genes 
up-regulated by PMK-1, 39 are also up-regulated in the swan-1; vhl-1 double mutants, and 29 
are over-expressed in the egl-9 loss-of-function mutants (Figure 3A, Table S5). These overlaps 
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are greater than expected by chance (p-values are 4.444E-34 and 6.237E-21 by Fisher’s exact 
test, respectively), and they identify genes that are regulated by PMK-1 and HIF-1. These 
include the lysozyme gene lys-2; C-type lectins (clec-67, clec-69), a gene with homology to 
ShK-like toxins (T24B8.5), the peptidase pcp-2, and far-3, which encodes a predicted fatty-acid 
binding protein (Tables S1 and S5). The genes misregulated by hyperactivation of HIF-1 also 
overlap with the genes regulated by SEK-1. For example, of the 101 genes shown to be 
positively regulated by SEK-1, 32 of these are also expressed at increased levels in swan-1 
(ok267); vhl-1(ok161) (p-value = 2.299E-22 by Fisher’s exact test) (Figure 3B). Interestingly, 
these genes include several CUB domain proteins and other genes implicated in stress response, 
such as clec-7, ugt-44, and T24B8.5 (Tables S1 and S6).  
We predicted that we might also find significant overlaps between the genes induced by 
HIF-1 over-activation and the genes activated by pore-forming toxins. Loss-of-function 
mutations in egl-9 have been shown to protect C. elegans from the Cry5B and VCC 
pore-forming toxins. Conversely, loss-of-function mutations in hif-1 causes the worms to be 
hypersensitive to Cry5B and VCC (BELLIER et al. 2009). To address this, we compared our 
datasets (Tables S1 and S2) with expression studies that identified Cry5B-responsive genes 
(HUFFMAN et al. 2004). Among the 500 genes up-regulated by Cry5B, 55 are also up-regulated 
in swan-1 (ok267); vhl-1(ok161) (p-value = 1.543E-14 by Fisher’s exact test) (Figure 3C). The 
co-regulated genes include known targets of the DAF-16/FOXO transcription factor, including 
dod-3, dod-22, the sodh-1 alcohol dehydrogenase, and the mtl-1 metallothionein gene (Tables S1 
and S7).  
Recognizing that some of these gene expression changes were also associated with 
response to Yesinia pestis (BOLZ et al. 2010), we asked whether the lists of genes up-regulated in 
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our mutants included a greater number of Y. pestis-responsive genes than that might be expected 
by chance. These data are illustrated in Figure 3D. While there is a significant overlap with genes 
differentially expressed in swan-1 (ok267); vhl-1(ok161) mutants (p-value = 2.180E-15), the 
overlaps with genes differentially expressed in the other two mutants are not compelling (p > 
0.001) (Tables S1 and S8). 
HIF-1 and DAF-16 function synergistically in hypoxia resistance  
We next asked whether the microarray data could help illuminate the intersection of HIF-
1 and DAF-16 functions. DAF-16 is a forkhead family DNA-binding transcription factor, and it 
is inhibited by the sole C. elegans insulin-like receptor DAF-2. DAF-16 and HIF-1 both have 
important roles in regulating longevity, metabolism, and resistance to pathogens and other 
stresses  (BELLIER et al. 2009; BUDDE and ROTH 2010; BUDDE and ROTH 2011; CHEN et al. 
2009; GEMS et al. 1998; JENSEN et al. 2010; KENYON et al. 1993; KIMURA et al. 1997; LARSEN et 
al. 1995; LEISER et al. 2011; LEISER et al. 2013; LUHACHACK et al. 2012; MEHTA et al. 2009; 
MILLER et al. 2011; SCOTT et al. 2002; SHEN et al. 2005; TREININ et al. 2003; TROEMEL et al. 
2006; ZHANG et al. 2009). However, the mechanisms by which these two stress-responsive 
transcription factors interact are not well understood. We were, therefore, intrigued to find that 
daf-18’s mRNA levels were up-regulated in rhy-1, egl-9, and swan-1; vhl-1 mutants, as daf-18 is 
an important negative regulator of the DAF-2 pathway: it encodes a lipid phosphatase 
homologous to the human PTEN tumor suppressor and antagonizes DAF-2 to positively 
regulates DAF-16 (OGG and RUVKUN 1998). daf-18’s mRNAs were up-regulated by 1.8, 2.2 and 
2.2-fold respectively in rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267); vhl-1(ok161) 
compared to N2 (q-values are 0.037, 0.006, 0.011, respectively) (Figure 4A). This result suggests 
a connection between HIF-1 and DAF-16 pathways. 
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We further identified 20 genes that have been shown to be regulated by DAF-16 are also 
differentially regulated in all the three HIF-1 over-activation mutants: rhy-1, egl-9, and swan-1; 
vhl-1 mutants. The expression profiles of these 20 genes in rhy-1, egl-9, and swan-1; vhl-1 
mutants are illustrated in a heat map in Figure 4B. This common molecular signature for DAF-16 
and HIF-1 activation includes increased expression of mtl-1 (metallothionein), sodh-1 (alcohol 
dehydrogenase), sqrd-1 (sulfide:quinone reductase), hsp-12.3 (small heat shock protein), 
ZK550.6 (phytanolyl-CoA hydroxylase), secreted protease inhibitors (swm-1, C25E10.8), and 
others.  
In addition, when we compared genes regulated by DAF-16 with each differentially 
expressed gene lists caused by HIF-1 over-activation, we found that the genes that are over-
expressed in rhy-1, egl-9 or swan-1; vhl-1 mutants include far more DAF-16 targets (MURPHY et 
al. 2003) than would be expected by chance (p-values are 1.42E-12, 5.26E-17 and 5.4E-11, 
respectively) (Figure 4C).   
What is the functional consequence of this convergence between HIF-1 and DAF-16 
functions? Prior studies have shown that loss-of-function mutations in daf-2 result in increased 
DAF-16 activity, and this, in turn, enables C. elegans to survive extended anoxia or high-
temperature anoxia (MENDENHALL et al. 2006; SCOTT et al. 2002). And in our prior study, daf-16 
mRNA levels were induced by hypoxia, independent of hif-1 and vhl-1 (SHEN et al. 2005). We 
examined the requirement for daf-16 in moderate hypoxia (0.5% oxygen, 21°C). In these 
conditions, wild-type embryos hatch within 24 hours and are able to develop to adults within 72 
hours, while hif-1-deficient mutants are less able to successfully complete development in 
moderate hypoxia (Jiang et al 2001; Padilla et al 2002). As shown in Table 5, animals carrying 
loss-of-function mutations in daf-16 are also less able to complete embryogenesis and larval 
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development in 0.5% oxygen. Interestingly, we found that animals carrying loss-of-function 
mutations in both daf-16 and hif-1 were more severely affected by moderate hypoxia than was 
either single mutants. About 52% hif-1-deficient eggs hatched within 24 hours in hypoxic 
conditions, and 10% developed to adulthood within 72 hours. For the two daf-16 loss-of-function 
alleles tested, about 43-46% daf-16-deficient eggs hatched within 24 hours in hypoxic 
conditions, and 30-39% developed to adulthood within 72 hours. Although the double mutants 
were fully viable in normal culture conditions, only 8% of the eggs hatched within 24 hours in 
hypoxic conditions, and <1% developed to adulthood within 72 hours. Thus, hif-1 and daf-16 
function synergistically to help animals develop and survive under hypoxia. 
Based on the results discussed above, we proposed a model to understand the relationship 
between HIF-1 and DAF-16 in hypoxia response. We predict that HIF-1 may positively regulate 
DAF-16 by regulating daf-18 expression. Further, HIF-1and DAF-16 function synergistically to 
help animals survive hypoxia (Figure 5). 
Discussion 
Prior studies suggest that RHY-1, EGL-9 and SWAN-1 function in common pathway(s) 
or in the same complex to regulate HIF-1 activity (DARBY et al. 1999; SHAO et al. 2010; SHEN et 
al. 2006; TRENT et al. 1983). However, this prediction is based on the measures of couple of 
HIF-1 targets and phenotypes. Here, by employing whole-genome transcriptome analyses, we 
are able to strengthen our model. And genes identified as commonly regulated by HIF-1 over-
activation in rhy-1, egl-9 and swan-1; vhl-1 provide richer understanding for HIF-1 related 
biological functions.  
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RHY-1, EGL-9 and SWAN-1 function in common pathway(s) to regulate HIF-1 
Our transcriptome data provide compelling evidence that the model in Figure 1 is correct 
and that RHY-1, EGL-9 and SWAN-1 act in common pathway(s) to repress HIF-1. Prior studies 
have shown that rhy-1, egl-9 and swan-1; vhl-1 mutants have similar phenotypes with respect to 
egg-laying defects, reduced brood size and resistance to Pseudomonas aeruginosa PAO1 fast 
killing (DARBY et al. 1999; SHAO et al. 2010; SHEN et al. 2006; TRENT et al. 1983). Here, we 
describe the gene expression changes that accompany these phenotypes. We showed that the 
molecular phenotypes of the rhy-1, egl-9 and swan-1; vhl-1 mutants are similar: the gene 
expression changes caused by these mutations are dramatically overlapped. This molecular 
similarity strengthen the notion that RHY-1, EGL-9 and SWAN-1 act in common pathway(s) to 
regulate HIF-1. In keeping with this, it has been suggested that in neurons, RHY-1 and EGL-9 
act in the same pathway to regulate HIF-1 for the oxygen-ON response in C. elegans (MA et al. 
2012). 
The diverse cellular processes regulated by HIF-1 may account for its diversified functions 
Misregulation of HIF-1 disrupts diverse processes, in addition to hypoxia adaptation 
(BELLIER et al. 2009; BUDDE and ROTH 2010; BUDDE and ROTH 2011; CHEN et al. 2009; LEISER 
et al. 2011; LEISER et al. 2013; LUHACHACK et al. 2012; MEHTA et al. 2009; SHAO et al. 2010; 
TREININ et al. 2003; ZHANG et al. 2009). However, it was not clear how HIF-1 can be such an 
all-rounder. Our analyses provide a more complete understanding of the gene expression changes 
that underpin these diverse phenotypes. The common sets of genes misregulated in rhy-1, egl-9 
and swan-1;vhl-1 have roles as diverse as in cell cycle and reproduction regulation, metabolism, 
cellular signaling, extracellular matrix, defense/immunity, detoxification/stress response, protein 
homeostasis, transcription and translation regulation, and transport. These diverse biological 
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processes regulated by HIF-1 over-activation suggest models for understanding why HIF-1 has 
multiple functions. For example, the commonly misregulated cell cycle and reproduction 
processes in rhy-1, egl-9 and swan-1; vhl-1 mutants may correspond to their similar 
developmental defect: the reduced brood size.  
The observation that genes up-regulated by HIF-1 over-activation overlap with genes 
activated by pore-forming toxin Cry5B infection may explain why HIF-1 is required for bacterial 
pore-forming toxins (PFT) resistance (BELLIER et al. 2009). We also found that genes up-
regulated by HIF-1 over-activation overlap with genes up-regulated by PMK-1 and SEK-1. As 
NSY-1/ SEK-1/ PMK-1 pathway has been shown to play major roles in P. aeruginosa PA14 
resistance (KIM et al. 2002), these overlaps may give clues to the function of HIF-1 in P. 
aeruginosa PAO1 fast killing resistance (BUDDE and ROTH 2011; SHAO et al. 2010). 
Insights to other SWAN-1 and EGL-9 functions 
The data also illuminate some of the RHY-1, EGL-9, or SWAN-1 functions that are 
independent of the HIF-1 pathway. Prior study shows that EGL-9 can regulate the trafficking of 
the glutamate receptor in an HIF-1-independent manner to respond to the oxygen levels in 
neurons (PARK et al. 2012). In agreement with this, 26% of the genes that were differentially 
expressed in egl-9 mutants were not differentially expressed in rhy-1 and swan-1; vhl-1 mutants. 
Similarly, 33% of the genes differentially expressed in swan-1; vhl-1 mutants were unique to this 
background. This suggests that SWAN-1 also has HIF-1 independent functions. It has been 
shown that SWAN-1 can negatively regulate Rac GTPase (YANG et al. 2006). 
HIF-1 interacts with DAF-16 to regulate hypoxia survival 
Importantly, these data demonstrate that DAF-16 and HIF-1 have complementary and 
overlapping roles in protecting C. elegans from moderate oxygen deprivation (0.5% oxygen, 
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21°C). The striking overlaps between genes up-regulated by DAF-16 and genes up-regulated by 
HIF-1 over-activation is in agreement with the prior observation that genes regulated by daf-2 as 
assayed by microarray were enriched for the predicted HIF-1 binding sites (MCELWEE et al. 
2004). Hypoxia survival assays further show that HIF-1 and DAF-16 function synergistically to 
regulate C. elegans hypoxia survival. Intriguingly, the mRNA levels of daf-18, the positive 
regulator of DAF-16, are up-regulated in egl-9, rhy-1, and swan-1; vhl-1. This suggests a 
mechanism of the cross-talk between HIF-1 and DAF-16: HIF-1 may promote DAF-16 function 
by enhancing the expression of daf-18 in HIF-1 persistent over-activation backgrounds. 
This study also opens the door to new questions about the genes and pathways that enable 
survival in low oxygen conditions. In the future, we would also like to test which of the genes 
co-regulated by egl-9, rhy-1, and swan-1 are direct targets of HIF-1? And what combination of 
DAF-16 and HIF-1 targets enables survival in low oxygen conditions?  
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Figure Legends 
Figure 1. Diagram illustrating HIF-1 regulation. When oxygen is abundant, HIF-1 is 
hydroxylated by the EGL-9 enzyme, and the modified HIF-1 protein is recognized by VHL-1 
and targeted for proteasomal degradation. HIF-1 forms a DNA-binding heterodimeric 
transcription complex with AHA-1. HIF-1 transcriptional activity is inhibited by EGL-9, 
SWAN-1 and RHY-1.  
Figure 2. Genes differentially expressed in rhy-1(ok1402), egl-9(sa307), and swan-1 
(ok267);vhl-1(ok161), relative to wild-type. (A, B) Venn diagrams illustrate the overlaps 
between mutant phenotypes. (A) Genes that are expressed at significantly higher levels in the 
mutants. (B) Genes that are that are expressed at significantly lower levels in the mutants, 
relative to wild-type N2.  (C,D) Pie charts illustrate the some of the biological processes 
regulated by the genes that are differentially expressed in all 3 mutant backgrounds. The number 
of genes in each category is indicated in parentheses. (C) Genes that are expressed at higher 
levels in rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267);vhl-1(ok161). (D) Genes expressed at 
lower levels in rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267);vhl-1(ok161).  
Figure 3. Venn diagrams illustrate overlaps between pathogen response genes and the 
expression differences in mutants with increased HIF-1 activity. (A) Significant over-
representation of genes positively regulated by PMK-1 among genes up-regulated in swan-1 
(ok267);vhl-1 (ok161) (p-value = 4.444E-34) and egl-9(sa307) (p-value = 6.237E-21). (B) 
Significant over-representation of genes positively regulated by SEK-1 among genes expressed 
at increased levels in swan-1 (ok267);vhl-1 (ok161) (p-value = 2.299E-22) or egl-9(sa307) (p-
value = 1.153E-17). (C) Significant over-representation of genes induced by Cry5B among genes 
expressed at increased levels in swan-1 (ok267) vhl-1 (ok161) (p-value = 1.543E-14) or egl-
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9(sa307) (p-value = 3.884E-05). (C) Genes induced by Y. pestis are over-represented among 
genes that are expressed at higher levels in swan-1 (ok267);vhl-1 (ok161) (p-value = 2.180E-15). 
The overlap between genes up-regulated by Y. pestis and genes up-regulated in egl-9(sa307) is 
less significant (p-value > 0.001). 
Figure 4. Convergence of the HIF-1- and DAF-16-responsive transcriptomes. (A) daf-18, 
the negative regulator of DAF-2 pathway, is up-regulated in rhy-1(ok1402), egl-9(sa307), and 
swan-1(ok267);vhl-1(ok161). (B) Heat map illustrates the relative expression of DAF-16-
responsive genes in the three mutant backgrounds. The color intensity corresponds to fold 
change relative to wild-type, and values < 0 (down-regulated) are green, values > 0 
(up-regulated) are red. (C) DAF-16 regulated genes overlapped significantly with genes up-
regulated in rhy-1(ok1402) (p-value = 1.415E-12), egl-9(sa307) (p-value = 5.255E-17), or 
swan-1(ok267);vhl-1(ok161) (p-value = 5.466E-11).  
Figure 5. Cross talk between HIF-1 and DAF-16. Both HIF-1 and DAF-16 protect C. elegans 
from hypoxic insult.  Some genes are commonly regulated by these two transcription factors, 
but they also have many independent functions.  Mutations that cause increased expression of 
HIF-1 targets result in increased daf-18 mRNA expression, and this would be expected to 
increase DAF-16 function.
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Table 1 Genes commonly regulated in rhy-1, egl-9 and swan-1;vhl-1 are involved in 
metabolism 
Genes commonly up-regulated in rhy-1, egl-9 and swan-1;vhl-1 rhy-1/N2 egl-9-1/N2 swan-1;vhl-1/N2 
Biological 
Process Molecular Function (Homology) Gene 
Fold 
change  q-value 
Fold 
change  q-value 
Fold 
change  q-value 
Lipid 
metabolism                 
  Methylmalonyl-CoA epimerase mce-1 1.73 6.21E-06 1.91 3.93E-07 1.81 9.26E-07 
  Methylmalonyl-CoA mutase mmcm-1 1.83 5.02E-05 2.21 1.23E-06 1.81 2.16E-05 
  
Propionyl Coenzyme A Carboxylase Alpha 
subunit pcca-1 2.45 7.23E-06 3.15 1.88E-07 2.23 7.69E-06 
  Propionyl Coenzyme A Carboxylase Beta subunit pccb-1 1.79 2.07E-05 2.22 2.85E-07 1.76 9.63E-06 
  Gamma butyrobetaine hydroxylase gbh-2 2.44 2.58E-05 3.62 2.07E-07 3.82 1.35E-07 
  Peroxisomal phytanoyl-CoA hydroxylase ZK550.6 1.93 6.80E-05 3.42 4.21E-08 3.49 3.93E-08 
  Arylacetamide deacetylase and microsomal lipase trcs-1 1.89 2.29E-02 2.26 3.11E-03 2.15 4.35E-03 
  Diacylglycerol acyltransferase Y53G8B.2 2.59 7.40E-07 3.44 1.54E-08 4.56 1.56E-09 
  
VAMP-associated protein involved in inositol 
metabolism F54H5.3 1.61 5.60E-03 1.89 3.71E-04 1.80 6.39E-04 
Carbohydrate 
metabolism                 
  Glycogenin protein gyg-2 2.27 1.64E-02 2.93 1.70E-03 2.77 2.31E-03 
  Phosphoenolpyruvate carboxykinase (PEPCK) W05G11.6 5.50 1.54E-05 9.33 3.36E-07 8.18 6.29E-07 
  Fructose-1,6-bisphosphate aldolase T05D4.1 1.63 3.47E-06 1.97 3.78E-08 1.61 1.47E-06 
  
Glucosamine-fructose 6-phosphate 
aminotransferase F22B3.4 1.93 4.90E-02 2.16 1.46E-02 1.98 2.44E-02 
  Glycosyl transferase family 11 T26E4.4 2.51 6.49E-04 1.98 2.37E-03 1.80 5.49E-03 
Amino acid 
metabolism                 
  Cysteine synthase cysl-1 2.23 1.79E-07 3.08 1.81E-09 1.82 1.40E-06 
  Cysteine synthase cysl-2 24.72 1.62E-09 31.96 3.94E-10 22.80 1.16E-09 
  Cysteine synthase cysl-3  4.13 8.32E-07 5.15 6.07E-08 5.34 4.87E-08 
  Glutamine synthetase gln-5 1.93 2.69E-02 2.56 2.05E-03 2.62 1.68E-03 
  
GLutamine synthetase (glutamate-ammonia 
ligase) gln-6 2.21 1.82E-02 2.51 4.10E-03 2.42 5.13E-03 
  Phosphoserine phosphatase SerB Y62E10A.3 3.05 3.39E-06 3.68 2.12E-07 1.69 9.00E-04 
  D-3-phosphoglycerate dehydrogenase (PHGDH) C31C9.2 4.39 3.44E-05 5.64 2.88E-06 2.54 6.08E-04 
  Phosphoserine aminotransferase F26H9.5 3.21 5.47E-06 3.83 4.23E-07 2.50 2.05E-05 
  
Glutamate decarboxylase/sphingosine phosphate 
lyase tag-38 5.89 7.07E-07 6.38 1.44E-07 3.10 2.22E-05 
  Tyrosine decarboxylase tdc-1 1.76 3.54E-03 1.86 8.75E-04 1.70 2.40E-03 
General 
metabolism                 
  O-Acyltransferase homolog oac-54 4.45 6.83E-05 10.81 2.36E-07 3.91 6.24E-05 
  SAM-dependent methyltransferases R08E5.3 14.70 5.38E-10 14.53 2.33E-10 9.76 1.29E-09 
  Malate/L-lactate dehydrogenase VF13D12L.3 2.30 1.22E-05 3.29 1.06E-07 2.26 5.32E-06 
  Succinyl-CoA synthetase B0365.1 1.77 8.30E-05 2.11 2.52E-06 1.75 4.00E-05 
  Succinyl-CoA synthetase D1005.1 2.33 1.98E-04 3.09 5.89E-06 1.61 4.71E-03 
  PhzC/PhzF-type epimerase T04A11.1 3.77 1.01E-04 4.66 1.07E-05 5.32 4.67E-06 
  PhzC/PhzF-type epimerase T04A11.2 11.40 1.67E-08 18.58 1.17E-09 8.08 4.04E-08 
  Tyrosinase tyr-1 1.83 3.24E-02 2.57 1.54E-03 2.87 6.86E-04 
  DeoxyUTPase dut-1 1.74 2.63E-03 2.08 1.50E-04 2.01 2.20E-04 
  Thymidylate synthase Y110A7A.4 1.64 1.38E-03 1.84 1.29E-04 1.87 1.00E-04 
Genes commly down-regulated in rhy-1, egl-9 and swan-1;vhl-1 
Lipid 
metabolism                 
  Acyl CoA DeHydrogenase acdh-2 -5.65 9.71E-05 -9.17 3.78E-06 -8.92 4.13E-06 
  fatty Acid CoA Synthetase family acs-2 -4.03 1.15E-05 -3.87 5.58E-06 -2.34 3.20E-04 
  Phospholipase D homolog T05C3.6 -2.43 3.74E-05 -2.56 8.62E-06 -3.25 8.18E-07 
  Choline/ethanolamine phosphotransferase cept-1 -1.75 8.92E-04 -2.02 6.63E-05 -2.11 3.87E-05 
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  Alkaline ceramidase W02F12.2 -1.70 7.73E-03 -1.79 2.09E-03 -1.62 6.04E-03 
  Beta-glucocerebrosidase Y4C6B.6 -1.82 1.94E-03 -7.88 6.97E-09 -10.21 1.73E-09 
  Fatty acyl-coA reductase fard-1 -1.66 6.25E-03 -2.28 8.55E-05 -1.67 2.63E-03 
  FAtty acid desaturase fat-7 -3.68 2.54E-05 -12.06 1.08E-08 -19.77 1.47E-09 
  Nematode fatty acid retinoid binding protein far-8 -1.86 5.91E-05 -2.50 4.25E-07 -1.66 1.33E-04 
  Lipid binding protein lbp-5 -1.72 1.73E-03 -2.45 1.13E-05 -2.15 4.91E-05 
  Protein involved in lipid storage K07A1.13 -1.66 1.16E-02 -1.64 6.05E-03 -1.86 1.58E-03 
  F-box C protein C08G5.2 -1.69 1.17E-03 -1.84 1.64E-04 -1.70 4.78E-04 
  Lipase superfamily lips-15 -3.00 1.01E-06 -4.11 2.25E-08 -4.08 2.57E-08 
Carbohydrate 
metabolism                 
  Alpha-Amylase C50B6.7 -1.72 1.23E-03 -4.68 2.45E-08 -7.35 1.54E-09 
  β-N-acetylhexosaminidase hex-5 -1.73 2.21E-02 -1.91 4.64E-03 -1.67 1.58E-02 
  Galactosyltransferase galt-1 -1.81 1.40E-04 -1.91 2.63E-05 -1.64 2.68E-04 
Amino acid 
metabolism                 
  Glycine cleavage system H protein gcsh-1 -1.95 2.29E-04 -2.28 1.57E-05 -2.99 8.48E-07 
  cystathionine gamma-lyase cth-1 -2.36 3.56E-04 -8.84 1.54E-08 -4.73 5.31E-07 
  Threonine dehydratase K01C8.1 -3.14 1.34E-05 -4.24 4.25E-07 -4.84 1.64E-07 
  Arginase family T21F4.1 -1.60 2.01E-04 -1.84 7.86E-06 -1.62 6.79E-05 
  Glutaminase glna-2 -2.07 1.29E-03 -2.42 1.30E-04 -1.81 2.34E-03 
  Tryptophan 2,3-dioxygenase C28H8.11 -1.71 6.40E-03 -2.14 2.83E-04 -2.89 1.54E-05 
DNA / RNA 
metabolism                 
  Cytidine deaminase cdd-1 -1.68 2.54E-03 -2.16 5.08E-05 -2.36 1.91E-05 
  Adenylate kinase and related kinases C29F7.3 -1.85 8.72E-03 -1.80 5.31E-03 -1.62 1.48E-02 
General 
metabolism                 
  Ornithine decarboxylase odc-1 -1.75 7.60E-04 -2.07 3.66E-05 -1.69 5.19E-04 
  
Human CLN (neuronal ceroid lipofuscinosis) 
related cln-3.1 -2.03 3.44E-05 -2.22 4.14E-06 -2.24 3.36E-06 
  3-oxoacid CoA-transferase C05C10.3 -1.71 1.86E-03 -1.74 6.79E-04 -1.75 5.94E-04 
  O-acyltransferase homolog F36G9.12 -2.56 1.54E-04 -3.55 4.07E-06 -2.59 6.11E-05 
  Alpha/beta hydrolase C44C1.5 -1.75 1.72E-03 -3.14 1.32E-06 -2.10 8.39E-05 
  Carboxylesterase F55F3.2 -1.63 4.51E-08 -1.88 1.21E-09 -3.02 2.29E-12 
  
Chondroitin 6-sulfotransferase and related 
sulfotransferases F36D1.8 -3.17 2.42E-04 -3.81 2.89E-05 -3.78 3.04E-05 
  NADH:flavin oxidoreductase ZK742.3 -1.87 5.57E-04 -3.18 7.51E-07 -1.82 3.39E-04 
 
Table 2 Genes commonly regulated in rhy-1, egl-9 and swan-1;vhl-1 are involved in cell 
cycle and reproduction regulation 
Genes commly up-regulated in rhy-1, egl-9 and swan-1;vhl-1 rhy-1/N2 egl-9-1/N2 swan-1;vhl-1/N2 
Biological Process Molecular Function (Homology) Gene 
Fold 
change  q-value 
Fold 
change  q-value 
Fold 
change  q-value 
Cell cycle and 
reproduction                 
  CDC25 family tyrosine phosphatase cdc-25.3 2.57 3.88E-03 3.74 1.58E-04 3.58 2.09E-04 
  Cyclin B cyb-3 1.64 3.11E-02 1.97 3.20E-03 1.89 4.44E-03 
  Paired zinc Finger protein pzf-1 1.93 9.74E-03 2.45 6.29E-04 2.35 8.55E-04 
  Regulator of microtubule dynamics rmd-1 1.89 4.90E-02 2.12 1.40E-02 2.15 1.25E-02 
  Membrane-associated protein perm-1 2.00 3.29E-02 2.39 5.79E-03 2.09 1.36E-02 
  Katanin mei-2 1.78 2.11E-02 2.11 2.55E-03 2.05 3.20E-03 
  Uncharacterized protein mesp-1 2.02 3.56E-02 2.73 3.17E-03 2.49 5.42E-03 
  RNA-binding domain spn-4 1.83 4.26E-02 2.11 9.20E-03 2.20 6.92E-03 
  
encodes two KH domain-containing 
RNA-binding proteins, GLD-3L and 
GLD-3S gld-3 1.74 4.17E-02 2.29 3.10E-03 1.83 1.64E-02 
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  Telomerase Reverse Transcriptase trt-1 1.66 9.58E-03 1.85 1.44E-03 1.75 2.52E-03 
  Major sperm protein (MSP) domain ssp-19 1.98 2.08E-02 2.42 2.55E-03 2.28 3.86E-03 
  Major sperm protein (MSP) domain ssp-33 1.87 2.57E-02 1.92 1.12E-02 1.87 1.32E-02 
  Cytosolic motility protein 
Y59E9A
L.2 2.13 1.43E-02 2.13 7.16E-03 1.78 2.57E-02 
  Maternal Effect Germ-cell defective meg-1 3.17 3.67E-02 5.74 2.29E-03 6.33 1.55E-03 
  Protein functions in reproduction W05F2.3 2.16 2.32E-02 2.39 6.62E-03 2.50 4.85E-03 
  Leucine-rich repeat (LRR) protein egg-6 1.67 1.29E-03 1.72 4.08E-04 1.69 4.78E-04 
  Similar to fatty acid-binding proteins EEED8.3 2.69 4.91E-02 4.31 4.26E-03 4.35 4.01E-03 
  
Glucosamine 6-phosphate N-
acetyltransferase gna-2 1.77 3.70E-02 2.12 5.29E-03 2.23 3.61E-03 
  CCCH-type Zn-finger protein mex-1 2.00 3.62E-02 2.37 6.85E-03 2.07 1.59E-02 
  
KH domain-containing RNA binding 
proteins mex-3 1.60 3.96E-02 2.05 2.54E-03 1.71 1.28E-02 
  CCCH zinc-finger protein mex-5 1.98 2.07E-02 2.21 4.77E-03 2.09 7.08E-03 
  Nuclear Autoantigenic Sperm Protein nasp-2 1.81 2.53E-02 2.11 3.99E-03 2.05 4.87E-03 
  
Protein tyrosine phosphatase, regulate 
the activity of the MBK-2 DYRK egg-5 1.83 3.52E-02 1.94 1.27E-02 1.85 1.75E-02 
  
Protein tyrosine phosphatase-like 
(PTPL) family, regulate the activity of 
the MBK-2 DYRK egg-3 1.75 2.45E-02 2.12 2.58E-03 2.01 3.83E-03 
  CCCH zinc-finger protein mex-6 1.83 4.53E-02 2.31 5.38E-03 2.13 9.27E-03 
  Receptor with LDL repeats egg-1 2.13 4.60E-02 2.51 1.12E-02 2.30 1.78E-02 
  Receptor with LDL repeats egg-2 2.08 2.75E-02 2.53 4.46E-03 2.54 4.24E-03 
  CCCH-type Zn-finger protein oma-1 1.65 3.84E-02 1.80 1.04E-02 1.62 2.44E-02 
  CCCH-type Zn-finger protein oma-2 2.14 2.80E-02 2.68 3.96E-03 2.58 4.89E-03 
 
Table 3 Genes commonly regulated in rhy-1, egl-9 and swan-1;vhl-1 are involved in stress 
response and immunity 
Genes commly up-regulated in rhy-1, egl-9 and swan-1;vhl-1 rhy-1/N2 egl-9-1/N2 swan-1;vhl-1/N2 
Biological Process Molecular Function (Homology) Gene 
Fold 
change  q-value 
Fold 
change  q-value 
Fold 
change  q-value 
Defense/Immunity                 
  C-type lectin clec-52 3.48 3.64E-08 16.40 2.56E-12 7.64 7.51E-11 
  C-type lectin clec-60 3.81 1.44E-02 5.81 1.38E-03 2.67 2.98E-02 
  C-type lectin clec-67 2.34 1.29E-03 6.97 2.81E-07 6.28 5.03E-07 
  C-type lectin clec-69 2.47 1.07E-03 8.00 1.91E-07 7.19 3.37E-07 
  C-type lectin clec-87 2.18 3.84E-02 2.54 9.23E-03 2.70 6.45E-03 
  C-type lectin clec-88 2.20 3.16E-02 2.82 4.28E-03 3.04 2.77E-03 
  C-type lectin clec-91 2.45 1.86E-02 2.86 3.88E-03 3.02 2.84E-03 
  Caenacin antimicrobial peptide  cnc-4 4.67 1.37E-04 3.96 1.51E-04 1.88 1.97E-02 
  lysozyme lys-2 1.76 1.33E-03 3.49 4.23E-07 2.34 2.17E-05 
  ShK-like toxin T24B8.5 8.12 3.69E-07 22.06 2.10E-09 16.66 5.52E-09 
Detoxification/stres
s response                  
  Cytochrome P450 family cyp-36A1 2.30 5.55E-04 2.90 3.07E-05 2.59 8.39E-05 
  
Flavin-containing monooxygenase 
family fmo-4 1.80 2.53E-03 2.98 6.73E-06 1.87 7.33E-04 
  
Related to short-chain alcohol 
dehydrogenases H04M03.3 1.66 3.56E-02 2.18 2.02E-03 2.22 1.65E-03 
  Alcohol dehydrogenases D2063.1 4.04 1.61E-07 2.93 9.34E-07 3.58 1.49E-07 
  Sorbitol dehydrogenase, class V sodh-1 3.82 2.07E-05 4.46 2.57E-06 1.89 2.84E-03 
  Glutathione S-Transferase gst-19 115.27 2.31E-13 170.00 4.53E-14 84.92 2.28E-13 
  Sulfide:quinone reductase sqrd-1 93.93 2.31E-13 159.05 4.53E-14 78.20 2.28E-13 
  sulfur dioxygenase ethe-1 4.04 2.90E-10 8.71 9.99E-13 6.75 2.29E-12 
  
Mercaptopyruvate sulfur 
transferase homolog mpst-3 4.10 4.96E-10 8.66 2.50E-12 4.55 7.51E-11 
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  Nitrilase nit-1 25.43 9.10E-12 29.11 2.56E-12 15.61 2.11E-11 
  
Predict to involved in 
anhydrobiosis lea-1 6.76 3.87E-06 6.84 1.25E-06 4.17 2.34E-05 
  Heat shock protein hsp-12.3 1.77 6.26E-03 4.96 4.21E-07 1.98 9.06E-04 
  Heat shock protein sip-1 2.69 6.49E-04 2.76 2.42E-04 2.56 4.21E-04 
  
Transcribed telomere-like 
sequence tts-1 6.09 2.25E-05 15.57 1.06E-07 70.80 1.03E-09 
  Metallothioneins mtl-1 8.73 1.54E-07 28.99 5.01E-10 24.59 8.79E-10 
Genes commly 
down-regulated in 
rhy-1, egl-9 and 
swan-1;vhl-1                 
Defense/Immunity                 
  C-type lectin clec-10 -1.75 3.01E-02 -3.58 7.47E-05 -5.03 8.31E-06 
  C-type lectin clec-51 -1.82 4.26E-05 -3.27 1.44E-08 -2.40 3.48E-07 
  C-type lectin clec-86 -2.97 7.23E-06 -6.57 8.04E-09 -5.53 2.30E-08 
  C-type lectin clec-230 -5.54 2.29E-06 -5.82 5.83E-07 -6.49 3.02E-07 
  C-type lectin T15B7.1 -1.71 2.54E-05 -1.62 2.50E-05 -2.45 4.57E-08 
  Lysozyme lys-5 -1.76 1.26E-03 -2.45 1.20E-05 -3.12 1.01E-06 
  CUB-like domain F54B11.11 -1.62 1.99E-02 -2.35 2.53E-04 -1.70 5.76E-03 
  
leukotriene A4 
hydrolase/aminopeptidase ZC416.6 -1.70 2.93E-02 -1.68 1.80E-02 -1.87 7.07E-03 
  Venom allergen-like protein vap-1 -2.45 1.39E-04 -2.58 3.60E-05 -4.91 1.81E-07 
  2 (Zwei) IG-domain protein zig-3 -6.32 5.53E-06 -6.65 1.48E-06 -7.17 9.26E-07 
  Fatty Acid/Retinol binding protein far-3 69.80 1.08E-10 57.70 5.64E-11 2.96 5.09E-05 
Detoxification/stres
s response                  
  short chain dehydrogenase C30G12.2 -2.50 1.80E-05 -3.78 1.35E-07 -3.67 1.60E-07 
  Short-chain dehydrogenase dhs-25 -2.68 1.28E-05 -3.32 6.12E-07 -3.09 1.10E-06 
  UDP-glucuronosyl transferase ugt-30 -2.32 6.49E-04 -2.86 4.45E-05 -3.82 4.43E-06 
  UDP-glucuronosyl transferase ugt-46 -1.61 1.09E-02 -2.30 1.07E-04 -2.89 1.16E-05 
  UDP-glucuronosyl transferase ugt-53 -1.84 7.75E-03 -3.09 3.74E-05 -3.97 5.49E-06 
  
UDP-glucuronosyl/UDP-
glucosyltransferase Y73B6A.3 -1.62 1.12E-02 -1.90 8.59E-04 -1.69 3.22E-03 
  Aldehyde dehydrogenase alh-5 -1.66 4.84E-03 -6.24 1.80E-08 -4.09 2.91E-07 
  
Transmembrane protein induced 
by ER-stress abu-4 -2.10 1.82E-02 -1.60 6.43E-02 -1.73 3.49E-02 
 
Table 4 Genes commonly up-regulated in rhy-1, egl-9 and swan-1;vhl-1 are involved in 
signaling/transcriptional regulation 
Genes commly up-regulated in rhy-1, egl-9 and swan-1;vhl-1 rhy-1/N2 egl-9-1/N2 swan-1;vhl-1/N2 
Biological Process Molecular Function (Homology) Gene 
Fold 
change  q-value 
Fold 
change  q-value 
Fold 
chan
ge  q-value 
Signaling/transcriptional 
regulation                 
  
A lipid phosphatase homologous to 
the human PTEN tumor suppresor daf-18 1.84 3.67E-02 2.21 5.52E-03 1.99 1.13E-02 
  Protein Wnt mom-2 1.85 2.07E-02 2.13 3.49E-03 2.13 3.32E-03 
  Regulator of G protein Signaling rgs-8.1 1.89 2.40E-02 2.85 6.29E-04 3.23 2.57E-04 
  Dioxygenase egl-9 2.14 1.39E-04 4.48 6.26E-08 4.60 5.00E-08 
  Serine/threonine protein kinase E02H4.6 2.19 8.48E-03 2.71 8.66E-04 2.35 2.35E-03 
  Serine/threonine protein phosphatase ZK938.1 1.83 4.13E-02 1.93 1.62E-02 1.80 2.68E-02 
  Protein tyrosine phosphatase 
Y18H1
A.1 1.74 2.75E-02 1.62 2.90E-02 1.69 1.96E-02 
  Protein tyrosine phosphatase F47B3.2 1.73 4.27E-02 1.70 2.77E-02 1.70 2.72E-02 
  Serine/threonine protein phosphatase F52H3.6 1.75 2.62E-02 1.76 1.40E-02 1.71 1.69E-02 
  Nuclear Hormone Receptor family nhr-57 28.36 5.22E-09 43.01 7.35E-10 12.67 4.67E-08 
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  Nuclear Hormone Receptor family nhr-62 2.52 6.03E-06 4.07 2.54E-08 1.79 1.63E-04 
  
WD-repeat protein/transcription 
regulation COMPASS complex wdr-5.3 1.78 2.42E-02 2.20 2.17E-03 1.90 7.11E-03 
  T-box family tbx-36 2.12 6.17E-03 2.84 3.02E-04 2.67 4.42E-04 
  C2H2 zinc finger transcription factor lsy-27 2.06 1.73E-02 2.60 1.72E-03 2.51 2.12E-03 
  CCCH-type Zn-finger protein pos-1 2.17 2.70E-02 2.63 4.74E-03 2.61 4.87E-03 
  Furry homolog protein sax-2 2.67 1.62E-06 2.26 3.90E-06 2.14 7.47E-06 
  Axon guidance T24D1.3 1.88 3.76E-02 2.34 4.77E-03 2.16 8.22E-03 
  
ADAM (A Disintegrin And Metallop
roteinase) unc-71 1.65 4.73E-03 1.85 5.31E-04 1.74 1.05E-03 
  Unnamed protein gfi-1 1.75 2.91E-03 2.12 1.48E-04 18.09 1.29E-10 
Genes commly down-
regulated in rhy-1, egl-9 
and swan-1;vhl-1                 
Signaling/transcriptional 
regulation                 
  7 transmembrane receptor B0334.6 -1.95 1.40E-03 -2.29 1.15E-04 -2.17 2.04E-04 
  7-transmembrane olfactory receptor str-146 -2.94 2.71E-04 -3.92 1.44E-05 -1.72 1.11E-02 
  Protein tyrosine kinase F20D6.5 -1.80 3.56E-04 -2.17 1.42E-05 -3.72 5.79E-08 
  Protein tyrosine kinase T01G5.1 -2.29 3.13E-05 -2.59 3.12E-06 -2.27 1.29E-05 
  CHK kinase-like 
H06H21
.8 -1.84 1.14E-03 -2.38 2.81E-05 -2.25 5.26E-05 
  Nuclear hormone receptor family nhr-101 -1.98 1.11E-04 -2.15 1.69E-05 -1.92 6.90E-05 
  Nuclear hormone receptor family nhr-114 -2.21 5.30E-04 -2.67 3.91E-05 -2.32 1.44E-04 
  Homeodomain protein ceh-60 -1.78 2.49E-04 -1.65 3.57E-04 -2.04 1.65E-05 
  Patched related family ptr-3 -1.86 2.74E-02 -1.70 3.08E-02 -2.16 4.78E-03 
  Patched related family ptr-23 -1.82 1.06E-02 -1.64 1.41E-02 -1.72 8.95E-03 
  Hedgehog-like protein grd-6 -2.78 8.27E-03 -2.68 4.88E-03 -2.24 1.40E-02 
  Hedgehog-like protein grd-11 -1.67 1.28E-03 -2.03 4.30E-05 -1.86 1.29E-04 
  Hedgehog-like protein grl-27 -2.17 2.34E-03 -2.15 1.17E-03 -2.75 1.38E-04 
  Hedgehog-like protein wrt-8 -3.66 1.98E-05 -2.97 3.68E-05 -4.96 8.01E-07 
  Hedgehog-like protein wrt-4 -2.07 4.18E-02 -3.31 1.69E-03 -2.78 4.27E-03 
  Small GTPase superfamily 
C52B11.
5 -1.64 2.10E-03 -1.96 8.21E-05 -1.95 9.62E-05 
  
PDZ and PTB domain-containing 
protein lin-10 -1.73 2.01E-04 -1.81 4.09E-05 -1.77 5.65E-05 
  BTB domain K08E4.7 -1.60 1.28E-02 -2.32 1.15E-04 -2.34 1.09E-04 
  Phosphotyrosine interaction domain K11E4.2 -1.90 3.76E-04 -2.56 5.63E-06 -3.83 1.30E-07 
  Glypican family lon-2 -1.72 8.54E-04 -1.66 6.47E-04 -1.94 7.36E-05 
 
Table 5 hif-1 and daf-16 function synergistically under hypoxia 
Genotype Condition Mean hatch ratio ± SEM 
(%) 
p-valuea  Mean adult ratio± SEM 
(%) 
p-valuea nb 
hif-1 (ia04) Hypoxia 52.21 ± 3.31 p < 0.0001 10.25 ± 1.99 p < 0.0001 280 
hif-1 (ia04) Normoxia 100.00 ± 0.00 - 100.00 ± 0.00 - 307 
daf-16 (mu86) Hypoxia 42.99 ± 2.27 p < 0.0001 30.20 ± 2.11 p < 0.0001 515 
daf-16 (mu86) Normoxia 100.00 ± 0.00 - 100.00 ± 0.00 - 223 
daf-16 (mgDf50) Hypoxia 45.52 ± 3.43 p < 0.0001 39.40 ± 3.38 p < 0.0001 240 
daf-16 (mgDf50) Normoxia 100.00 ± 0.00 - 100.00 ± 0.00 - 222 
daf-16(mgDf50);hif-1 
(ia04) 
Hypoxia 8.00 ± 1.66 p < 0.0001 0.38 ± 0.38 p < 0.0001 351 
daf-16(mgDf50);hif-1 
(ia04) 
Normoxia 100.00 ± 0.00  100.00 ± 0.00  209 
     a hypoxia against normoxia for each genotype. 
     b n is the total number of young adults assayed in three independent experiments. 
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Figure 1. Diagram illustrating HIF-1 regulation.  
 
Figure 2. Genes differentially expressed in rhy-1(ok1402), egl-9(sa307), and swan-1 
(ok267);vhl-1(ok161), relative to wild-type. 
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Figure 3. Venn diagrams illustrate overlaps between pathogen response genes and the expression 
differences in mutants with increased HIF-1 activity. 
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Figure 4.  Convergence of the HIF-1- and DAF-16-responsive transcriptomes. 
 
Figure 5. Cross talk between HIF-1 and DAF-1 
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CHAPTER 4. GENOME-WIDE PROFILING OF HYPOXIA-INDUCED GENES 
Abstract 
Oxygen is an essential molecule to all the aerobic organisms. However, during normal 
development, disease and homeostasis, organisms are often facing the challenge of hypoxia 
(oxygen deprivation). In metazoans, HIFs (hypoxia-inducible factors) are the master regulators 
of hypoxia response. HIFs are evolutionarily conserved in metazoan, the homolog of HIF in C. 
elegans is HIF-1. In this study, we used C. elegans as a model to study the function of HIF-1. 
We are aimed to answer these fundamental questions related to hypoxia response and HIF-1 
function: (1) which genes are responding to short-term hypoxia treatment? (2) Under short-term 
hypoxia, which genes’ mRNA levels are dependent on HIF-1? (3) Which genes are potential 
HIF-1 direct targets? We combined Affymetrix microarray technique and ChIP-seq to address 
these questions. We found that HIF-1 mediated hypoxia gene expression changes are involved in 
multiple biological processes, genes involved in lip metabolism are newly identified by this 
study. Collectively, these functions are important for C. elegans development and survival under 
hypoxia. We also found that short-term hypoxia-responsive genes overlap with H2S responsive 
genes, and HIF-1-dependent hypoxia-responsive genes overlap with genes regulated by DAF-16. 
Further, we found that potential HIF-1 direct targets identified by ChIP-seq are enriched in the 
differentially expressed gene lists identified by microarray in response to hypoxia treatment and 
constitutive HIF-1 high activation.  
Introduction 
Oxygen is essential to all the aerobic organisms for energy production and cellular redox 
environment maintenance. However, during development, disease and homeostasis, animals are 
often challenged by hypoxia (lack of oxygen). Majority of the transcriptional response to 
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hypoxia is mediated by HIF (hypoxia-inducible factor) complex. In mammals, HIF complex 
consists of an α subunit and a β subunit, and they are both bHLH (basic-helix-loop-helix)-PAS 
(PER/ARNT/SIM) domain proteins (SEMENZA 2012; WANG et al. 1995). There are three 
homologous HIFα proteins in human genome: HIF-1, -2 and -3α, and three ARNT/HIFβ 
proteins: HIF-1, -2 and -3β (TAKAHATA et al. 1998). HIFβ has multiple bHLH-PAS dimerization 
partners and is relatively abundant. In contrast, HIFα is short-lived under well-oxygenated 
conditions, thus dedicated to hypoxia response (BERRA et al. 2006; KAELIN and RATCLIFFE 2008; 
SEMENZA et al. 1996). The stability of HIFα is regulated by PHD/VHL pathway. When the 
oxygen level is high enough, HIFα is hydroxylated by the family of dioxygenases PHD, using 
oxygen as one of the substrates. The hydroxylated HIFα is targeted by E3 ligase VHL (von 
Hippel-Lindau tumor suppressor) for proteasomal degradation. 
HIF complex is evolutionarily conserved from human to C. elegans. C. elegans is a 
powerful system for studying HIF-1 function and hypoxia response. C. elegans is short-lived and 
easy to maintain in the lab. The genome of C. elegans is known. And C. elegans is amenable for 
reverse and forward genetics. Besides these advantages, it has only one HIFα and one HIFβ 
homolog, which simplifies the functional study of HIF-1 pathway. The corresponding human 
HIFα, HIFβ homologs in C. elegans are HIF-1 and AHA-1. (EPSTEIN et al. 2001; JIANG et al. 
2001; POWELL-COFFMAN et al. 1998). While a hif-1α -/- mouse dies by E9.0 with severe vascular 
defects (IYER et al. 1998; RYAN et al. 1998), C. elegans hif-1(ia04) loss-of-function mutants are 
phenotypically normal in room air. However, hif-1(ia04) loss-of-function mutants are defective 
in hypoxia adaption (0.5% or 1% O2) (JIANG et al. 2001; PADILLA et al. 2002). The oxygen-
dependent HIF-1 degradation by PHD/VHL pathway is conserved in C. elegans. HIF-1 degrades 
quickly upon reoxygenation in 8-10 minutes (EPSTEIN et al. 2001; JIANG et al. 2001). The 
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corresponding homologs of PHD and VHL are EGL-9 and VHL-1 in C. elegans (EPSTEIN et al. 
2001). Besides regulating HIF-1 stability, egl-9 also inhibits HIF-1 activity in C. elegans.  
Thus, HIF-1 is constitutively active in egl-9 loss-of-function mutants. 
In a prior study, with two-color cDNA microarrays, we identified gene expression 
changes in response to 4 hours 0.1% oxygen in L3-stage worms (SHEN et al. 2005). In 
subsequent studies, we refined the conditions for oxygen deprivation experiments and 
determined that some targets exhibited the most robust responses after 2 hours hypoxia in 
L4-stage worms. With this knowledge and with the advantages of newer microarray 
technologies, we sought to describe the consequences of short-term hypoxia and HIF-1mediated 
gene expression changes under short-term hypoxia. In this study, we treated L4-stage C. elegans 
with 2 hours 0.5% oxygen. We then monitored the short-term hypoxia induced mRNA 
abundance changes by Affymetrix microarray and we asked which genes’ mRNA levels are 
dependent upon HIF-1. Finally, combining genome-wide gene expression studies with ChIP-seq, 
we were able to identify high confidence HIF-1 direct targets. 
Materials and Methods 
Strains 
The wild-type C. elegans used in this study was N2 Bristol. The mutant strains used in 
this study are listed in the Supplemental Table S1. All the worms were maintained at 20°C using 
the standard methods unless otherwise mentioned (BRENNER 1974).  
Gene expression microarray experiment and data analysis 
Randomized complete block design was followed for the microarray experiment, with 
three independently repeated experiments treated as blocks. Each block included eight 
treatments: N2 (wild-type animals), N2 with hypoxia treatment, hif-1(ia04), hif-1(ia04) with 
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hypoxia treatment, vhl-1(ok161), rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267); vhl-1(ok161) 
double mutants. One experimental unit was assigned to each treatment within each block. To get 
sufficient RNA for hybridization, about 1,000 synchronized L4-stage larvae were pooled as one 
experimental unit. Total RNA isolated from each experimental unit using Trizol (Invitrogen) was 
hybridized onto one Affymetrix GeneChip® C. elegans Genome array to analyze gene 
expression. Probe synthesis, labeling, hybridization, washing, staining, and scanning were 
performed by the GeneChip facility at Iowa State University. The resulting CEL files were 
normalized and summarized using the robust multichip average (RMA) algorithm (IRIZARRY et 
al. 2003) in R (R development core team, 2009; Gentleman et al, 2004). An analysis of variance 
(ANOVA) model was then fitted to the summarized expression measures for each probeset 
separately, with the block (3 levels) and the treatment (8 levels) treated as fixed effect factors 
following the experimental design. Residual model diagnostics identified no severe violations of 
model assumptions. Linear contrasts of treatment means that are of interest were tested using the 
general F-test for each contrast and each probeset separately. For each contrast of interest, 
histograms of p-values from all probesets were plotted. To account for multiplicities of 
hypothesis testing, conservative estimates of false discovery rates (FDR) were calculated 
according to the q-value procedure of Storey and Tibshirani (STOREY and TIBSHIRANI 2003) for 
each contrast separately. Probesets were converted to gene names using the Affymetrix 
annotation file “Celegans.na30.annottrimmed.csv” and wormbase (WS220). To avoid 
redundancy, we kept one probeset per gene. For probesets that hybridized to multiple genes, all 
the gene names are listed in Supplemental Tables S2 and S3. The total number of unique 
probesets detected was 18, 011. The gene functions were annotated using wormbase (WS220) 
(HARRIS et al. 2010).  
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In this chapter, we discuss the comparison of gene expression change between N2 
wild- type and hif-1(ia04) under short-term hypoxia. The gene expression changes in HIF-1 
negative regulator mutants: vhl-1(ok161), rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267); vhl-
1(ok161) double mutants, compared to N2 has been described in chapter 3.  
Consensus motifs at the promoters of HIF-1 dependent genes under hypoxia 
We analyzed the 1.5 kb regulatory regions immediately 5’ to the translational start(s) of  
HIF-1-dependent hypoxia-responsive genes for identifying the consensus motif using Regulatory 
Sequence Analysis Tools oligo-analysis (RSAT) (THOMAS-CHOLLIER et al. 2008). The 
predefined C. elegans nucleotide frequency provided by RSAT was used as the background. The 
oligomer length was set at 5 bp. All the other parameters were set as default.  
HIF-1 chromatin immunoprecipitation (ChIP) 
The strain used in the CHIP experiment was ZG434 (hif-1(ia04); egl-9(sa307); 
iaIS28[Phif-1::hif-1::HA::myc]) (Zhang et al. 2009). Because HIF-1 will be quickly degraded 
upon reoxygenation in 8-10 minutes (EPSTEIN et al. 2001; JIANG et al. 2001), we performed the 
ChIP experiment in egl-9 mutant background to stabilize HIF-1 and maintain HIF-1 activity. To 
take advantage of the commercially available ChIP grade anti-HA antibody, an HA-tagged HIF-
1 transgene iaIS28[Phif-1::hif-1::HA::myc]) was used (Zhang et al. 2009), and the endogenous 
hif-1 gene was knocked out. The strain was maintained at 20°C. In dealing with the egg-laying 
defect caused by egl-9 loss-of-function mutation to generate enough synchronized L4-stage 
worms for the ChIP experiment, adults were manually picked to lay eggs on the NGM plates 
seeded with OP50 for 5-6 hours. L4-stage worms were harvested at the end of 58-60 hour(s). In 
this way, we could harvest about 10,000 L4-stage animals from 650-780 adults. About 50,000 L4 
worms were pooled for one ChIP experiment. The following ChIP protocol was modified from 
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Zhong et al. (ZHONG et al. 2010). The worms were washed off the plates using M9 and 
transferred to a 15 ml conical tube. They were centrifuged at 4,000 rpm for 30 seconds. We then 
removed the supernatant and transferred the worms to a 1.5 ml microcentrifuge tube. We washed 
the worms once more with M9 and resuspended the worms in a solution of 1.7 ml M9 and 97 l 
37% formaldehyde solution to cross-link the protein and DNA. The worms were incubated for 
30 minutes with rotation at 24-25°C. We washed the worms twice with 1.7 ml 0.1 M Tris pH7.5 
to quench the formaldehyde, followed by two washes in M9, and one wash in RIPA lysis buffer 
(50 mM Tris-HCl pH8, 150 mM NaCl, 2 mM EDTA pH8, 1% Nonidet P-40, 0.1% sodium 
deoxycholate, 0.1% SDS) supplemented with protease inhibitors (Roche Cat#11697498001, 
Complete Protease Inhibitor Cocktail Tablets and PMSF). We removed the supernatant and 
stored the worm pellet at -80°C. The frozen samples were used for the ChIP experiment within 2 
weeks. For one ChIP experiment, 5 tubes of worm pellet were thawed, with about 10,000 worms 
in each tube, adding 210 l RIPA lysis buffer with protease inhibitor to each tube. Using a 
Branson sonifer microtip located at Iowa State University MBB 1238, the samples were 
sonicated 5-6 times on ice/salt water, each time for 2 seconds at 30% amplitude, cooling the 
samples for 2 minutes between each sonication. The lysate from these 5 tubes was combined to 
one tube and centrifuged at 14,000 rpm for 20 minutes. We took 600 l supernatant as the IP 
sample, and 60 l supernatant as the input sample, and took 3 x 60 ul supernatant to 3 tubes as 
the sonication test samples. In the IP sample, we added 6 l ChIP grade anti-HA tag antibody 
(Abcam, cat. no. ab9110), rocking gently at 4°C for 1 hour. In the input and sonication test 
samples, we added 2 ul 10% acrylamide carrier (Sigma, cat. no. A9099) and 150 l -20°C 
ethanol, put at -80°C for 30 minutes. We took 20 l protein A-Sepharose beads (Sigma, cat. no. 
P9424) and added 1 ml ice-cold PBS supplemented with 0.5% BSA. We centrifuged protein A-
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Sepharose beads at 4°C for 3 minutes at 6,400 rpm. We repeated the washing twice. We added 
the protein A-Sepharose beads to the IP sample, shaking gently at 4°C for another 1 hour. We 
washed the beads by adding 1 ml NET buffer (50 mM Tris-HCl pH8, 150 mM NaCl, 2 mM 
EDTA pH8, 0.1% Nonidet P-40, 0.02% NaN3) and shook the beads for 10 minutes at 4°C. We 
then centrifuged the beads at 4°C for 3 minutes at 6,400 rpm. We repeated the NET washing 
twice. Finally we washed the beads with 1 ml TE (10 mM Tris-HCl pH8, 2 mM EDTA pH8) for 
10 minutes. To elute DNA, we added 210 ul newly prepared elution buffer (1% SDS and 100 
mM NaHCO3) to the beads. We incubated the beads at 65°C for 30 min, we vortexed the beads 
every 5 minutes. We centrifuged the beads for 2 minutes at 6,400 rpm and took the supernatant. 
We Added 2 l 40 g/ml RNase to the supernatant, incubated the solution at 37°C for 30 
minutes to digest RNA. We added 2 l 10 mg/ml proteinase K to the solution and incubated the 
solution at 65°C for 4 hours to reverse the cross-linking. We added 5 volumes of Qiagen Buffer 
PB to the solution and purified the DNA with Qiagen MinElute column. The DNA was eluted 
with 24 ul water. We stored the purified DNA at -20°C. We thawed the input and sonication test 
samples and centrifuged the samples for 15 min at 4°C to precipitate the DNA. We washed the 
pellet with 70% ethanol. The pellet was air-dried and dissolved in 310 l elution buffer. We 
added 3 l 4 mg/ml RNase to the dissolved DNA solutions and incubated the samples at 37°C 
for 30 minutes. We added 3 l 10 mg/ml proteinase K to the solutions and incubated the 
solutions at 65°C for 4.5 hours to reverse the cross-linking. We purified the input and sonication 
test DNA samples in the same way as the IPed DNA using the Qiagen kit. We ran the sonication 
test DNA on 1.5% Agarose gel to check the extent of sonication, the distribution should be 200-
800 bp. 
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ChIP-Seq library preparation and sequencing 
The ChIP-Seq library preparation and sequencing were performed by the Iowa State 
University DNA facility. In brief, NEXTflex™ ChIP-Seq Barcodes kit (ILLumina compatible) 
(BIOO Scientific Corp., cat. no. 514123) was used to prepare multiplexed single-end genomic 
DNA libraries. The gel slices corresponding to the 200-300 bp maker were cut and purified. The 
purified DNA was amplified and sequenced in a single flow cell on the IlluminaHiSeq 2000 
platform. The length of single-end reads was 50 bp. 
ChIP-Seq data analysis 
We first checked the quality of the raw reads. In our hands, the quality scores of both the 
input and IP samples are above 30, indicating high quality data. We use Galaxy online software 
to remove the sequencing artifacts and clip the adapter sequences in silico 
(https://main.g2.bx.psu.edu/). Reads were mapped to C. elegans reference genome WS220 using 
bowtie 0.12.8 (LANGMEAD et al. 2009), allowing no more than 2 mismatches along the whole 
read length. Reads that could not mapped to the genome were removed. The reads kept at this 
step can be separated into two classes: unique-reads and multi-reads. Unique reads uniquely 
mapped to one position in the genome and multi-reads mapped to more than one positions in the 
genome. Unique-reads were automatically kept for the following peak calling analysis. For 
multi-reads, there are two situations. If one of the mapped positions has a mapping probability 
greater than 0.5, this position was kept for the following peak calling analysis for this multi-read. 
If none of the positions have the mapping probabilities greater than 0.5, this multi-read was 
excluded from the following peak calling analysis. The mapping probabilities were calculated 
using CSEM algorithm (ChIP-Seq multi-read allocation using E-M algorithm) (CHUNG et al. 
2011). The sum of the mapping probabilities for each multi-read is 1, thus, in our procedure, by 
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using the cutoff of greater than 0.5 for the mapping probability for each multi-read, only one 
mapping position was used. Reads mapped to mitochondrial genome were also excluded from 
the peak calling analysis. At the end, for the input sample, totally 30,993,447 reads were kept for 
peak calling analysis, accounting for about 15-fold genome coverage, including 99.47% 
unique-reads (30,829,483) and 0.53% multi-reads (163,964). For the IP samples, totally 
18,186,819 reads were kept for peak calling analysis, accounting for about 9-fold genome 
coverage, including 99.60% unique-reads (18,113,791) and 0.40%multi-reads (73,028). To 
smooth the data, the coordinates of the mapped reads were shifted to 3’ directions by 100 bp and 
the counts were assigned to bins. The bin size was set at 100 bp. Bin-level counts were analyzed 
by fitting the MOSAiCS two-sample analysis/two-signal-component model to call peaks. 
MOSAiCS (MOdel-based one and two Sample Analysis and Inference for ChIP-Seq Data) is a 
statistical framework for the analysis of ChIP-seq data (KUAN et al. 2011). False discovery rate 
(FDR) was set at 0.05. The minimum size of the peak region was set as 100 bp, neighboring 
peaks were merged. Genes that are nearest to the peaks or contain the peaks were first annotated 
using CisGenome (JI et al. 2008) and then genes contained in the same operon were manually 
added by referring to wormbase WS220 (HARRIS et al. 2010). 
The signal images of genome-wide mapping coverage were generated by bedtools 
v2.17.0 (QUINLAN and HALL 2010), scaling to the normalizing factor estimated by NCIS (LIANG 
and KELES 2012). IGB (Integrated Genome Browser) (NICOL et al. 2009) was use to view the 
signal images and overlay the images to C. elegans genome WS220 (HARRIS et al. 2010). 
Heat map 
Heat maps for gene expression profiles were generated by PermutMatrix graphical 
analysis program (CARAUX and PINLOCHE 2005; EISEN et al. 1998). Average linkage clustering 
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was performed using the estimated fold change values. Green color represents negative values 
(down-regulated), and red color represents positive values (up-regulated). The intensity of the 
color represents the magnitude of the expression levels. Other parameters were set as default.  
Microarray datasets comparisons 
In order to determine whether the overlap between the differentially expressed gene lists 
from different microarray datasets is greater than expected by chance, Fisher’s exact test was 
performed. The number of 18, 011 unique probesets assayed on the microarray was used as the 
total population size. p-value < 0.001 was used as the cutoff to declare the overlap is 
significantly higher than expected by chance. 
RNA interference  
Bacterial feeding mediated RNAi was performed as described (KAMATH et al. 2003; 
TIMMONS et al. 2001). Most of the RNAi clones were purchased from the Ahringer RNAi library 
(Geneservice, Cambridge, UK) and were validated by sequencing. For F57B9.1, gbh-2, and 
Y40B10A.6, the RNAi constructs were generated by cloning the coding regions into the L4440 
double-T7 vector (TIMMONS et al. 2001).  
Hypoxia survival and development assay 
For each genotype, 20 young adults (one day after L4 molt) were put on one NGM plate 
with OP50 (OD=0.6) to lay eggs for 0.5 hour. After counting the eggs laid, the plates were put 
into the hypoxia chamber for 24 hours (0.5% oxygen, 21°C). After 24 hours, the plates were 
taken out of the hypoxia chamber, and the un-hatched eggs were counted immediately. After 
that, all the plates were maintained in the room air. The adult worms were counted at 72 hour 
since the eggs had been laid. Wild-type control eggs hatched within 24 hours and reached 
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adulthood within 72 hours. The experiment was repeated three times for each genotype on three 
different days. The normoxia controls were done in parallel. 
 For RNAi experiments, to generated parent generation, 20 N2 adults maintained with 
OP50 food were first transferred to the RNAi plates to lay eggs for 1 hour. Three days later, we 
randomly picked 20 young adults grown up from these eggs as RNAi parents and transferred 
them to new RNAi plates to lay eggs for 0.5 hour. After counting the eggs laid, the plates were 
put into the hypoxia chamber for 24 hours (0.5% oxygen, 21°). The downstream procedures were 
same as that for mutant genotypes described above. skn-1 RNAi was used as a technical control 
for monitoring the RNAi effectiveness. The dead egg ratios caused by skn-1 RNAi for the three 
biological repeats were 93%, 94% and 97%, indicating good RNAi efficacy. Complete loss-of 
function mutation in skn-1 causes 100% dead eggs.  
The number of animals assayed for each strain in normoxia or hypoxia was between 186 
and 661. The binary hatched vs. unhatched or adult vs. non adult data were analyzed by 
fitting a generalized linear model using a logit link function with JMP 9 statistical software (SAS 
Institute Inc., Cary, NC, 2010). For each genotype, replicates and oxygen conditions were used 
as factors in the model. For situations in which such models were inappropriate, randomization 
tests were used. 
Results 
Identification of genes that respond to 2 hours hypoxia (0.5% oxygen) 
To define the immediate changes in gene expression caused by oxygen deprivation, we 
treated wild-type animals with 0.5% oxygen for 2 hours at 21°C. Using a standard microarray 
platform, we compared the mRNA expression patterns in N2 wild-type animals under hypoxia 
and under room air conditions. Among the 18,011 unique probesets assayed, we found that the 
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mRNA abundance of 687 genes showed significant changes in response to the short-term, 
moderate hypoxia treatment (FDR q-value ≤ 5% and fold change ≥ 1.6). Of these 687 genes, the 
mRNA levels of 441 genes were induced by hypoxia, while the mRNA levels of 246 genes were 
repressed by hypoxia. The highest gene expression induction caused by this short-term hypoxia 
treatment was 93.70 fold (tts-1, transcribed telomerase-like sequence), and the lowest repression 
was 8.58 fold (gcsh-1, glycine cleavage system H protein). The top 20 genes with the greatest 
hypoxia induction are listed in table 1, and the top 20 genes repressed most by hypoxia are listed 
in Table 2. Detailed information was provided in the supplemental tables S2 and S3.  
Prior studies had identified several genes that were induced by longer hypoxia treatments, 
and we asked whether our microarray studies showed these genes to be responsive to 2 hours 
hypoxia. First, we queried F22B5.4, nhr-57, fmo-12/fmo-2, egl-9, phy-2, and cah-4. With RNase 
protection assays, Bishop et al. had demonstrated that these genes could be induced by 18 hours 
exposure to 0.1% oxygen in mixed-stage C. elegans populations (BISHOP et al. 2004). Using 
RNA blot, Shen et al. had validated other gene expression changes induced by 4 hours exposure 
to 0.5% oxygen. These genes were: F22B5.4, nhr-57, fmo-12/fmo-2, egl-9, phy-2, 
K10H10.2/cysl-2, F26A3.4, and C12C8.1/hsp-70 (SHEN et al. 2005). As shown in Table S2, the 
microarray experiments presented here showed that all of these genes were expressed at 
significantly higher levels after the animals were exposed to 0.5% oxygen for 2 hours.  
In our prior assay, using two-color cDNA microarrays, we found that exposure of 
L3-stage worms to 0.1% oxygen for 4 hours caused 490 genes to be differentially expressed (fold 
change ≥ 1.5, p-value < 5%) (SHEN et al. 2005). When comparing the 2 hours hypoxia-
responsive genes (687 genes) identified here with the 4 hours hypoxia-responsive genes (490 
genes) described in the prior study, we found 50 genes were commonly regulated in these two 
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sets of experiments. The overlap is statistically significant (p-value = 2.46E-10, by Fisher’s exact 
test).  Meanwhile, these two datasets have their own unique set of genes relating to their 
experimental specificities, that is, L4-stage worms vs. L3-stage worms, 2 hours 0.5% oxygen 
treatment vs. 4 hours 0.1% oxygen treatment, and Affymetrix oligonucleotide microarray 
technology vs. two-color cDNA microarray technology. 
We next asked which hypoxia-dependent changes in gene expression were mediated by 
or dependent upon the HIF-1 transcription factor. We compared the hypoxia responses in 
wild-type animals with those in a mutant lacking a functional hif-1 gene. When using an FDR 
(q-value) of 5% or less, we identified 145 genes for which hypoxia induced gene expression 
changes were significantly different in hif-1(ia04) mutants relative to N2 (Table S4). The 27 
genes with the greatest differences between wild-type animals and hif-1 deficient mutant are 
listed in Table 3. For 76 of these 145 genes, HIF-1 promotes their hypoxia-induced gene 
expression: their hypoxia induction is higher in N2 than in hif-1(ia04) mutants. The heat map in 
Figure 1A illustrates their hypoxia-induced fold changes in N2, in hif-1(ia04) mutants and the 
relative fold changes. The corresponding fold change values of these 76 genes are provided in 
the Supplemental Table S4.We next asked which hypoxia-dependent changes in gene expression 
were mediated by or dependent upon the HIF-1 transcription factor. We compared the hypoxia 
responses in wild-type animals with those in a mutant lacking a functional hif-1 gene. When 
using an FDR (q-value) of 5% or less, we identified 145 genes for which hypoxia induced gene 
expression changes were significantly different in hif-1(ia04) mutants relative to N2 (Table S4). 
The 27 genes with the greatest differences between wild-type animals and hif-1 deficient mutant 
are listed in Table 3. For 76 of these 145 genes, HIF-1 promotes their hypoxia-induced gene 
expression: their hypoxia induction is higher in N2 than in hif-1(ia04) mutants. The heat map in 
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Figure 1A illustrates their hypoxia-induced fold changes in N2, in hif-1(ia04) mutants and the 
relative fold changes. The corresponding fold change values of these 76 genes are provided in 
the Supplemental Table S4. 
Our analyses also identified 69 genes for which HIF-1 had a negative effect on 
hypoxia-induced changes in gene expression, their hypoxia induction is lower in N2 than in hif-
1(ia04) mutants. Their hypoxia-induced fold changes in N2, in hif-1(ia04) mutants and the 
relative fold changes are illustrated in Figure 1B. The corresponding fold change values of these 
69 genes are provided in the Supplemental Table S4. 
In our previous two-color microarray assay, 62 genes were identified to be 
HIF-1-dependent hypoxia-responsive genes (SHEN et al. 2005). Our newly identified 76 genes 
that were positively regulated by HIF-1 under hypoxia overlap with those 62 genes (p-value = 
4.98E-12, by Fisher’s exact test). The overlapped 9 genes are: F22B5.4, egl-9, phy-2, fmo-
12/fmo-2, K10H10.2/cysl-2, efk-1, F45D11.2, F57B9.1, and dod-3.  
In a parallel study (chapter 3), we identified genes that were differentially expressed in 
mutants with constitutively active HIF-1 (in vhl-1, egl-9, rhy-1 loss-of-function mutants and vhl-
1; swan-1 double mutants). We reasoned that some of these genes might also be induced by 2 
hours hypoxia. In our analyses, there are 23 genes that were up-regulated by HIF-1 under short-
term hypoxia and up-regulated in all the 4 HIF-1 negative regulator mutants, including efk-1, 
egl-9, mce-1, mmcm-1, F22B5.4, K10H10.2/cysl-2, ethe-1, sqrd-1, dod-3, tts-1, and phy-2, et al.. 
And 3 genes were down-regulated by HIF-1 under short-term hypoxia and down-regulated in all 
the 4 HIF-1 negative regulator mutants. The molecular functions and hypoxia-induced fold 
changes in N2, in hif-1(ia04) mutants and the relative fold changes for these 26 genes are listed 
in Table 4.  
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HIF-1 regulates metabolism, stress response and other functions under hypoxia 
To understand HIF-1-dependent adaptive changes induced by hypoxia, we examined the 
predicted molecular functions of HIF-1-dependent hypoxia-responsive genes. These functions 
are involved in multiple biological processes, including metabolism, stress response, signaling 
and transcriptional regulation, protein homeostasis, and transport (Figure 1C, Table S4).  
Our analyses reveal a major role for HIF-1 in mobilizing lipid stores for cellular energy 
as an immediate response to moderate hypoxia. Wild-type L4-stage animals responded to 2 hours 
exposure to 0.5% oxygen by up-regulating genes that catalyze several steps of mitochondrial 
fatty acid β oxidation (mce-1, mmaa-1, mmcm-1, gbh-2). MCE-1 (Methylmalonyl-CoA 
epimerase), MMAA-1 (Methylmalonic aciduria type A protein) and MMCM-1 (Methylmalonyl-
CoA mutase) are involved in the metabolism of propionyl-CoA, which is the final step of the 
odd-chain fatty acids β oxidation. GBH-2 (Gamma butyrobetaine hydroxylase) is involved in the 
synthesis of carnitine, which is required for the transport of fatty acids from the cytosol into 
mitochondria for β oxidation. Genes involved in peroxisomal fatty acid α oxidation (Y105C5B.9 
and ZK550.6) and β oxidation (F59F4.1) are also up-regulated in wild-type animals but not in 
hif-1(ia04) mutants (TableS4).  
C. elegans also respond to short-term hypoxia by up-regulating several genes involved in 
stress response or detoxification. Some of these genes, including phase II detoxification genes 
(ugt-33, gst-19), phase I detoxification genes (fmo-1, fmo-2), sulfide quinone oxidoreductase 
sqrd-1, heat shock protein hsp-12.3, and transcribed telomere-like sequence tts-1, were induced 
to higher levels in wild-type compared to hif-1(ia04) mutants. Genes with predicted roles in 
oxygen binding (glb-1) and catecholamine neurotransmitters degradation (Y40B10A.6) were 
also induced to higher levels in wild-type compared to in hif-1(ia04) mutants. 
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Further, these data also revealed that hif-1(ia04) mutants respond to short-term hypoxia 
in ways different from wild-type animals. For example, certain phase II detoxification genes 
(ugt-25, ugt-28, ugt-44, gst-9), regulators of transcription or cellular signaling (nhr-10, nhr-112, 
nhr-117, nhr-232, mdt-28, nipi-3), ABC transporter (pgp-9) and genes with predicted roles in 
protein degradation (fbxa-60, fbxa-82, fbxa-98, skr-3), RNA processing (dct-7), and immunity 
response (tir-1) were induced to higher levels in hif-1(ia04) mutants, relative to wild-type 
animals (TableS4). 
In mammals, the core element for HIF-1 binding site is 5’-RCGTG-3’ (MOLE et al. 2009; 
SCHODEL et al. 2011; WANG and SEMENZA 1993; WENGER et al. 2005). To find sequences that 
were over-represented in the regulatory regions of genes that exhibited HIF-1-dependent 
expression, we analyzed the 1.5 kb regulatory sequences upstream the translation start sites of 
HIF-1 regulated genes under hypoxia using RSAT (Regulatory Sequence Analysis Tools oligo-
analysis) (THOMAS-CHOLLIER et al. 2008). Only one enriched consensus motif was identified 
among the regulatory sequences of genes positive regulated by HIF-1 under short-term hypoxia. 
The enriched consensus motif was: 5’-ACGTG-3’ (E-value = 7E - 06). This motif is the same as 
that identified in mammals. With the E-value cutoff of 0.1%, there was no enriched consensus 
motif identified in the regulatory regions of HIF-1 down-regulated genes under hypoxia. Among 
the 77 genes that are positively regulated by HIF-1 under short-term hypoxia, 87% (66) of them 
contained 5’-ACGTG-3’ motif in the regulatory regions. Among the 69 genes positive regulated 
by HIF-1 under short-term hypoxia, 68% (47) of them contained 5’-ACGTG-3’ motif in the 
regulatory regions. The frequency of the presence of this motif in the regulatory regions of each 
HIF-1-dependent hypoxia-responsive gene is listed in the Supplemental Table S4. 
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Effects of HIF-1-dependent hypoxia-responsive genes in hypoxia adaptation 
To further understand HIF-1 function for hypoxia survival, we examined the requirement 
for individual genes that were induced by short-term hypoxia in a HIF-1-dependent manner and 
have not been shown to have essential roles in growth or development under normal culture 
conditions. The actual number of genes tested was further limited by the availability of the 
mutant and RNAi strains. Couple of genes up-regulated in HIF-1 negative regulator mutants 
(Chapter 3) and have related functions with genes up-regulated by hypoxia in a HIF-1-dependent 
manner were also tested.  
Genes involved in multiple biological processes, including lipid metabolism, protein and 
amino acid metabolism, carbohydrate metabolism, transport, detoxification/stress response, and 
extracellular matrix were extensively tested. While most of these genes had statistically 
significant but moderate effects on hypoxia development and survival, phy-2 and efk-1 had 
greater impacts on these phynotypes. None of phy-2 loss-of -function mutants made to 
adulthood. As an interesting discovery, efk-1 will be discussed more in the following paragraph. 
In general, these observations are consistent with Shen et al (SHEN et al. 2005), and support the 
model that many hif-1 targets have moderate and incremental roles, and the collective impact of 
failing to regulate all these genes is lethal under hypoxia (Table S5 and Figure2A-E). 
Translation is energy costive, during hypoxia, the overall mRNA translation is inhibted to 
help animals survive hypoxia (KORITZINSKY et al. 2006). In mammals, translation inhibition 
during hypoxia is regulated by unfolded protein response (UPR) or by mTOR pathway. Under 
short-term hypoxia (1-2 hours hypoxia), translation inhibition is accomplished by activating the 
unfolded protein response (UPR). Under prolonged hypoxia, translation inhibition is achieved by 
inhibiting mTOR-dependent phosphorylation of EF2k, 4E-BP1 and ribosomal S6 kinase (Under 
normal conditions, mTOR phosphorylates EF2k, 4E-BP1 and ribosomal S6 kinase to promote 
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translation) (YEE KOH et al. 2008). We queried our microarray data to identify the mRNA 
expression of UPR components (hsp-4, ire-1, xbp-1, atf-6, gcn-2, and pek-1) and the 
corresponding C. elegans homologues for mTOR, EF2k and ribosomal S6 kinase: CeTOR/LET-
363, EFK-1 and RSKS-1. There is no apparent 4E-BP1 homologue in C. elegans genome (LONG 
et al. 2002; MAO and CROWDER 2010; RYAZANOV et al. 1997). Interestingly, we found that the 
mRNA levels of xbp-1, pek-1 and efk-1 were induced by hypoxia. However, only the mRNA 
levels of efk-1 were up-regulated in a HIF-1-dependent manner (Table S6). After 2 hours 
hypoxia treatment, efk-1 mRNA induction was 3.16-fold in N2 wild- type animals (q-value = 
1.07E-05), and the induction was 1.31-fold in hif-1(ia04) mutants (q-value = 0.12), the relative 
fold change is 2.40 (q-value = 0.02). Our prior study also showed that efk-1 mRNA levels were 
induced by 4 hours hypoxia in a HIF-1-dependent manner (SHEN et al. 2005). Remarkably, 
evidence from our ChIP-seq data (see the following) supports that efk-1 is a potential HIF-1 
direct target (Table 5 and Figure 4). We thus focused our attention on efk-1. We speculated that 
under hypoxia, HIF-1 directly up-regulates efk-1; and up-regulation of efk-1 causes the inhibition 
of protein translation, which will help the animals survive hypoxia. Thus, we hypothesized that 
knocking-out of efk-1 would impair C. elegans survival in hypoxia (Figure 2F). However, prior 
studies had shown that efk-1 RNAi did not have a significant impact on C. elegans 
embryogenesis in hypoxia (SHEN et al. 2005). Recognizing that RNAi may not totally deplete 
gene function, we repeated these experiments using an efk-1 deletion mutant. As expected, 
mutation in efk-1 dramatically affected  C. elegans survival under hypoxia, as  64% of eggs 
failed to achieve adulthood after exposure to hypoxia (0.5% oxygen) for 24 hours (Figure 2G). 
Thus far, besides hif-1 and phy-2, efk-1 is another gene with striking individual effect on C. 
elegans hypoxia adaptation. 
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Genes regulated by HIF-1 overlap with genes regulated by H2S 
Since recent studies have shown that hif-1 mutants have increased sensitivity to H2S, and 
H2S treatment increased HIF-1 protein levels (BUDDE and ROTH 2010; BUDDE and ROTH 2011), 
we asked whether short-term oxygen deprivation caused changes in gene expression were similar 
to those caused by H2S exposure. After the adult worms were exposed to H2S for 1 hour, the 
mRNA levels of 17 genes were changed, 16 were up-regulated and 1 was down-regulated 
(MILLER et al. 2011). We found that 3 genes up-regulated by 1 hour H2S are also up-regulated by 
HIF-1 after 2 hours hypoxia. This overlap is statistically significant (p-value = 4.04E-05, by 
Fisher’s exact test). These three genes are: gst-19, F02H6.5/sqrd-1, K10H10.2/cysl-2, which 
function in phase II detoxification, H2S metabolism and cysteine synthesis, respectively. This 
result is consistent with previous qRT-PCR assays that H2S exposure increase the mRNA levels 
of F02H6.5/sqrd-1 and K10H10.2/cysl-2 in a HIF-1-dependent manner, and F02H6.5/sqrd-1 and 
K10H10.2/cysl-2 are required for H2S survival (BUDDE and ROTH 2010; BUDDE and ROTH 2011; 
MILLER et al. 2011).  
After the adult worms were exposed to H2S for 12 hours, the mRNA levels of 402 genes 
were changed (MILLER et al. 2011). We found that 31 of these genes are also regulated by 2 
hours hypoxia. This overlap is statistically significant (p-value = 1.92E-04, by Fisher’s exact 
test). The overlapped genes include genes that are involved in phase II detoxification (GSTs and 
HSPs), and genes that are required for H2S survival (F02H6.5/sqrd-1, C33A12.7/ethe-1, 
K10H10.2/cysl-2) (BUDDE and ROTH 2011). The heat map in Figure 3A shows the hypoxia 
induction of these 31 genes in N2 wild-type animals.  
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Genes regulated under hypoxia overlap with genes regulated by DAF-16 
We also compared our data set with genes regulated by DAF-16. Murphy et al. identified 
that 251 genes were up-regulated by DAF-16, and 242 genes were down-regulated by DAF-16 
(MURPHY et al. 2003). Among the 441 genes up-regulated by 2 hour hypoxia, 48 of them are 
also up-regulated by DAF-16 (Figure 3C). The overlap is greater than expected (p-value = 
4.22E-29, by Fisher’s exact test). Genes up-regulated by short-term hypoxia and DAF-16 are 
involved in stress response (mtl-1, dod-3, CYPs, UGTs, HSPs, and sqrd-1), lipid metabolism 
(acs-2, ZK550.6, stdh-1), carbohydrate metabolism (gpd-2), amino acid metabolism (hgo-1), and 
cellular signaling (Y40B10A.6). For details, see the Supplement Table S8. 
Further, 12 HIF-1-positively-regulated genes under short-term hypoxia are also up-
regulated by DAF-16. The overlap is greater than expected by chance (p-value = 6.80E-10, by 
Fisher’s exact test). These 12 genes are involved in lipid metabolism (ZK550.6, fat-5, stdh-1), 
carbohydrate metabolism (gpd-2), amino acid metabolism (hgo-1, asns-2), stress response (dod-
3, hsp-12.3, sqrd-1), and cellular signaling (Y40B10A.6). The heat map in Figure 3B shows the 
hypoxia induction of these 12 genes in N2 and hif-1 (ia04). 
Identification of HIF-1 direct targets by ChIP (chromatin immunoprecipitation) 
Genes identified by microarray can be HIF-1 direct or indirect targets. Among genes that 
are differentially expressed in hypoxia or in mutants with persistent HIF-1 activation, which are 
the direct targets of HIF-1? To answer this question, we performed the ChIP-seq experiment. 
With the cutoff of minimum posterior probability ≤ 5% and the fold enrichment ≥ 1.6, we 
identified 986 peaks using MOSAiCS. We annotated these peaks to 826 nearest genes. We 
recognized that this is a subjective way to link the peaks to genes, as the nearest genes may not 
exactly be the ones that are transcribed by HIF-1. However, to be simple and expedient, we 
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tentatively considered these 826 genes to be potential HIF-1 direct targets. Among these 826 
potential direct targets, 88 are differentially expressed in egl-9 (sa307) mutants relative to wild-
type (Figure 4). Totally, there are 1259 genes that are differentially expressed in egl-9 (sa307) 
mutants. We would like to see whether the potential HIF-1 direct targets are enriched among 
genes that are differentially expressed in egl-9 mutants. To test this, we compared the enrichment 
of potential HIF-1 direct targets in the differentially expressed gene list in egl-9 mutants 
(88/1259 = 0.07) to the enrichment of potential direct targets in the non-differentially expressed 
gene list in egl-9 mutants (738/16752 = 0.04). Fisher’s exact test showed that potential HIF-1 
direct targets are enriched among genes that are differentially expressed in egl-9 mutants (p-
value = 3.2E−5). We treated those 88 genes that are identified by both microarray and ChIP-seq 
as high confidence HIF-1 direct targets in egl-9 mutants. These genes include efk-1, sqrd-1, fmo-
2, dod-24, mmcm-1, dpy-18, gpd-2, gpd-3, lysozyme genes (lys-5, lys-6), heat shock protein 
genes (hsp-16.48, hsp-16.11, hsp-16.2), and genes with predicted roles in protein degradation 
(fbxa-192, fbxa-91, fbxa-60) (Table S8). 
Similarly, we also tested whether potential HIF-1 direct targets are enriched in the 
hypoxia-responsive gene list. Among the 826 potential HIF-1 direct targets, 51 are differentially 
expressed under hypoxia (Figure 4). And there are totally 687 genes that are differentially 
expressed under hypoxia in N2 wild-type animals. Fisher’s exact test showed that the enrichment 
of potential HIF-1 direct targets in the differentially expressed gene list under hypoxia (51/687 = 
0.07) is greater than the enrichment of potential HIF-1 direct targets in the non-differentially 
expressed gene list under hypoxia (775/17324 = 0.04) (p-value = 3.7E−4). We treated those 51 
genes identified by both methods are high confidential HIF-1 targets under short-term hypoxia. 
These genes include efk-1, sqrd-1, fmo-2, mmcm-1, dpy-18, gpd-2, nucleosome remodeling 
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factor (nurf-1), heat shock protein genes (hsp-16.48, hsp-16.11, hsp-16.41, hsp-16.2), and genes 
with predicted roles in protein degradation (fbxa-156, fbxa-91) (Table S8). There are 25 HIF-1 
direct targets that are differentially expressed in hypoxia and in egl-9 mutants, including efk-1, 
sqrd-1, fmo-2, gpd-2, mmcm-1, dpy-18, hsp-16.11, hsp-16.2, hsp-16.48. The information of the 
peaks that are nearest to these 25 genes are listed in table 5, including the positions of the peaks 
and the fold enrichment. 
As discussed above, efk-1 is a favorite gene in our microarray assays. As a representative 
case, the signal intensity of the HIF-1 ChIP peak at the promoter region of efk-1 was shown in 
Figure 5. This peak was 1498 bp upstream the transcription start of efk-1. The average ChIP 
count in this peak region was 306, the normalized input count was 24, and the average ratio of 
the ChIP count to the input count was about 11 fold (aveLog2Ratio = 3.46). This peak was 300 
bp wide and contained a HIF-1 binding site 5’-acgtg-3’. More signal images of the identified 
peak regions are provided in Supplemental Figure S1.  
Discussion 
HIF transcription factor complex is the master regulator of hypoxia response. This study 
was dedicated to understand HIF-1 function and short-term hypoxia response with the aid of new 
biotechnologies. With Affymetrix whole genome expression data, we were able to have new 
sights for HIF-1 mediated short-term hypoxia response. By performing HIF-1 ChIP-seq, for the 
first time, we were able to have a view of genome-wide HIF-1 binding sites. 
Refined understanding of HIF-1 target genes 
Our prior two-color cDNA microarray experiment is a foundational work for 
understanding HIF-1 function. This experiment was performed by exposing L3-stage worms to 
0.1% oxygen for 4 hours, although the northern blot validation was performed on L4-stage 
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worms after 0.5% oxygen treatment for 4 hours (SHEN et al. 2005).  In our following study, we 
found that under 0.5% oxygen, HIF-1 activity reporter Pnhr-57:GFP’s levels actually peaked 
after 2 hours treatment rather than after 4 hours treatment (Chapter 2). We were inspired to test 
what would be the immediate transcriptional response in C. elegans after 2 hours hypoxia 
treatment. In this study, we exposed L4-stage worms to 0.5% oxygen for 2 hours. Then we 
measure the genome-wide mRNA abundance using Affymetrix microarray. By comparing the 
hypoxia response in wild-type animals with hif-1 deficient animals, we identified 145 genes 
whose mRNA levels are dependent on HIF-1. Among these, genes involved in lipid metabolism 
is of particular interest, as this group was not identified by our prior microarray assay (SHEN et 
al. 2005). Genes identified in this group include elo-5 and fat-5. In supporting of our discovery, 
it has been shown that HIF-1 regulate the mRNA levels of elo-5 and fat-5 in the AMPK 
compromised C. elegans dauer (XIE and ROY 2012). The discrepancy between our current 
dataset and prior dataset may be due to the difference of the worm stages, as L4-stage worms 
accumulate more lipid in the gut, which gives them an alternative choice to use lipid as energy 
source under hypoxia besides employing glycolysis. Prior study also shows that anoxia treatment 
change lipid accumulation and body shape in adult C. elegans (TAGHIBIGLOU et al. 2009). Our 
study suggests a potential link between HIF-1 and lipid metabolism and lipid-related diseases. 
Shen et al. tested the individual effects on hypoxia viability of 16 HIF-1-dependent 
genes. phy-2 is the only one that has the dramatic effect on hypoxia development and survival. In 
this study, HIF-1-dependent hypoxia-responsive genes were also intensively tested for hypoxia 
viability, totally 31 individual mutants and RNAi knocking down were tested. Only phy-2 and 
efk-1 (see the following discussion) mutants showed strong hypoxia sensitive phenotypes, most 
of the genes had moderate individual effects for hypoxia development and survival. Collectively, 
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these two sets of experiments suggested that hif-1 phenotype is caused by the incremental effects 
of the multiple biological processes regulated by HIF-1.  
HIF-1 directly regulates efk-1 to inhibit protein translation in hypoxia? 
Protein homeostasis is associated with stress response,  metabolic diseases, cancer and 
neurodegenerative disorders. Mainting the balance between protein sysnthesi, folding, transport 
and degradstion is vital to cell functions (CALAMINI et al. 2012; GARCIA et al. 2007; NEEF et al. 
2011; TOYAMA and HETZER 2013). Translation is costive, during hypoxia, the overall mRNA 
translation is inhibted (KORITZINSKY et al. 2006). In mammals, under short-term hypoxia (1-2 
hours hypoxia), translation inhibition is accomplished by activating the unfolded protein 
response (UPR). And under prolonged hypoxia, translation inhibition is achieved by inhibiting 
mTOR-dependent phosphorylation of EF2k (elongation factor 2 kinase), 4E-BP1 and ribosomal 
S6 kinase (BROWNE and PROUD 2004; CONNOLLY et al. 2006; INOKI et al. 2005; KOUMENIS and 
WOUTERS 2006; WANG et al. 2001; YEE KOH et al. 2008).  
It has been shown that the activation of UPR and inhibition of translation protected C. 
elegans from high temperature hypoxia stress (ANDERSON et al. 2009; MAO and CROWDER 
2010). In our analyses, among the components of UPR and mTOR pathways in C. elegans, efk-1 
is the only one that is positively regulated by HIF-1 after 2 hours hypoxia treatment. In addition, 
efk-1 mRNA levels were also up-regulated in all the 4 HIF-1 negative regulator mutants (See 
Chapter 3). Our ChIP-seq data suggests efk-1 is a potential HIF-1 direct target, which let us 
propose that HIF-1 may directly regulates efk-1 to inhibit protein translation, thus help animals to 
survive hypoxia. Our functional assay proves that efk-1 is critical in hypoxia adaptation: 
knocking-out of efk-1 causes 64% eggs fail to achieve adulthood after hypoxia treatment. And it 
has been shown that C. elegans EFK-1 is functional, as it can phosphorylate rabbit EF-2 
103 
 
 
(RYAZANOV et al. 1997). In the future, it would be interesting to test whether over-expression of 
EFK-1 can inhibit protein translation and promote survival under hypoxia. Or, whether 
knocking-out of efk-1 will promote protein translation and impair the hypoxia survival. 
Another thing deserve notice is that efk-1 was also identified as HIF-1 hypoxia 
responsive genes by Shen et al. However, in our prior study, efk-1 RNAi did not affect C. 
elegans viability under hypoxia (SHEN et al. 2005). In this study, using loss-of-function mutants, 
we showed that 64% of efk-1(ok3609) mutants fail to achieve adulthood after hypoxia treatment. 
We attribute the discrepancy between these two sets of experiments to two reasons. First, the efk-
1(ok3609) allele used in this study could be a very strong loss-of-function mutation compared to 
RNAi. It is a 517 bp deletion across exon 2 and exon 3, and causes a premature stop in all the 
transcript isoforms. Second, the hypoxia viability assay protocol used in this study is slightly 
different from the one used by Shen et al. In this study, the laid eggs were allowed to be in the 
room air for less than 30 minutes before putting them into the hypoxia chamber. As in Shen et 
al., the laid eggs could stay in the room air for as long as 1.5 hours before putting them into the 
hypoxia chamber. We actually compared these two protocols, we found that shortening the room 
air exposure time makes the assay more sensitive.  
In mammals, under prolonged hypoxia, mTOR regulates EF2k, 4E-BP1 and ribosomal S6 
kinase to inhibit translation inhibition (BROWNE and PROUD 2004; CONNOLLY et al. 2006; INOKI 
et al. 2005; KOUMENIS and WOUTERS 2006; WANG et al. 2001; YEE KOH et al. 2008). Thus, we 
were intrigued to test whether efk-1 deficiency can rescue the severe developmental phenotypes 
caused by Cetor/let-363 loss-of-function mutation: being arrest at L3 and having the intestinal 
atrophy (LONG et al. 2002). However, in our assay, the double mutants lacking both CeTOR and 
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EFK-1 function failed to suppress the Cetor/let-363 phenotype (data not shown). We speculate 
that this is due to Cetor has many other important functions that are not through efk-1.  
Limitations of the ChIP assay in this study and improvement in the future 
In this study, by performing ChIP-seq, we are able to have a look at the genome-wide 
HIF-1 binding sites for the first time. Howerver, we need recognize several limitations in this 
assay. First, in this study, to stabilize HIF-1 and use the commericially available anti-tag 
antibody, a HIF-1 transgene in egl-9 mutants was used and the endogenous hif-1 was knocked 
out. This transgene corresponds to one hif-1 alternative splicing isoform. However, according to 
wormbase (HARRIS et al. 2010), HIF-1 has 5 isoforms. Thus, in the future, if we can generate 
antibody to recognize all the 5 isoforms, the binding sites identified will be more approaching to 
the in vivo situations. Second, single-end sequencing was peformed in this study. In the future, if 
we perform paired-end sequencing, the assay will be improved. Paired-end reads will improve 
the mapping efficacy and accuracy, thus we can make full use of the sequencing depth and 
potentially increase the number of peaks to be detected.  
Gene expression difference in short-term hypoxia and constitutive HIF-1 activity  
When compare the microarray data presented in this Chapter and Chapter 3, we notice 
that about more genes are differentially expressed in egl-9 mutants than in short-term hypoxia, 
1259 genes vs. 687 genes, and more potential HIF-1 direct targets are differentially expressed in 
in egl-9 mutants than in short-term hypoxia, 88 genes vs. 51 genes, despite egl-9 mutation 
mimics hypoxia treatment in many ways. For example, hypoxia treatment and egl-9 mutation 
shift the worm oxygen preference to the same direction (CHANG and BARGMANN 2008). 
Similarly, both hypoxia treatment and egl-9 mutation protect C. elegans from pore-forming toxin 
infection (BELLIER et al. 2009). We tentatively propose several reasons to explain this difference. 
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1) The differentially expressed genes identified in egl-9 mutants include more secondary and 
tertiary effects caused by HIF-1 constitutively activation, which increases the number of 
differentially expressed genes. 2) Constitutive high HIF-1 activity in egl-9 helps maitain high 
levels of transcripts generated by HIF-1. 3) Mutation in egl-9 changes the physiological 
conditions in worms, such as salt concentrations, which in turn affect HIF-1 binding activity, as 
the case for NF-κB (NATOLI et al. 2005). 4) At some postions, HIF-1 may need cooperative 
collaboration from other transcription factors, and these partners are induced slowly. In this 
situation, these genes will not be induced by short-term hypoxia treatment, but can be expressed 
in egl-9 mutants. 5) The chromatin status in egl-9 mutants is different from that after short-term 
hypoxia. In Arabidopsis, the immediate response to shading involves gene expression change, 
wheras continuing shading causes chromocenters decondensation (VAN ZANTEN et al. 2012). 
Consider egl-9 mutatio as a constitutive hypoxia situation, it is speculative that in egl-9 mutants, 
the chromatin status and nucleosome position may be more prone for HIF-1 binding. 
Interstingly, we found that the mRNA levesl of the nucleosome remodeling factor (nurf-1) is 
induced by 2 hours hypoxia treatment in wild-type animals. And nurf-1 is a potential HIF-1 
direct targets (Table S8 and Supplemental Figure S1). In the future, it will be exciting to test how 
HIF-1 and hypoxia affect chromatin structure and subsequent gene expression. 
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Figure Legends 
Figure 1. Genes responded to hypoxia in HIF-1 dependent way. (A) Heat map of the fold 
changes of the 76 genes positively-regulated by HIF under hypoxia ((N2 hypoxia - N2 control) - 
(hif-1 hypoxia - hif-1 control) > 0). (B) Heat map of the fold change of the 69 genes negatively-
regulated by HIF-1mutant under hypoxia (N2 hypoxia - N2 control) - (hif-1 hypoxia - hif-1 
control) < 0). In both figure A and B, values < 0 are green, values > 0 are red. The color 
intensity corresponds to the level of fold change. (C) Genes induced by hypoxia in a HIF-1 
dependent manner are predicted to mediate metabolism, stress response, and other processes. 
The number of genes for each group is indicated in the parentheses.  
Figure 2. HIF-1 dependent hypoxia responsive genes affected animals’ development and 
survival. (A) Genes involved in lipid metabolism affected animals’ development and survival.  
(B) Genes involved in detoxification/stress response affected animals’ development and survival. 
(C) Genes involved in extracellular matrix affected animals’ development and survival. (D) 
Genes involved in amino acid and protein metabolism affected animals’ development and 
survival. (E) Genes involved in other function tested affected animals’ development and survival. 
(E) Diagram illustrating relationship between HIF-1, EFK-1 and protein translation. (F) Mutation 
of efk-1 mutants affected animals’ development and survival. Detailed information including 
percent hatched is provided in Table S6. *** means p =< 0.0001, ** means p =< 0.001, * means 
p =< 0.05, and NS means p > 0.05. 
Figure 3. Comparison of short-term hypoxia microarray datasets with other datasets. (A) 
The mRNA levels of 31 genes were changed by 2 hours hypoxia and 12 hours H2S treatment. 
The heat map shows the short-term hypoxia treatment induced fold changes of these 31 genes. 
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(B) There are 12 genes positively regulated by HIF-1 under short-term hypoxia also up-regulated 
by DAF-16. The heat map shows the hypoxia induction of these 12 genes in N2 and hif-1 (ia04). 
Figure 4. Overlap of genes identified by microarray and ChIP-seq. 
Figure 5. HIF-1 ChIP peak at the efk-1 promoter region. The peak is 1498 bp before the 
transcription start site. The red track is the signal intensity of the ChIP sample, the green track is 
the signal intensity of the input sample. The gene model track shown is the (-) tires of UCSC 
ensGene track, that is, the transcription direction of genes in the view is from the right to the left. 
From top to bottom, the three transcript isoforms shown for efk-1 are: F42A10.4a.1, F42A10.4b, 
and F42A10.4a.2. The pink bar indicates the coordinate of the HIF-1 binding site 5’-acgtg-3’ 
within the peak region: 6,170,148-6,170,153. 
Table 1 Top 20 genes induced highest in N2 wild-type animals following short-term 
hypoxia 
Gene Name 
Description Hypoxia-
induced fold 
change wild 
type q-value:  
Hypoxia-
induced fold 
change hif-1 q-value 
Fold change: 
hypoxia Δ 
N2/ hif-1 
q-value: 
 
tts-1 
Transcribed 
telomere-like 93.70 2.30E-09 23.24 8.15E-08 4.03 2.60E-02 
dod-3 
downstream of DAF-
16 57.42 2.26E-10 20.34 8.02E-09 2.82 1.65E-02 
F45D11.14 
Uncharacterized 
35.75 1.63E-08 4.87 2.32E-05 7.34 1.33E-03 
comt-4 
Catechol-O-
methyltransferase  33.25 9.24E-11 -1.31 8.35E-02 43.44 6.17E-09 
hsp-16.41 
Heat shock protein 
18.77 1.55E-06 5.80 1.25E-04 3.24 2.22E-01 
hsp-16.11 
Heat shock protein 
13.65 4.82E-05 6.54 6.48E-04 2.09 7.98E-01 
hsp-16.48 
Heat shock protein 
12.86 1.05E-04 8.39 4.09E-04 1.53 9.76E-01 
hsp-16.2 
Heat shock protein 
11.06 1.34E-04 5.06 2.71E-03 2.18 7.87E-01 
F09F7.6 
Uncharacterized 
protein 9.26 1.48E-08 11.88 8.02E-09 -1.28 8.11E-01 
acs-2 
Acyl-CoA synthase 
9.17 1.56E-05 29.56 2.44E-07 -3.22 1.97E-01 
sqrd-1 
Sulfide quinone 
oxidoreductase 8.55 2.30E-09 1.15 2.87E-01 7.43 3.36E-06 
sodh-1 
Alcohol 
dehydrogenase 8.08 2.09E-07 10.52 7.34E-08 -1.30 8.85E-01 
F45D11.2 
DUF684 family 
7.73 5.60E-05 1.32 4.16E-01 5.86 3.49E-02 
phy-2 
Collagen prolyl 4-
hydroxylase 7.44 2.44E-07 -1.10 5.25E-01 8.22 7.38E-05 
cyp-37B1 
Cytochrome P450 
7.15 2.24E-07 7.92 1.28E-07 -1.11 1.00E+00 
mtl-1 
metallothionein 
7.13 3.84E-07 2.80 1.13E-04 2.54 5.08E-02 
dct-1 
BNIP3 family 
6.99 1.08E-07 4.78 6.76E-07 1.46 6.02E-01 
F22H10.2 
Uncharacterized 
protein 6.61 8.57E-06 9.37 1.47E-06 -1.42 8.90E-01 
cnc-4 
Caenacin peptide 
6.36 1.87E-05 19.47 1.98E-07 -3.06 1.24E-01 
C06B3.6 
Uncharacterized 
protein 6.32 5.40E-06 27.03 3.07E-08 -4.28 1.11E-02 
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Table 2 Top 20 genes repressed highest in N2 wild-type animals following short-term 
hypoxia 
Gene Name Description 
Hypoxia-induced 
fold change wild type q-value 
Hypoxia-
induced fold 
change hif-1 q-value 
Fold 
change: 
hypoxia 
Δ 
N2/hif-
1 q-value 
gcsh-1 Glycine Cleavage System H protein -8.58 2.73E-09 -7.38 8.20E-09 -1.16 9.38E-01 
F42A10.7 Uncharacterized protein -7.14 2.36E-08 -6.24 4.33E-08 -1.14 9.75E-01 
hacd-1 Hydroxy-Acyl-CoA dehydrogenase -5.60 4.41E-06 -1.50 9.38E-02 -3.73 1.17E-02 
cpt-4 Carnitine Palmitoyl Transferase -5.25 5.20E-05 -4.55 8.94E-05 -1.15 1.00E+00 
C47A4.2 Equilibrative Nucleoside Transporter -4.97 4.01E-08 -3.77 1.98E-07 -1.32 6.23E-01 
M03B6.1 Uncharacterized protein -4.55 7.13E-06 -4.13 1.08E-05 -1.10 1.00E+00 
T05E7.1 Acyl-CoA thioester hydrolase -4.34 1.01E-04 -6.41 1.03E-05 1.48 8.60E-01 
T22B7.7 Uncharacterized protein -3.90 1.44E-04 -3.09 5.87E-04 -1.26 9.77E-01 
elo-2 Fatty acid elongation -3.81 4.82E-10 -1.75 1.57E-06 -2.18 5.46E-05 
Y48E1B.8 Nucleotide-diphospho-sugar transferase -3.68 8.94E-04 -1.61 1.60E-01 -2.29 4.76E-01 
F31D4.8 Uncharacterized protein -3.64 1.63E-06 -3.27 2.94E-06 -1.11 1.00E+00 
hmit-1.1 Myo-inositol transporter -3.55 1.75E-02 -2.76 5.12E-02 -1.29 1.00E+00 
pgp-1 P-GlycoProtein related -3.52 3.10E-06 -3.67 1.86E-06 1.04 1.00E+00 
F22E5.1 DUF1647 family -3.46 2.67E-05 -2.33 5.60E-04 -1.48 6.91E-01 
odc-1 Ornithine decarboxylase -3.41 4.72E-07 -2.35 1.16E-05 -1.45 3.62E-01 
F08A8.2 Acyl-CoA oxidase -3.36 1.56E-02 -3.03 2.56E-02 -1.11 1.00E+00 
nspe-7 Nematode Specific Peptide family, group E -3.34 1.62E-02 1.43 4.12E-01 -4.77 2.13E-01 
F21C10.9 GNAT domain -3.29 2.66E-04 -2.15 6.83E-03 -1.53 7.82E-01 
nas-27 Astacin-like metalloprotease -3.29 2.56E-02 -3.86 1.28E-02 1.17 1.00E+00 
K01D12.8 Uncharacterized protein -3.26 1.86E-04 -4.65 1.55E-05 1.43 8.45E-01 
 
Table 3 Hypoxia-induced increases in gene expression: greatest differences between wild-
type animals and hif-1-deficient mutants 
Gene 
Name Description 
N2 
hypoxia 
fold 
change 
(hypoxia/ 
normoxia) q-value 
hif-1 hypoxia/ 
normoxia fold 
change q-value 
Relative 
change (N2 
fold 
change/ 
hif-1 fold 
change) q-value 
Consensu
s sites 
(ACGTG
) 
Y40B10A.
6 O-methyltransferase 33.25 9.24E-11 -1.31 8.35E-02 43.44 6.17E-09 4 
phy-2 collagen prolyl 4-hydroxylase 7.44 2.44E-07 -1.10 5.25E-01 8.22 7.38E-05 6 
sqrd-1 Sulfide quinone oxidoreductase 8.55 2.30E-09 1.15 2.87E-01 7.43 3.36E-06 3 
F45D11.2 nematode specific protein 7.73 5.60E-05 1.32 4.16E-01 5.86 3.49E-02 0 
cysl-2 
/K10H10.2 Cysteine synthase 3.28 4.42E-05 -1.43 9.59E-02 4.69 1.47E-03 4 
W05G11.6 
phosphoenolpyruvate 
carboxykinase (PEPCK) 3.10 3.50E-04 -1.41 1.86E-01 4.36 1.03E-02 1 
ZK550.6 
Peroxisomal phytanoyl-CoA 
hydroxylase 4.26 2.95E-08 -1.02 6.40E-01 4.35 2.01E-05 1 
smf-3 divalent cation transporter 4.20 2.08E-07 -1.03 6.28E-01 4.33 7.38E-05 1 
C32H11.4 Unknown 2.55 1.34E-04 -1.59 1.98E-02 4.06 1.40E-03 1 
tts-1 
Transcribed telomere-like 
sequence 93.70 2.30E-09 23.24 8.15E-08 4.03 2.60E-02 0 
gbh-2 
Gamma butyrobetaine 
hydroxylase 3.23 1.36E-06 -1.21 1.83E-01 3.91 1.36E-04 3 
glb-1 Globin 3.07 1.46E-07 -1.19 9.99E-02 3.66 2.24E-05 6 
F22B5.4 Integral membrane protein 3.46 1.67E-05 -1.04 6.28E-01 3.61 3.53E-03 7 
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egl-9 dioxygenase 3.41 1.29E-06 1.04 6.10E-01 3.27 7.05E-04 3 
hsp-12.3 Heat shock protein 2.85 4.99E-05 -1.06 6.03E-01 3.01 8.99E-03 2 
Y37A1B.5 Selenium binding protein 3.04 3.36E-07 1.03 6.10E-01 2.95 1.97E-04 2 
pcp-2 Prolyl carboxy peptidase like 2.19 1.23E-04 -1.34 7.07E-02 2.93 2.62E-03 1 
dod-3 Integral to membrane 57.42 2.26E-10 20.34 8.02E-09 2.82 1.65E-02 1 
ugt-33 UDP-glucuronosyl transferase 2.44 6.24E-06 -1.12 3.48E-01 2.74 7.76E-04 1 
C40H1.2 Unknown 2.18 2.20E-06 -1.22 5.44E-02 2.65 1.13E-04 1 
fmo-2 
Flavin-containing 
monoOxygenase family 2.17 2.67E-05 -1.17 2.26E-01 2.53 1.72E-03 3 
F59F4.1 Acyl-CoA oxidase 2.65 7.90E-05 1.05 6.09E-01 2.52 2.40E-02 3 
Y53G8B.2 2-acylglycerol O-acyltransferase 3.16 1.09E-07 1.29 2.32E-02 2.46 4.75E-04 0 
efk-1 Elongation factor Kinase 3.16 1.07E-05 1.31 1.22E-01 2.40 2.31E-02 5 
K04F10.1 homolog of human SCA1 1.95 1.28E-04 -1.18 2.25E-01 2.30 5.93E-03 2 
ethe-1 Sulfur dioxygenase 3.51 1.70E-09 1.54 2.44E-05 2.27 5.46E-05 2 
mce-1 Methylmalonyl-CoA epimerase 2.32 8.41E-08 1.05 4.69E-01 2.22 7.31E-05 5 
 
Table 4 Genes regulated by hypoxia and differentially expressed in all 4 HIF-1 negative 
regulator mutants 
Gene Molecular function 
Consen
sus 
site(acg
tg) # 
N2 
hypoxia 
fold 
change 
(hypoxia/n
ormoxia) q-value 
hif-1 
hypoxia 
old change 
(hypoxia/n
ormoxia) q-value 
Relative fold 
change (N2 
hypoxia fold 
change/hif-1 
hypoxia fold 
change) q-value 
Regulated by 
HIF-1 
efk-1 
Elongation factor 
Kinase 5 3.16 1.07E-05 1.31 1.22E-01 2.40 2.31E-02 Up-regulated 
egl-9 dioxygenase 3 3.41 1.29E-06 1.04 6.10E-01 3.27 7.05E-04 Up-regulated 
gbh-2 
Gamma 
butyrobetaine 
hydroxylase 3 3.23 1.36E-06 -1.21 1.83E-01 3.91 1.36E-04 Up-regulated 
gst-19 
Glutathione S-
Transferase 1 1.85 2.49E-04 -1.18 2.14E-01 2.19 9.13E-03 Up-regulated 
hsp-12.3 Heat shock protein 2 2.85 4.99E-05 -1.06 6.03E-01 3.01 8.99E-03 Up-regulated 
phy-2 
collagen prolyl 4-
hydroxylase 6 7.44 2.44E-07 -1.10 5.25E-01 8.22 7.38E-05 Up-regulated 
tts-1 
Transcribed 
telomere-like 
sequence 0 93.70 2.30E-09 23.24 8.15E-08 4.03 2.60E-02 Up-regulated 
C32H11.4 
Uncharacterized 
protein 1 2.55 1.34E-04 -1.59 1.98E-02 4.06 1.40E-03 Up-regulated 
ethe-1 
Uncharacterized 
protein 2 3.51 1.70E-09 1.54 2.44E-05 2.27 5.46E-05 Up-regulated 
mce-1 
Methylmalonyl-
CoA epimerase 5 2.32 8.41E-08 1.05 4.69E-01 2.22 7.31E-05 Up-regulated 
sqrd-1 
Sulfide quinone 
oxidoreductase 3 8.55 2.30E-09 1.15 2.87E-01 7.43 3.36E-06 Up-regulated 
F22B5.4 
Uncharacterized 
protein 7 3.46 1.67E-05 -1.04 6.28E-01 3.61 3.53E-03 Up-regulated 
H12D21.7 
Uncharacterized 
protein 3 1.24 1.24E-02 -1.44 2.19E-04 1.79 1.66E-03 Up-regulated 
K10H10.2
/cysl-2 Cysteine synthase 4 3.28 4.42E-05 -1.43 9.59E-02 4.69 1.47E-03 Up-regulated 
Y37A1B.
5 
Uncharacterized 
protein 2 3.04 3.36E-07 1.03 6.10E-01 2.95 1.97E-04 Up-regulated 
ZK550.6 
Peroxisomal 
phytanoyl-CoA 
hydroxylase 1 4.26 2.95E-08 -1.02 6.40E-01 4.35 2.01E-05 Up-regulated 
glb-1 Globin 6 3.07 1.46E-07 -1.19 9.99E-02 3.66 2.24E-05 Up-regulated 
mmcm-1 
Methylmalonyl-
CoA mutase 2 1.69 1.03E-04 -1.03 6.00E-01 1.74 1.45E-02 Up-regulated 
dod-3 
Downstream Of 
DAF-16 (regulated 
by DAF-16) 1 57.42 2.26E-10 20.34 8.02E-09 2.82 1.65E-02 Up-regulated 
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F45D11.1
4 
Uncharacterized 
protein 4 35.75 1.63E-08 4.87 2.32E-05 7.34 1.33E-03 Up-regulated 
R08E5.3/
cysl-3 
Uncharacterized 
protein 6 3.03 5.26E-06 1.43 2.78E-02 2.12 2.96E-02 Up-regulated 
W05G11.
6 
phosphoenolpyruv
ate carboxykinase 
(PEPCK) 1 3.10 3.50E-04 -1.41 1.86E-01 4.36 1.03E-02 Up-regulated 
Y53G8B.
2 
Uncharacterized 
protein 0 3.16 1.09E-07 1.29 2.32E-02 2.46 4.75E-04 Up-regulated 
T28A11.2 
Uncharacterized 
protein 0 -1.28 3.83E-02 1.47 2.60E-03 -1.88 1.28E-02 
Down-
regulated 
acdh-2 
Acyl CoA 
deHydrogenase 1 1.05 5.80E-01 3.22 2.85E-05 -3.08 1.17E-02 
Down-
regulated 
acs-2 
Fatty Acid CoA 
Synthetase family 0 5.29 1.51E-06 16.74 1.29E-08 -3.17 1.07E-02 
Down-
regulated 
 
Table 5 HIF-1 direct targets differentially expressed in egl-9 mutants and in hypoxia  
chrID peakStart peakStop peakSize minP aveLog2Ratio 
Differentially 
expressed in 
egl-9 (sa307) 
Regulated by 
hypoxia in N2 
chrI 9322500 9322699 200 4.68E-03 2.84  C12C8.2 C12C8.2 
chrV 5770700 5771299 600 1.76E-19 4.87  C53A3.2 C53A3.2 
chrV 18152400 18153199 800 6.33E-22 5.52 C14A6.2 C14A6.2 
chrIV 13734000 13734199 200 8.62E-03 3.43 C47A4.2 C47A4.2 
chrIV 1153900 1154099 200 6.82E-03 4.38 C50A2.3 C50A2.3 
chrV 3776600 3776799 200 2.07E-02 2.91 cysl-3/R08E5.2 cysl-3/R08E5.2 
chrIII 11376900 11377099 200 4.38E-07 4.07 dpy-18 dpy-18 
chrIII 6170000 6170299 300 1.02E-10 3.46 efk-1 efk-1 
chrV 2321000 2323499 2500 4.03E-32 5.07 F15E11.15 F15E11.15 
chrII 2676100 2676299 200 1.20E-02 3.67 F22E5.1 F22E5.1 
chrIII 1256000 1256699 700 1.95E-18 4.96 fbxa-91 fbxa-91 
chrI 14157800 14157999 200 2.32E-05 3.95 fipr-22 fipr-22 
chrIV 10686700 10687099 400 2.17E-10 4.61 fmo-2 fmo-2 
chrX 3112400 3112799 400 5.47E-03 3.22 gpd-2 gpd-2 
chrV 3558800 3558999 200 3.30E-12 5.05 grl-30 grl-30 
chrV 9090700 9090899 200 6.68E-03 2.75 hsp-16.11 hsp-16.11 
chrV 1805000 1805299 300 2.30E-08 3.34 hsp-16.2 hsp-16.2 
chrV 9088800 9088999 200 7.92E-03 3.15 hsp-16.48 hsp-16.48 
chrV 12917800 12918099 300 2.10E-04 3.48 lipl-1 lipl-1 
chrX 3112400 3112799 400 5.47E-03 3.22 mai-1 mai-1 
chrIII 3897400 3897699 300 8.14E-06 4.60 mmcm-1 mmcm-1 
chrIII 3897100 3897299 200 4.52E-08 5.13 mmcm-1 mmcm-1 
chrV 3776600 3776799 200 2.07E-02 2.91 R08E5.3 R08E5.3 
chrIV 14218100 14218499 400 6.99E-27 4.97 sqrd-1 sqrd-1 
chrIV 14049000 14049199 200 7.33E-04 3.29 Y37A1B.5 Y37A1B.5 
chrIV 2900300 2900799 500 5.93E-09 4.33 Y54G2A.36 Y54G2A.36 
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Figure 1. Genes responded to hypoxia in HIF-1 dependent way.  
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Figure 2. HIF-1 dependent hypoxia responsive genes affected animals’ development and 
survival.  
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Figure 3. Comparison of short-term hypoxia microarray datasets with other datasets.  
 
 
Figure 4. Overlap of genes identified by microarray and ChIP-seq. 
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Figure 5. HIF-1 ChIP peak at the efk-1 promoter region.  
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CHAPTER 5. GENERAL CONCLUSION 
Summary 
The hypoxia-inducible factor (HIF) has been described as the master regulator of 
transcriptional changes that enable hypoxia adaptation. HIF is conserved and expressed by all 
extant metazoan species analyzed to date (LOENARZ et al. 2011; SEMENZA 2000; SEMENZA 
2012). Mammalian HIF is heterodimeric, consisting of an α subunit and a β subunit, which are 
both bHLH (basic-helix-loop-helix)-PAS (PER/ARNT/SIM) domain proteins (SEMENZA 2012; 
WANG et al. 1995). While HIFβ has multiple bHLH-PAS dimerization partners and is relatively 
abundant, HIFα is short-lived under well-oxygenated conditions. Thus, HIFα is apparently 
dedicated to regulate oxygen-sensitive gene expression (BERRA et al. 2006; KAELIN and 
RATCLIFFE 2008; SEMENZA et al. 1996). The corresponding homologs of HIFα and HIFβ in C. 
elegans are termed as HIF-1 and AHA-1. As in mammals, AHA-1 is abundant and has multiple 
dimerization partners, HIF-1 is stabilized under hypoxia but quickly degraded upon 
reoxygenation. Hence, HIF-1 is responsive to the hypoxia adaptation (EPSTEIN et al. 2001; JIANG 
et al. 2001a; POWELL-COFFMAN 2010; POWELL-COFFMAN et al. 1998). 
In this dissertation, I used C. elegans as a model system to study HIF-1 function and 
regulation. In the first part of my thesis, in collaboration with colleagues in the lab, I studied the 
cross talk between HIF-1 and SKN-1. The SKN-1 transcription factor is a key regulator of 
oxidative stress response in C. elegans (AN and BLACKWELL 2003; INOUE et al. 2005; OLIVEIRA 
et al. 2009a; OLIVEIRA et al. 2009b; TULLET et al. 2008). Major findings in this part are: 1) skn-1 
attenuates HIF-1 protein levels and HIF-1 function. skn-1 RNAi increases HIF-1 protein levels 
and increases the expression of  Pnhr-57:GFP levels, an indicator of HIF-1 activity. 2) There 
are differential requirements for skn-1 and hif-1. skn-1 is required for t-butyl peroxide resistance 
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but not required for hypoxia adaptation. In contrast, hif-1 is required for hypoxia adaptation but 
not required for t-butyl peroxide resistance. 3) SKN-1/NRF promotes egl-9 expression. skn-1 
RNAi decreases egl-9 mRNA levels. Induction of Pegl-9:GFP by heat shock and gsk-3 RNAi 
require skn-1 function and the putative SKN-1 binding site in the egl-9 promoter. Our data 
suggests that under certain conditions SKN-1 positively regulates ELG-9 to inhibit HIF-1 protein 
levels and activity.  
The second part of the thesis is dedicated to understand the phenotypes of 4 known HIF-1 
negative regulator mutants and the consequences of HIF-1 over-activation. Affymetrix 
microarrays were used to measure the whole genome mRNA expression in vhl-1(ok161), 
rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267); vhl-1(ok161) compared to N2 wild-type 
animals.  The major findings in this part are: 1) Gene expression profiles of rhy-1(ok1402), egl-
9(sa307), and swan-1 (ok267); vhl-1(ok161) animals are similar. Genes commonly regulated in 
these 3 mutants have varied roles in cellular metabolism, cell cycle and reproduction, cellular 
signaling, protein homeostasis, defense/immunity, detoxification/stress response, transcription and 
translation, and transport. The fact that genes misregulated in rhy-1(ok1402), egl-9(sa307), and 
swan-1 (ok267); vhl-1(ok161) have roles in reproduction or early embryogenesis correlates with 
the observation that HIF-1 over-activation decreases fecundity, as assayed by viable progeny 
produced by rhy-1 and egl-9 loss-of-function mutants or swan-1; vhl-1 double mutants (SHAO et 
al. 2010; SHEN et al. 2006). 2) HIF-1 pathway and pathogen immune response pathways co-
regulate many genes. Genes up-regulated in egl-9(sa307), and swan-1 (ok267);vhl-1(ok161) 
overlap with genes up-regulated by PMK-1 and SEK-1. The NSY-1/SEK-1/PMK-1 cascade is 
critical in responding to P. aeruginosa PA14 slow killing (KIM et al. 2002; TROEMEL et al. 2006). 
Additionally, genes up-regulated in egl-9 mutatants or swan-1; vhl-1 double mutants overlap with 
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genes up-regulated by the infection of pore-forming toxin Cry5B. Further, genes up-regulated in 
egl-9(sa307) also overlap with genes up-regulated by the infection of Y. pestis. 3) HIF-1 and DAF-
16 function synergistically to protect animals from hypoxia insult. About 90% of hif-1 loss-of-
function mutants fail to achieve adulthood after hypoxia treatment, and about 60-70% daf-16 loss-
of-function mutants fail to achieve adulthood after hypoxia treatment. Knocking out both hif-1and 
daf-16 caused even more severe phenotype, as less than 1% eggs achieve adulthood after hypoxia 
treatment. Genes over-expressed in rhy-1(ok1402), egl-9(sa307), and swan-1 (ok267);vhl-1(ok161) 
overlap with genes up-regulated by DAF-16 (MURPHY et al. 2003). Intriguingly, daf-18 mRNA 
was up-regulated in the rhy-1, egl-9, and swan-1 vhl-1 mutants, and DAF-18 is the positive 
regulator of DAF-16 (OGG and RUVKUN 1998).  
The third part of the thesis combines microarray analyses and ChIP-seq to understand 
HIF-1 function. The microarray study in this part focuses on HIF-1-dependent gene expression 
changes under short-term hypoxia (2 hours, 0.5% oxygen). ChIP-seq is aimed to identify HIF-1 
direct targets. The main findings in this part are: 1) We identify genes that respond to short-term 
hypoxia in N2.  2) Further, we identify the subset of genes that exhibit HIF-1-dependent 
responses to the hypoxia treatment. 3) Genes regulated by HIF-1 overlap with genes regulated by 
H2S. 4) Genes regulated by hypoxia overlap with genes regulated by DAF-16. 5) We identify 
potential HIF-1 direct targets using ChIP-seq. And potential HIF-1 direct targets are enriched in 
the differentially expressed gene lists identified by microarray in response to hypoxia treatment 
and constitutive HIF-1 high activation in egl-9 mutants. 
General Discussion 
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Hypoxia resistance and survival 
While our research group has studied the impacts of short-term moderate hypoxia, other 
groups, i.e. Crowder, Padilla and Roth group, have investigated the mechanisms by which C. 
elegans can resist more severe hypoxic insult. Most of work from Crowder group are focusing on 
high-temperature hypoxia. They usually treated the animals with 0.3% oxygen at 26.5°C or 
28°C. They found that the activation of UPR and the inhibition of translation protect C. elegans 
from high temperature hypoxia stress (ANDERSON et al. 2009; MAO and CROWDER 2010), this 
correlates with our finding that the mRNA levels of some of the UPR components (xbp-1, pek-1) 
and translation regulators (efk-1) were up-regulated by hypoxia (Chapter 4). Crowder group also 
shows that daf-2 mutants are resistant to high temperature hypoxia stress and daf-16 mutants are 
sensitive to high temperature hypoxia stress (MABON et al. 2009; SCOTT et al. 2002). These 
results are related with our data that DAF-16 has a role in hypoxia survival (Chapter 3). 
Most of the hypoxia treatment by Padilla and Roth are long-term anoxia (<0.001% 
oxygen, more than 24 hours). They found that C. elegans can survive 24 hours of anoxia by 
entering into a suspended animation without any observable cellular activities including cell 
division and development process. The mechanism for anoxia survival is different from that for 
hypoxia survival, as hif-1 deficient animals can survival anoxia. Suspended animation requires 
spindle check and cell-cycle check (HAJERI et al. 2005; NYSTUL et al. 2003; PADILLA et al. 
2002). They found that daf-2 mutants can survival more than 3 days anoxia treatment, which 
requires the functions of daf-16 and two nearly identical homolog gpd-2 and gpd-3 
(MENDENHALL et al. 2006). Interestingly, in our analyses, gpd-2 was up-regulated by hypoxia in 
a HIF-1-dependent manner. They also found that mutants with reduced progeny survive long-
term anoxia better, and this is independent upon hif-1and daf-16 (MENDENHALL et al. 2009). 
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Gene expression profiles in response to 2 hours and 4 hours of hypoxia  
In the study presented here, when we exposed L4-stage worms to 0.5% O2 for 2 hours, 
the mRNA abundance of 687 genes was changed. In our previous study, Shen et al. treated L3-
stage worms with 0.1% oxygen for 4 hours and identified 490 hypoxia responsive genes (SHEN 
et al. 2005a). There are couple of differences between the experimental details of these two 
studies: the stages of worms, the oxygen concentration and the duration of the hypoxia treatment, 
and the microarray platforms used. In this study, L4-stage worms were treated with 0.5% oxygen 
for 2 hours, and Affymetrix GeneChip® C. elegans Genome arrays were used to measure gene 
expression changes. Whereas Shen et al. exposed L3-stage worms to 0.1% oxygen for 4 hours, 
and two-color microarrays were used for the assay (JIANG et al. 2001b; SHEN et al. 2005a). Apart 
from these differences, we found 50 genes commonly regulated by hypoxia treatment in these 
two datasets. And this overlap is greater than expected by chance (p-value = 2.458E-10).  
In addition, Shen et al. identify 62 HIF-1-dependent hypoxia-responsive genes in L3-
stage worms after 4 hours 0.1% oxygen treatment. In this study, we identify 145 HIF-1- 
dependent hypoxia-responsive genes in L4-stage worms after 2 hours 0.5% oxygen treatment, 76 
of them are positively regulated by HIF-1, and 69 of them are negatively regulated by HIF-1. We 
find that 9 genes are positively regulated by HIF-1 under both hypoxia treatment conditions and 
in both L3 and L4 stages, indicating they are important for hypoxia survival. Thus, some 
common mechanisms are used under both oxygen conditions and development conditions. Both 
datasets identified that under hypoxia, HIF-1 regulated genes are involved in metabolism, 
signaling, stress response and extracellular matrix remodeling. Besides the common genes 
identified, new genes are identified as HIF-1-dependent hypoxia-responsive genes in this study. 
For example, 20 genes involved in lipid metabolism are newly identified, including genes 
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involved in mitochondrial fatty acid β oxidation, peroxisomal fatty acid α and β oxidation, and 
lipid synthesis, including elo-5 and fat-5. This is consistent with what have been shown that HIF-
1 regulates the mRNA levels of the de novo fatty-acid synthesis genes elo-5 and fat-5 in the 
AMPK compromised C. elegans dauer (XIE and ROY 2012).  
To get a closer comparison for these two data sets. We check whether the top 20 hypoxia-
induced genes from Shen et al. are also induced in our current data set (See Table 1). One of 
these 20 genes is not included on the Affyetrix microarrays. Among the rest of 19 genes, 10 
genes are induced by 2 hours hypoxia, 7 are induced by both 2 hours hypoxia treatment and 
induced in all of the HIF-1 negative regulator mutants, 2 genes are not induced by 2 hours 
hypoxia treatment but induced in at least one of the HIF-1 negative regulator mutants, 5 genes 
are not affected by 2 hours hypoxia and mutations in the HIF-1 negative regulator mutants, 2 
genes are not induced by 2 hours hypoxia treatment but repressed in one or two the HIF-1 
negative regulator mutants. 
To date, mutations that cause the most severe hypoxia sensitive phenotypes are hif-1, daf-
16, phy-2, and efk-1. Shen et al. tested 16 genes for hypoxia survival. In this study, we tested 31 
genes for hypoxia survival. Both studies showed that relatively few genes regulated by HIF-1 
have critical roles for survival in moderate hypoxia. This suggests a model in which HIF-1 
regulates many genes, and while no one of them is absolutely essential for survival in 0.5% 
oxygen, many have individual, incremental effects, and their collective impact is great.  
The complexity of the cross talk between HIF-1 and SKN-1 in C. elegans 
HIF-1 is the master regulator of hypoxia response, while SKN-1 is the key regulator for 
oxidative stress (AN and BLACKWELL 2003; EPSTEIN et al. 2001; INOUE et al. 2005; JIANG et al. 
2001a; OLIVEIRA et al. 2009a; POWELL-COFFMAN 2010; SHEN et al. 2005a; TULLET et al. 2008). 
125 
 
 
It’s intriguing that skn-1 is identified as a HIF-1 negative regulator from the RNAi screening: 
skn-1 RNAi increases the expression of HIF-1 functional reporter Pnhr-57:GFP. Protein blot 
assays confirm that skn-1 RNAi increased Pnhr-57:GFP protein levels in room air and hypoxia. 
Additionally, skn-1 RNAi increases HIF-1 protein levels up to 2-3.5-fold. The question naturally 
arises as to how skn-1 affects HIF-1 protein levels and activity. We proposed that skn-1 regulates 
egl-9 to inhibit HIF-1 abundance and function. Our initial hypothesis is based on two rationales. 
One is that in silico analysis showed that there is a putative SKN-1 binding site in the egl-9 
promoter region. The other is that egl-9 is an important negative regulator for HIF-1; it affects 
both HIF-1 stability and activity(SHAO et al. 2009). Our experimental data support the 
hypothesis. We demonstrate that skn-1 RNAi increases egl-9 mRNA levels. Also, the expression 
of Pegl-9:GFP can be induced by conditions that activate SKN-1, such as heat shock and gsk-3 
RNAi. Further, the induction of Pegl-9:GFP requires skn-1 function and the putative SKN-1 
binding site in the egl-9 promoter.  
It makes considerable physiological sense that oxidative stress pathway somehow inhibits 
hypoxia pathway, thus enabling the cell to concentrate its energy to deal with the major stress the 
organism is facing. Our data also show that skn-1 function is required for the survival of 
oxidative stress, but not for the survival of hypoxia. In contrast, hif-1 mutants are resistant to 
t-butyl peroxide oxidative stress but sensitive to hypoxia treatment. Our finding was in parallel 
with observations from mammals: upon reperfusion and re-oxygenation of the tissue, HIF-1α is 
degraded quickly and Nrf2 is up-regulated to limit the oxidative damage (KIM et al. 2007; 
LEONARD et al. 2006). In addition, it has been shown that while continuous hypoxia induces only 
HIF-1α, intermittent hypoxia induces both HIF-1α and Nrf2 (MALEC et al. 2010). Nrf2 is 
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homologous to SKN-1 in human, it activates phase II detoxification genes to mitigate the effects 
of the oxidative insults.  
Thus far, our data support the notion that SKN-1 and HIF-1 are required in different 
conditions, and SKN-1 regulates egl-9 to inhibit HIF. This idea is also supported by the fact that 
genes regulated by HIF and SKN-1 are largely non-overlapping. However, the relationship 
between SKN-1 and HIF-1 is not as simple as this. For example, as one of the few common 
genes regulated by SKN-1 and HIF-1, the mRNA levels of cysl-2 are dependent on both SKN-1 
and HIF-1, no matter in room air or in hypoxia. So, the relationship between SKN-1 and HIF-1 is 
context dependent. 
Even further, when we queried the skn-1 mRNA expression in our microarray data 
presented in chapter 3 and 4, we found that skn-1 mRNA levels are up-regulated in all known 4 
HIF-1 negative regulator mutants, although not up-regulated by short term hypoxia (see the 
following Table 1). Under normal conditions, SKN-1:GFP is just expressed in two ASI neuron 
nuclei; and under oxidative stress, SKN-1:GFP is also induced to express in the intestine nuclei 
(AN and BLACKWELL 2003). We speculate that maybe 2 hours hypoxia treatment is not intense 
enough to induce skn-1 expression in more tissues, thus difference is high enough to be detected. 
And maybe, in the HIF-1 negative regulator mutants, skn-1 is activated multiple places, so it 
becomes detectable. This may be similar to the situation of Pnhr-57:GFP, the HIF-1 function 
indicator. It is not visible under normal conditions, but strongly expressed in the intestine in the 
vhl-1 mutants, and expressed even stronger and in more tissues in rhy-1 and egl-9 mutants (SHEN 
et al. 2006). Thus, the regulation between HIF-1 and SKN-1 may be bi-directional, rather than 
single-directional. And in the future, it will be important to validate the skn-1 mRNA expression 
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using qRT-PCR in the HIF-1 negative regulator mutants. Also, it will be interesting to test the 
expression of SKN-1:GFP in HIF-1 negative regulator mutants. 
The cross talk between HIF-1 and DAF-16 in C. elegans 
DAF-2 tyrosine kinase is the C. elegans insulin/insulin-like growth factor receptor, it 
dramatically affects C. elegans longevity and stress resistance. Most of the effects of DAF-2 
requires downstream transcription factor DAF-16. DAF-16 is a FOXO/forkhead transcription 
factor. Phosphorylation of DAF-16 by DAF-2/AGE-1(PI3K)/AKT-1, 2 kinases cascade prevents 
its entry into the nucleus (KENYON 2005; KENYON et al. 1993; LIN et al. 2001; OGG et al. 1997). 
It has been speculated that there is a cross talk between HIF-1 and DAF-2/DAF-16 pathway. For 
example, McElwee et al. showed that genes regulated by daf-2 as assayed by Affymetrix 
microarrays were enriched for the predicted HIF-1 binding sites (MCELWEE et al. 2004). 
Furthermore, it’s noticeable that both HIF-1 and DAF-2/DAF-16 pathways have been shown to 
have roles in regulating  longevity, reproduction, lipid metabolism, dauer formation, pathogen  
and stress resistance, including the hypoxia resistance (BELLIER et al. 2009; BUDDE and ROTH 
2010; BUDDE and ROTH 2011; CHEN et al. 2009; DARBY et al. 1999; GALLAGHER and MANOIL 
2001; GEMS et al. 1998; JENSEN et al. 2010; KENYON et al. 1993; KIMURA et al. 1997; LARSEN et 
al. 1995; LEISER et al. 2011; MEHTA et al. 2009; MULLER et al. 2009; SCOTT et al. 2002; SHEN et 
al. 2005b; TREININ et al. 2003; TROEMEL et al. 2006; ZHANG et al. 2009). Recently, it has been 
shown that life-span extension caused by hypoxia requires both HIF-1 and DAF-16 and is 
antagonized by SKN-1(LEISER et al. 2013). However, it is not very clear how HIF-1 and DAF-
2/DAF-16 connect to each other under certain conditions.  
Our findings shed some light on the relationship between HIF-1 and the DAF-2/DAF-16 
pathway. First, the overlap between genes regulated by HIF-1 and genes regulated by DAF-16 
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substantiated the notion that there is a connection between HIF-1 and DAF-2/DAF-16 pathway. 
Genes up-regulated by DAF-16 overlap with genes up-regulated in rhy-1, egl-9, and swan-1 
(ok267);vhl-1(ok161) mutants (Chapter 3), and overlap with genes up-regulated by 2 hours short-
term hypoxia, also overlap with genes positively-regulated by HIF-1 under short-term hypoxia 
(Chapter 4). Second, functional analysis showed that daf-16 has a role in hypoxia development 
and survival. Up to 70% of daf-16 loss-of-function mutant worms fail to achieve adulthood after 
hypoxia treatment. About 90% of hif-1 loss-of-function mutants fail to achieve adulthood after 
hypoxia treatment, consistent with prior findings (PADILLA et al. 2002). When both hif-1and daf-
16 are knocked out, more than 99% eggs fail to achieve adulthood after hypoxia treatment. 
Third, the fact that daf-18 mRNA levels are up-regulated in rhy-1, egl-9, and swan-1 
(ok267);vhl-1(ok161) mutants compared to N2 suggests a mechanism for the relationship 
between HIF-1 and DAF-2/DAF-16. That is, in these mutants, HIF-1 may promote DAF-16 
through DAF-18. DAF-18 is lipid phosphatase, homologous to the human PTEN tumor 
suppressor. It dephosphorylates AGE-1-generated PIP3 to limit the activation of AKT-1 and 
AKT-2 kinases, thus positively regulates DAF-16 (DORMAN et al. 1995; LIN et al. 2001; OGG 
and RUVKUN 1998). In the future, it is important to validate the daf-18 mRNA expression using 
qRT-PCR.  
The discovery that DAF-16 target genes are expressed at increased levels in egl-9, rhy-1, 
and vhl-1; swan-1 mutants presents new important questions. Do the HIF-1 and DAF-16 
pathways converges at these promoters, acting in parallel (additive effect) to regulate genes such 
as mtl-1, sodh-1, sqrd-1 et al.? If HIF-1 and DAF-16 act on individual enhancers, do they exhibit 
cooperative binding (synergistic effect)? Alternatively, do HIF-1 and DAF-16 act in a single 
pathway, in which HIF-1 promotes daf-18 expression, thereby acting DAF-16: HIF-1→DAF-
129 
 
 
18→DAF-16→ DAF-16 targets? To distinguish these possibilities, in the future we can use qRT-
PCR to compare the mRNA levels of certain DAF-16 targets in egl-9;daf-16 double mutants, in 
egl-9;hif-1 double mutants and in egl-9;daf-16;hif-1 triple mutants. If the mRNA levels of DAF-
16 targets in the triple mutants are similar to that in egl-9;daf-16 double mutants, then it supports 
that HIF-1 and DAF-16 act in a single pathway. If the decrease of the mRNA levels of DAF-16 
targets in the triple mutants is equal to that the sum of the decrease in egl-9;daf-16 double 
mutants and in egl-9;hif-1 double mutants, then it supports that HIF-1 and DAF-16 act additively 
to regulate DAF-16 targets. If the decrease of the mRNA levels of DAF-16 targets in the triple 
mutants are greater than the sum of the decrease in egl-9;daf-16 double mutants and in egl-9;hif-
1 double mutants, then it supports that HIF-1 and DAF-16 act synergestically to regulate DAF-
16 targets. 
At the end, it needs to be recognized that the relationship between HIF-1 and DAF-
2/DAF-16 is complex and context dependent. Although when HIF-1 is constitutively over-
activated in rhy-1, egl-9, swan-1; vhl-1 mutants background, HIF-1 may up-regulate DAF-16 
activity through daf-18, it also has been shown that hif-1 RNAi promotes DAF-16 nuclear 
relocalization (LEISER et al. 2011). Further, despite daf-18 mRNA is up-regulated in rhy-1, egl-9, 
swan-1; vhl-1 mutants, it is not up-regulated in vhl-1(ok161). It has been shown that vhl-1 RNAi 
has no significant effect on the DAF-16 nuclear translocation (MEHTA et al. 2009; MULLER et al. 
2009). It will be insightful to further check whether DAF-16 nuclear translocation is promoted in 
rhy-1, egl-9, swan-1; vhl-1 mutants. 
Understanding why HIF-1 has multiple functions in C. elegans 
It has been shown that besides the hypoxia response, HIF-1 is also involved in other 
diverse biological processes, such as heat acclimation, H2S and HCN response, P. aeruginosa 
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PAO1 and bacterial pore-forming toxins (PFT) immunity, and lifespan regulation (BELLIER et al. 
2009; BUDDE and ROTH 2010; BUDDE and ROTH 2011; CHEN et al. 2009; LEISER et al. 2011; 
MEHTA et al. 2009; SHAO et al. 2010; TREININ et al. 2003; ZHANG et al. 2009). However, it is 
not clear how HIF-1 can be a Jack of all trades. Our data presented in this dissertation suggest 
models that can be tested.  
First, genes regulated by HIF-1 are involved in multiple cellular processes. For example, 
constitutively over-activation of HIF-1 in rhy-1, egl-9, swan-1; vhl-1 mutants affects 
metabolism, cellular signaling, extracellular matrix, defense/immunity, detoxification/stress 
response, protein homeostasis, transcription and translation regulation, transport, cell cycle and 
reproduction. And genes regulated by short-term hypoxia in a HIF-1 dependent manner have 
roles in metabolism, stress response, signaling and transcriptional regulation, protein 
homeostasis, and transport. 
Second, convergence of HIF pathway and pathogen immune response pathways helps 
understand why HIF-1 have function in pathogen resistance. HIF-1 is required for C. elegans to 
resist the Pseudomonas aeruginosa PAO1 fast killing pore-forming toxins Cry5B and VCC 
(BELLIER et al. 2009; BUDDE and ROTH 2011; DARBY et al. 1999; GALLAGHER and MANOIL 
2001; SHAO et al. 2010). In our analyses, we find that genes up-regulated in egl-9(sa307), and 
swan-1 (ok267);vhl-1(ok161) overlap with genes up-regulated by PMK-1 and SEK-1. The NSY-
1/SEK-1/PMK-1 cascade is critical in responding to P. aeruginosa PA14 slow killing (KIM et al. 
2002; TROEMEL et al. 2006). Additionally, genes up-regulated in egl-9(sa307), and swan-1 
(ok267);vhl-1(ok161) overlap with genes up-regulated by pore-forming toxin Cry5B. Further, 
Genes up-regulated in egl-9(sa307) also overlap with genes up-regulated by Y. pestis. These 
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overlapped genes have been implicated in immunity response, such as lysozymes, C-type lectins, 
ShK-like toxins, pepidase and CUB domain genes (BOLZ et al. 2010; TROEMEL et al. 2006).  
Third, convergence of HIF pathway and H2S response pathways suggests HIF-1 has 
function in H2S resistance. Survival to high concentration of H2S (250ppm or higher) requires 
hif-1, sqrd-1, ethe-1, cysl-1 and cysl-2 (BUDDE and ROTH 2010; BUDDE and ROTH 2011). H2S 
exposure induces HIF-1 as assayed by western blot. qRT-PCR assays show that H2S induction of 
sqrd-1 and cysl-2 mRNA requires HIF-1 (BUDDE and ROTH 2010; BUDDE and ROTH 2011; MA 
et al. 2012; MILLER et al. 2011). In our analyses, we find that genes respond to H2S (MILLER et 
al. 2011) overlap with genes regulated by hypoxia. The overlapped genes include phase II 
detoxification genes (gst-19, hsp-16.2, hsp-16.41, hsp-16.48), and genes required for H2S 
survival (F02H6.5/sqrd-1, C33A12.7/ethe-1, K10H10.2/cysl-2) (BUDDE and ROTH 2011). The 
mRNA levels of gst-19, F02H6.5/sqrd-1, C33A12.7/ethe-1, K10H10.2/cysl-2 are also HIF-1 
dependent under short-term hypoxia. Collectively, these findings suggest hypoxia pathway 
components are involved in H2S response.  
The limitations of the ChIP-seq analysis in this dissertation 
In this study, we used combinatorial approach to identify HIF-1 direct targets. Genes are 
identified as high confidence HIF-1 direct targets by incorporating the whole genome 
transcriptome analyses with ChIP-seq. This combinatory approach is more informative than any 
one approach alone. Microarray data can tell us which mRNA levels are responsive to hypoxia 
treatment and dependent upon the hif-1 genotype, but it cannot tell us which genes are directly 
bound by HIF-1. On the contrary, ChIP-seq can tell us where HIF-1 is binding, but cannot tell us 
whether this binding is functional. When we combine gene expression analyses with ChIP-seq, 
we can identify HIF-1 direct targets with high confidence.  
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In this study, we use ChIP-seq to identify HIF-1 direct targets. Our reads are single-ended 
and 50 bp long, and during the library preparation, the inserts are about 80-180 bp. To analyze 
this kind of single-ended data, the current methods assume that the lengths of the inserts are 
uniform (usually treated as 200 bp fragments) and the transcription factor sits in the middle of 
the inserts. Thus, to find the peaks where the transcription factors bind, the mapped reads were 
either extended to 3’ direction for 200 bp or shifted to the 3’ direction for 100 bp. And to be a 
peak, it must have about equal number of reads from both (+) and (-) strands. In reality, this is 
achieved by setting the size of the peak, if the peaks is smaller than certain size, say 100 bp, it 
will be treated as a singleton, not a peak (PARK 2009; PEPKE et al. 2009). This process helps 
smoothing the single-ended ChIP-seq data, especially when the reads are very short. However, 
this also causes problems. For example, I observed that for a possible peak within nhr-57, the 
HIF-1 activity indicator, the numbers of the raw reads from (+) and (-) strands are about equal, 
however, the expansion between these raw (+) and (-) strands are about 98 bp, less than 100 bp. 
After shifting, the expansion is even narrower, thus, although nhr-57 may be a true HIF-1 direct 
target, it will be treated as a singleton and excluded from the peak list in our current analysis. In 
the future, if we use paired-end reads, we then will not need to extend or shift the mapping, and 
the result will be more approach to the truth. 
In this study, to do chromatin IP, we ectopically expressed a HIF-1 transgene in egl-9; 
hif-1 double mutants. This HIF-1 transgene corresponds to one HIF-1 isoforms. There are 5 
isoforms of HIF-1 based on wormbase (HARRIS et al. 2010). Although because of its oxygen-
dependent degradation, we have to perform chromatin IP in a HIF-1-stabilizing mutant 
background, we can use endogenous HIF-1 for IP, if we can generate antibody recognizing all of 
133 
 
 
the five isoforms of HIF-1. In this way, we can have more complete information for HIF-1 in 
vivo binding.  
In addition, we can incorporate biological replicates to account for the variability. In this 
study, initially we had three biological replicates. One replicate was excluded from analysis, 
because the quality of reads was low. The other replicate was also excluded because the 
background was high (the background was 0.96, estimated by NCIS (LIANG and KELES 2012)), 
due to the gentle wash. We kept the replicate with stringent wash (the background was 0.92, 
estimated by NCIS) for the analyses by modeling the ChIP counts as a mixture of background 
and signal using mosaics (KUAN et al. 2011). Our data fits the mosaics two-sample analysis/two-
signal-component model well (Figure 1). Still, if we have biological replicates, then we can 
identify consistent signals from the background, and the analysis will be more robust. 
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Figure Legends 
Figure 1. Fitting ChIP-seq data with MOSAICS mixture models.  
 
 Table 1 Induction status of the top 20 hypoxia induced genes from Shen et al. 2005 
    Data from this thesis 
Gene 
Shen 
et al. 
foldΔ 
in N2 
Induced by 
2hr 
hypoxia* 
Induced in 
vhl-1 
(ok161)* 
Induced in 
rhy-1 
(ok1402)* 
Induced in 
egl-9 
(sa307)* 
Induced in swan-
1(ok267);vhl-1 
(ok161)* 
fmo-2 6.31 Yes Yes No Yes Yes 
oac-54/W07A12.6 6.14 No Yes Yes Yes Yes 
F22B5.4 6.02 Yes Yes Yes Yes Yes 
rhy-1/W07A12.7 5.58 No Yes Yes Yes Yes 
phy-2 4.85 Yes Yes Yes Yes Yes 
Y44A6C.1 4.59 Yes Yes No No Yes 
efk-1 4.21 Yes Yes Yes Yes Yes 
nhr-57 4.09 Yes Yes Yes Yes Yes 
F59B10.4 3.89 Yes Yes No Yes Yes 
egl-9 3.7 Yes Yes Yes Yes Yes 
F45D11.16 3.42 Not included on Affymetrix arrays 
dod-3/C24B9.9 3.24 Yes Yes Yes Yes Yes 
dpf-6 3.18 No No No No No 
W04E12.4 3.17 No No No Repressed No 
clec-245/C31G12.2 3.16 No No No No No 
Y38E10A.23 3.12 No No No No No 
R10D12.1 3.11 No No No Repressed Repressed 
K10H10.2 3.07 Yes Yes Yes Yes Yes 
npp-6 3.05 No No No No No 
hecd-1/C34D4.14 3.04 No No No No No 
   *Fold change ≥ 1.60, q-value ≤ 0.05. 
Table 2 skn-1 mRNA levels in the microarray data 
 Fold change q-value 
N2 hypoxia/N2 1.20 0.33 
hif-1 hypoxia/hif-1 1.39 0.11 
Relative hypoxia induction 
(N2/hif-1) 
-1.17 0.99 
vhl-1 vs. N2 2.07 0.0018 
rhy-1 vs. N2 1.61 0.023 
egl-9 vs. N2 1.60 0.014 
vhl-1;swan-1 vs. N2 2.30 0.00038 
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Figur1. Fitting ChIP-seq data with mosaics mixture models. 
 
